Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,rRNA binding (GO:0019843),0.7932706029542936,2.066464412739,0.0,0.0,0.0,17/42,7.76%,RPL23;RPS3;RPS9;RPL11;RPS14;RPS5;RPL5;RPS13;RPLP0;RPL12;CAVIN1;ANG;DDX28;EMG1;SBDS;MRPS11;MRPL11
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.7638782139157398,2.0617526659058316,0.0,0.0,0.0,39/57,15.41%,COX4I1;UQCR11;UQCR10;NDUFA2;COX6B1;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA4L2;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A
prerank,MHC protein binding (GO:0042287),0.8556200361880651,1.9962277587169062,0.0,0.0,0.0,8/20,6.06%,CD74;TUBB;CD81;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.5247178023958551,-1.987322615576119,0.0,0.19329511178651193,0.099,21/44,15.66%,NSD1;KMT2C;SETD5;ASH1L;SETD2;SMYD3;EHMT1;KMT2A;KMT5C;KMT5B;ASH2L;NSD3;SETDB1;KMT2D;WDR82;SETD7;EHMT2;EZH2;SETD4;PRDM9;SETD1B
prerank,nucleotidyltransferase activity (GO:0016779),-0.6479585780577327,-1.9702981113664872,0.0,0.11765789413092032,0.115,13/19,20.66%,REV1;NUDT5;TENT4B;CRPPA;TUT7;PAPSS2;TERT;PAPSS1;TUT1;CGAS;TUT4;TENT2;YRDC
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.7729752601867568,1.9410472267531815,0.0,0.0011785121284378472,0.007,28/34,18.07%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.7729752601867568,1.9410472267531815,0.0,0.0011785121284378472,0.007,28/34,18.07%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,proton transmembrane transporter activity (GO:0015078),0.7384332283341118,1.9380342598650377,0.0,0.00112239250327414,0.008,16/39,10.32%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;ATP6V1F;COX6A1;COX7A2L;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLC33A1;MFSD3
prerank,histone demethylase activity (GO:0032452),-0.5771323849505371,-1.9173074125373952,0.0,0.1451114027614684,0.205,12/27,14.04%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;JARID2;KDM3A;FBXL19;KDM5C;KDM4C;PHF8;KDM4D
prerank,I-SMAD binding (GO:0070411),-0.7198712933874734,-1.9108976425597537,0.0037593984962406013,0.11597706707190718,0.217,11/13,13.79%,SMAD3;SMAD6;AXIN1;SMAD9;TGFBR1;SMURF1;SMAD1;SMAD7;SMAD4;TGFB1I1;SMAD2
prerank,mRNA 5'-UTR binding (GO:0048027),0.7869475178091995,1.9027851390458759,0.0011904761904761906,0.0019241014341842403,0.016,6/24,0.56%,RPL41;RPL26;RPS14;RPS7;RPL5;RPS13
prerank,cytochrome-c oxidase activity (GO:0004129),0.8512859282054369,1.877270555741066,0.0,0.002525383132366816,0.024,8/15,4.90%,COX4I1;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;NDUFA4L2
prerank,amyloid-beta binding (GO:0001540),0.6730833800367164,1.8758866251361677,0.0,0.0022447850065482806,0.024,40/79,18.26%,APOE;CST3;CD74;CLU;PFDN5;ITM2A;C1QA;ITM2C;ITM2B;PGRMC1;NLGN1;PRNP;ITGB2;TREM2;CRYAB;GRIA2;PFDN6;SORL1;GRIN1;CACNA1A;LRPAP1;ATP1A3;GSAP;GRIA4;GRIN2A;APBB1;RAMP3;GRIA1;MSR1;LILRB3;LILRB1;VBP1;TLR6;PFDN1;MAPK8IP2;ACHE;BACE1;CLSTN1;APBA2;GRIN2B
prerank,MHC class II protein complex binding (GO:0023026),0.8931427453982468,1.8740431388231997,0.0,0.002104485943639013,0.025,7/11,5.43%,HSPA8;CD74;CD81;HSP90AA1;HSP90AB1;PKM;YWHAE
prerank,MHC class I protein binding (GO:0042288),0.8554858326455508,1.872561881664758,0.0,0.0020662225628455765,0.026,6/13,6.06%,TUBB;ATP5F1B;TUBB4B;ATP5F1A;TAPBP;TAP2
prerank,tau-protein kinase activity (GO:0050321),-0.605431548460892,-1.8443751177749765,0.0,0.1801846607262094,0.383,9/20,14.72%,ROCK2;ROCK1;SIK3;MARK1;DYRK1A;MARK3;GSK3B;MARK2;TAOK1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.7412737044023765,-1.843963901261352,0.003278688524590164,0.1509942974680144,0.385,7/10,18.12%,NSD1;SETD5;ASH1L;SETD2;NSD3;PRDM9;SETD3
prerank,R-SMAD binding (GO:0070412),-0.6257852137738069,-1.8369640732861527,0.0,0.13734758253650292,0.399,8/18,13.79%,LDLRAD4;SMAD3;SMAD6;SMURF1;PMEPA1;DROSHA;SMAD4;SMAD2
prerank,active ion transmembrane transporter activity (GO:0022853),0.7051809316773446,1.8216702286276518,0.0011641443538998836,0.008908990494738488,0.098,15/37,9.48%,COX4I1;UQCR11;UQCR10;COX6B1;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L;SLCO1C1;UQCRH;UQCRQ;NDUFA4L2;UQCRC1;SLCO4C1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.5057534074140162,-1.8125242058002422,0.0,0.1485430913402869,0.458,11/38,11.62%,SORBS1;GAB2;LRRK2;FRS2;IRS1;AXIN1;DLG5;SPAG9;MMS19;NCK1;SAV1
prerank,glutamate receptor activity (GO:0008066),0.7749705181987281,1.804010966182057,0.0,0.012303148593581921,0.148,11/19,11.81%,GRM5;GRIA2;GRID2;GRIK5;GRIK2;GRM8;GRM7;GRIA4;GRID1;GRM1;GRIA1
prerank,lipoprotein particle receptor binding (GO:0070325),0.7290255736020723,1.7935116114215242,0.0,0.014250376246927031,0.183,10/27,11.32%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.7583060929268077,1.7919056717089792,0.0,0.013693188539944511,0.189,10/22,11.32%,APOE;CLU;SNX17;HSP90B1;AP2M1;SYT1;LRPAP1;CLTC;APBB1;DNAJA1
prerank,ligand-gated ion channel activity (GO:0015276),0.7211774851965099,1.7748018419037725,0.0,0.01757245762938576,0.242,19/30,22.36%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;CNGA3;GRIA4;GRIN2A;GRID1;GRIA1;CHRNA4;CNGB1;GRIN2B;ANXA6;GRIA3;GRIK1;CHRNA3
prerank,ligand-gated channel activity (GO:0022834),0.724324357613666,1.772533879235194,0.0,0.017430095344963117,0.253,19/29,22.36%,GABRB1;GRIA2;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;CNGA3;GRIA4;GRIN2A;GRID1;GRIA1;CHRNA4;CNGB1;GRIN2B;ANXA6;GRIA3;GRIK1;CHRNA3
prerank,SUMO transferase activity (GO:0019789),-0.6152368431544353,-1.7694850828694733,0.0,0.19422890459707481,0.58,7/16,9.56%,RANBP2;NSMCE2;HDAC4;PIAS1;PIAS2;TOPORS;CBX4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.711239419525893,-1.7680434511614336,0.006896551724137931,0.1768230066081831,0.585,5/10,13.98%,SETD5;ASH1L;EHMT1;SETDB1;EHMT2
prerank,poly(U) RNA binding (GO:0008266),-0.5708399578411445,-1.7322808516954273,0.004830917874396135,0.21835471521179886,0.697,14/20,26.78%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4;PABPC4L;RBMS2;FMR1;KHDRBS1;DIS3L2;HNRNPH1;PABPC5;PABPC1L
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6485175088794868,-1.7298126625493213,0.011363636363636364,0.20464069443485072,0.703,7/12,14.04%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,tau protein binding (GO:0048156),0.6509857931965163,1.7164191906595152,0.0022624434389140274,0.046719587948786084,0.577,9/40,4.81%,APOE;ACTB;CLU;HSP90AA1;HSP90AB1;LGMN;S100B;MAP1A;PIN1
prerank,translation elongation factor activity (GO:0003746),0.7953323429518917,1.7112223420359942,0.0,0.04833671925284554,0.605,6/14,5.39%,EEF1A1;EEF2;EEF1B2;EIF5A;EIF5AL1;EEF1A2
prerank,cell adhesion mediator activity (GO:0098631),0.714239342445278,1.6973660520375966,0.004993757802746567,0.05694738963487169,0.679,13/24,15.44%,BSG;DSCAM;CNTN4;SIRPA;LRRC4C;BCAM;ESAM;ROBO4;EMB;NINJ1;JAM3;IGSF9;DSCAML1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.4792586661618129,-1.6941978919574026,0.014388489208633094,0.24307345161113209,0.785,11/38,10.18%,PARD3;ZFYVE1;PLA2G4A;PLEKHA4;SNX12;SESTD1;DENND1A;ATG2B;HIP1;ATG2A;KIF16B
prerank,retinoic acid binding (GO:0001972),-0.6189218066576528,-1.684669690476978,0.018656716417910446,0.23915767868244212,0.806,1/12,3.24%,NR2F2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5112381618154449,-1.660133241776242,0.016129032258064516,0.26758766779489307,0.864,11/25,10.18%,GAB2;FCHSD2;ZFYVE1;MAPKAP1;PLEKHA4;ADAP2;PLEKHA2;SESTD1;HIP1;DAPP1;KIF16B
prerank,lipoprotein particle binding (GO:0071813),0.7092042950334093,1.6587268869030622,0.003865979381443299,0.0984097712692148,0.848,8/20,12.32%,PLTP;TREM2;SORL1;HSPD1;MAPT;LPL;STAB1;MSR1
prerank,endopeptidase inhibitor activity (GO:0004866),0.5873855927504378,1.6584069846472205,0.0,0.09424270689423433,0.849,21/82,13.02%,CST3;GAPDH;TIMP2;SERPINH1;A2M;SPOCK2;PRNP;SERPINF1;SERPINE2;UBE2Z;PCSK1N;AGT;SPOCK1;CSTB;SPOCK3;TIMP1;SERPING1;ITIH3;TIMP3;SERPINA9;BST2
prerank,lysine-acetylated histone binding (GO:0070577),-0.5681868140670293,-1.6567985235813352,0.009433962264150943,0.242434585217661,0.872,12/20,20.19%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,acetylation-dependent protein binding (GO:0140033),-0.5681868140670293,-1.6567985235813352,0.009433962264150943,0.242434585217661,0.872,12/20,20.19%,MLLT3;BRD4;BAZ2A;ATAD2B;KMT2A;PSME4;TRIM24;BRD7;PHIP;CARM1;DPF2;TAF1
prerank,retinoic acid receptor binding (GO:0042974),-0.5660013896619973,-1.6501190267204546,0.023622047244094488,0.2381171666935292,0.882,6/17,9.60%,NSD1;NRIP1;RARG;CNOT1;ASXL1;PPARG
prerank,disordered domain specific binding (GO:0097718),0.6770760060389063,1.6456132066780782,0.00865265760197775,0.1070176852034865,0.887,8/23,8.29%,CALM1;GAPDH;HSP90AA1;HSP90AB1;FKBP8;CALM3;FN1;CLTC
prerank,thyroid hormone receptor binding (GO:0046966),-0.48205836236881106,-1.640748372831325,0.005434782608695652,0.24009287569272011,0.895,12/28,22.22%,NSD1;MED13;TRIP12;JMJD1C;THRAP3;NCOR1;BRD8;TACC1;TAF7;MED1;NCOA6;NCOA3
prerank,microtubule minus-end binding (GO:0051011),-0.6062031129641611,-1.634684179904868,0.01953125,0.23783702885036034,0.903,8/13,19.04%,MACF1;CEP290;CAMSAP1;NUMA1;TUBGCP6;HAUS7;TUBGCP5;CAMSAP2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.4852243711748828,-1.6283651668647534,0.03125,0.23691657593709126,0.914,14/32,20.10%,FTO;KDM2A;TET2;KDM7A;TET3;TMLHE;P4HTM;KDM4C;PHF8;EGLN1;ALKBH3;EGLN3;PHYHD1;ALKBH4
prerank,retinoid X receptor binding (GO:0046965),-0.6368728942453544,-1.626720422071088,0.017123287671232876,0.2288980849456086,0.918,6/11,20.70%,NSD1;NRIP1;RARG;PPARG;TACC1;NCOA6
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7237570630000951,1.623962255115882,0.011538461538461539,0.13914159564026607,0.949,11/17,21.95%,GRIA2;GRIK5;GRIK2;GRIN1;GRIN3A;GRIA4;GRIN2A;GRIA1;GRIN2B;GRIA3;GRIK1
prerank,ubiquitin protein ligase binding (GO:0031625),0.5441882971409179,1.6224553639576775,0.0,0.1363033455976116,0.956,62/254,11.69%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;TMBIM6;PRDX6;PINK1;MAP1LC3A;TXNIP;CCT2;GABARAPL2;CHEK2;PSMD1;AUP1;RTN4;HSPA1B;GABARAPL1;UCHL1;PRR5L;YWHAE;VCP;RPA2;BAG5;BAG1;UBA52;ARRDC1;ISG15;TRIM28;SCAMP3;HSPD1;SYT11;PRKAR1A;RBX1;NDUFS2;NEDD8;UQCRC1;JUN;MC1R;APBB1;SUMO2;DNAJA1;WFS1
prerank,transmitter-gated ion channel activity (GO:0022824),0.6643005683358579,1.6215582218448004,0.00591016548463357,0.13261499115608302,0.957,12/29,11.99%,GABRB1;GRIA2;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRIA4;GRID1;GLRA2;GABRA3;GABRB3
prerank,phosphatidylinositol binding (GO:0035091),-0.3794728601507516,-1.6212691053993873,0.0,0.2266924146547297,0.923,35/91,16.96%,PARD3B;ITPR1;PARD3;FCHO2;PITPNC1;ZFYVE1;ITPR2;APPL2;BCAS3;PITPNM2;EEA1;SNX12;SESTD1;ZFYVE9;DENND1A;ANKFY1;HIP1;SNX24;WDFY3;PICALM;SNX9;TNFAIP8L3;DENND1B;TULP3;ESYT3;NUMA1;SNX2;PIGK;SNX1;ING2;RUBCN;PASK;SH3YL1;SNX13;APPL1
prerank,Toll-like receptor binding (GO:0035325),0.7573838148036316,1.608456599388633,0.005649717514124294,0.14930938050499606,0.976,8/11,16.24%,TOLLIP;S100A8;S100A9;TIRAP;TLR6;UNC93B1;TLR1;DAB2IP
prerank,ribosome binding (GO:0043022),0.6027910158889348,1.605270516679062,0.00340522133938706,0.1495086942530973,0.98,13/46,12.71%,RPSA;EEF2;RACK1;SEC61B;SHFL;TMEM147;EIF3C;SBDS;NOMO1;TMCO1;NAA10;SEC61A1;NCLN
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.5357309143977851,1.6000454761462644,0.0,0.1537290697587891,0.986,64/269,11.69%,RPL23;RPS27A;ACTG1;RPL11;HSPA8;RPL5;CLU;TUBB;UBC;GABARAP;UBB;TUBA1B;ATP6V0C;ELOB;HSP90AA1;HSP90AB1;CALR;LAPTM5;CKB;UBXN1;HSPA5;TPI1;SLC25A5;MAP1LC3B;TMBIM6;PTPRN;PRDX6;PINK1;MAP1LC3A;TXNIP;CCT2;GABARAPL2;CHEK2;PSMD1;AUP1;RTN4;HSPA1B;GABARAPL1;UCHL1;PRR5L;YWHAE;VCP;RPA2;BAG5;BAG1;UBA52;ARRDC1;ISG15;TRIM28;SCAMP3;HSPD1;SYT11;PRKAR1A;RBX1;NDUFS2;NEDD8;UQCRC1;JUN;MC1R;APBB1;SUMO2;SUMO3;DNAJA1;WFS1
prerank,monocarboxylic acid binding (GO:0033293),0.6934386349216847,1.591497975312479,0.015444015444015444,0.16434632229191598,0.991,1/18,0.23%,PSAP
prerank,mannose binding (GO:0005537),0.7567365576574693,1.5880780681838722,0.018387553041018388,0.16588780167342876,0.991,6/12,13.96%,MBL2;LMAN2;LMAN1;CLEC6A;CLN5;CLEC4D
prerank,RNA binding (GO:0003723),0.5191414220781629,1.576332407529106,0.0,0.18469494762861885,0.995,300/1321,14.53%,TMSB4X;RPL41;TPT1;FAU;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL17;MRPL23;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPL11;HSPA8;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;PPIA;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;CMSS1;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;ALDOA;EEF2;RPS20;RPS18;RPL36;RPL22;UBC;VIM;RPS25;RACK1;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;CAVIN1;TUBA1B;PCBP1;RPL23A;HSP90AA1;RPL7A;HSPB1;HSP90AB1;RPL14;GRN;SNRPG;RPL31;CALR;RPL36A;LGALS1;TUBB4B;RPS28;PPIB;RPL35;EIF1;RPL4;PARK7;SEC61B;RPL10;HNRNPAB;RPS6;SERPINH1;NDUFV3;SF3B5;RCAN3;RPL10A;TXN;CKAP4;SLC25A5;ATP5F1A;EIF4G2;NME1;EIF3D;RPN1;MAGOHB;MAGOH;POLR2D;SHFL;HNRNPK;NPM1;RPS27L;EIF1B;DDX39B;HSPE1;PEBP1;MRPL43;EIF5A;APOBEC2;RAN;S100A16;CANX;RALY;SYF2;HSP90B1;SRP14;QKI;LGALS3;ELAC2;BTF3;PKM;ANG;SNRPD2;ZFP36L1;PLEC;NCL;LSM4;DDX28;LSM8;MEX3D;LSM6;ENO1;RTN4;NOP10;EMG1;PUF60;HSPA1B;MRPL4;ZFP36L2;PARP1;RBFOX3;FLNA;YWHAE;RBM42;HMGB3;SNRPA;AHNAK;PCBP4;EIF3I;VCP;MANF;NUCKS1;SNRPF;MRPL28;PFN1;TFRC;MSN;EIF3C;SBDS;FBL;RPL22L1;SRSF9;MRPL14;SRFBP1;STRAP;MRPL41;MRPL27;LIN28B;CSTB;P4HB;RIMS1;CORO1A;MRPS11;TRIM28;EDF1;PDIA3;HNRNPA0;MRPL11;MRPS14;HSPD1;MYO5A;DDX49;ZYX;CLTC;NOL12;RBM15B;YWHAG;IFIT1;MAPT;CSRP1;METAP2;YBX1;NPM3;PRPF38B;SLC25A11;RRP1B;RRP1;SARS1;SARS2;JUN;DCN;PRDX1;NELFCD;KARS1;NHP2;EPPK1;HMGB1;AARS2;SLC3A2;ZFP36;POP7;WDR3;RTRAF;H1-0;TARDBP;POLR2G;DEK;EXOSC2;FASN;RNASEH1;KHDRBS3;PRPF8;EIF4A1;SUMO2;SRSF2;RALYL;APEX1;SF3A2;KCTD12;NIP7;ACAA2;PABPC1;FAM50A;SSRP1;NTPCR;DDX11;MRPL54;RTCB;ACTN1;RBM4B;SNW1;L1TD1;SORBS2;SF3B2;PRMT1;BST2;HSPA1A;ATXN2L;IMP4;TOE1;CARS1;YWHAZ;EIF3B;MRPL37;MRPL2;HNRNPU;MRPL44;MTCL1;POP4;NOL7;ZC3H8;SND1;TSN;RO60;NUFIP2;RRP7A;HEXIM1;MRPS24;PIN4;HNRNPA1;SUCLG1;GTPBP10;NONO;TUFM;CHCHD1;ARF1;TRUB2;CTU1
prerank,poly-purine tract binding (GO:0070717),-0.47559061269049463,-1.574294260984058,0.022598870056497175,0.2926039771898721,0.963,11/27,15.12%,RBMS3;RBMS1;RBPMS;ATXN1;DDX1;DAZAP1;PATL1;ZC3H14;PABPC4;PABPC4L;RBMS2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6295533132874104,-1.5721616880102105,0.03459119496855346,0.28533720153807185,0.966,4/10,13.40%,KDM2A;KDM7A;KDM4C;PHF8
prerank,histone methyltransferase activity (GO:0042054),-0.45659877987993475,-1.570154102171126,0.012195121951219513,0.2779829366829436,0.967,13/32,16.75%,KMT2C;SETD2;SMYD3;EHMT1;KMT5B;NSD3;SETDB1;SETD7;EHMT2;CARM1;EZH2;PRDM9;PRMT6
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3413561397307008,-1.5699566607070794,0.0,0.2680607894855782,0.967,62/228,14.77%,RNF220;PDZRN3;HECTD1;RNF216;UBR4;RNF152;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;CBLB;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;UBE4B;ARIH2;RNF144A;UBR3;UBR1;SMURF1;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UHRF2;UBR2;RNF41;NEURL2;ZNRF1;SH3RF2;NFX1;TOPORS;RNF138;TRIM24;RC3H2;ASB2;ITCH;RNF217;RNF115;UBE3C;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;TRIM41;DTX1;WWP2;TRIM7;UBOX5;RNF185
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6403083767939459,1.56942633423385,0.014492753623188406,0.19432695658960003,0.997,9/28,12.57%,CHRNA9;GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3;CHRNA4
prerank,nucleosomal DNA binding (GO:0031492),0.6706774769419063,1.5608599892946255,0.012594458438287154,0.20829459110394133,0.999,3/21,3.83%,ACTB;H3-3A;MBD3
prerank,endopeptidase regulator activity (GO:0061135),0.5943162162955218,1.5482159014149315,0.013872832369942197,0.23332135016276642,0.999,9/40,11.79%,CST3;PSME1;A2M;PSME2;PCSK1N;PSENEN;CSTB;VSIR;ITIH3
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3548688836008813,-1.5471119974286587,0.0,0.29492511931898546,0.977,65/232,14.77%,RNF220;PDZRN3;HECTD1;RNF216;UBR4;RNF152;NSMCE2;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;PIAS1;CBLB;PIAS2;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;ARIH2;RNF144A;UBR3;UBR1;SMURF1;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UFL1;UHRF2;UBR2;RNF41;NEURL2;ZNRF1;SH3RF2;NFX1;TOPORS;RNF138;CBX4;TRIM24;RC3H2;ASB2;ITCH;RNF217;RNF115;UBE3C;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;TRIM41;DTX1;WWP2;TRIM7;RNF185
prerank,Tat protein binding (GO:0030957),0.7516951020776331,1.543233798846224,0.04096045197740113,0.23834472470569396,0.999,6/10,16.94%,ACTB;NPM1;GABARAPL1;DNAJA1;DLL1;TRIM32
prerank,copper ion binding (GO:0005507),0.5830163722149175,1.5420320255386515,0.010285714285714285,0.234701372914379,1.0,13/42,16.09%,ATOX1;MT3;PARK7;SOD1;PRNP;S100A13;COX17;ANG;ATP13A2;AOC3;CUTA;HEPH;RNF7
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5951139638240226,1.5417626298161335,0.005747126436781609,0.22934466288941793,1.0,8/38,12.85%,SERPINH1;A2M;SERPINF1;SERPINE2;AGT;SPOCK1;SERPING1;SERPINA9
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6785231851288248,1.5378820696460669,0.026785714285714284,0.23365190092197244,1.0,7/19,11.91%,GRID2;GABRG3;GRIK5;GRIK2;GABRA2;GRID1;GABRA3
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.510668043716695,-1.537785744279843,0.02702702702702703,0.3007521244558352,0.983,8/18,14.11%,TGFBR3;SMAD3;SMAD6;TGFBR1;SMAD7;FERMT2;SMAD2;TGFB3
prerank,protease binding (GO:0002020),0.5364566038331021,1.5371109091236168,0.004149377593360996,0.2296415061698891,1.0,26/99,13.50%,CST3;PSAP;UBC;COL1A1;PARK7;TIMP2;A2M;PRNP;PINK1;TNF;NTRK2;ECM1;FLOT1;ADAMTS4;VCP;TNFAIP3;FN1;SELL;CSTB;CLTC;COL3A1;TIMP1;SYVN1;TIMP3;COL1A2;RIPK2
prerank,cholesterol binding (GO:0015485),0.5744907691897182,1.5310770522780448,0.014444444444444444,0.23872056650430049,1.0,17/47,18.96%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;SOAT2;STARD3NL;OSBPL3;ANXA6;VDAC2
prerank,poly-pyrimidine tract binding (GO:0008187),-0.494041075810613,-1.5209781947402217,0.02127659574468085,0.3211500234087787,0.989,10/23,19.05%,RBMS3;RBMS1;ATXN1;DAZAP1;PATL1;PABPC4;PABPC4L;RBMS2;FMR1;KHDRBS1
prerank,peptidase inhibitor activity (GO:0030414),0.6113232936654559,1.518168207276458,0.014423076923076924,0.2662274932319715,1.0,7/33,11.79%,CST3;TIMP2;A2M;PCSK1N;CSTB;TIMP1;ITIH3
prerank,nuclear receptor binding (GO:0016922),-0.3470859029558026,-1.5098147971303122,0.0,0.33302063859544356,0.99,33/111,13.79%,FOXP1;NSD1;SMAD3;TCF7L2;NRIP1;STAT5B;MED13;BCAS3;TACC2;NCOA1;TRIP12;BAZ2A;JMJD1C;THRAP3;ARID1A;CNOT1;NCOR1;KDM3A;ASXL1;LCOR;SMARCE1;STRN;MMS19;DCAF1;ESR1;PPID;DCAF13;KDM4C;BRD8;RNF14;TGFB1I1;SIRT1;PPARGC1B
prerank,bHLH transcription factor binding (GO:0043425),-0.5092506693919866,-1.509367328597893,0.05581395348837209,0.32355920886003087,0.99,5/19,6.24%,SMAD3;FHL2;TCF12;CREBBP;SP1
prerank,phospholipase binding (GO:0043274),-0.5700251604753009,-1.5054034880775038,0.06329113924050633,0.32032489012526316,0.991,5/13,11.31%,ARHGAP6;PAFAH1B1;PRKN;PDPK1;DGKQ
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7223148583709771,1.5011185403666458,0.04061624649859944,0.30809674214875155,1.0,5/11,15.93%,CNGA3;CNGA4;AQP1;HCN1;CNGB1
prerank,insulin-like growth factor I binding (GO:0031994),0.7006471854179083,1.4971961652422179,0.030789825970548863,0.3124970309399967,1.0,4/13,4.18%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,glutathione transferase activity (GO:0004364),0.628329506492787,1.489534084312145,0.03288672350791717,0.32884229691760186,1.0,9/23,17.02%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;ALOX5AP;LTC4S
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.4265322028957153,-1.4876222050571142,0.022058823529411766,0.3431853365785079,0.993,16/34,20.46%,SETD2;SMYD3;EHMT1;KMT5B;NSD3;SETDB1;CAMKMT;SETD7;EHMT2;EZH2;SETD4;PRDM9;SETD3;VCPKMT;METTL21A;SETD6
prerank,peptidase activator activity (GO:0016504),0.6235675016361637,1.4867671649276144,0.03656998738965952,0.33042259302909577,1.0,8/22,9.55%,PSME1;PSME2;PINK1;PSENEN;MAL;VCP;VSIR;PCOLCE
prerank,alanine transmembrane transporter activity (GO:0022858),0.7082958674091531,1.4856219564066182,0.05409153952843273,0.3270460709008372,1.0,4/12,9.99%,SLC38A5;SLC1A4;SLC6A6;SLC3A2
prerank,calcium ion binding (GO:0005509),0.4963700927376603,1.4846190723783468,0.0,0.32345948953731624,1.0,100/323,20.39%,TPT1;SPARC;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;KCNIP4;S100A11;HSPA5;NRXN1;SPOCK2;RCN3;S100B;PRNP;S100A10;CALM3;TGM2;ANXA5;GJB2;S100A13;S100A16;CANX;HSP90B1;LTBP4;S100A8;S100A9;BNIP2;CDH20;SLC25A13;ADGRL3;SPOCK1;GRIN1;SYT1;F9;SELL;CLEC6A;CALB1;ENPP2;CDH18;SDF4;SYT12;SYT11;TUBB4A;CLEC3B;LPL;LCP1;CDK5R1;RPH3A;SYT6;SYT4;DNER;AOC3;RASGRP3;PLA2G4F;PDCD6;TRPM2;MAN1B1;AIF1;CDH12;PCDHB8;HPGDS;PCP4;CDH19;DCHS1;CETN3;FKBP9;DHH;KCNIP1;SLC8A1;SYT10;CDH7;RASGRP1;CDH24;EFHD1;CPNE6;RYR2;SYT2;EFHD2;CDH10;CETN2;CDH5;SLIT3;SLIT1;SRI;SCIN;S100A4;GCA;TKT;NCS1;ANXA6;PPP3CA;CALM2;SNCA;S100G;PKD2L1;AGRN;CANT1;CAPN3
prerank,chemokine activity (GO:0008009),0.5843099861578626,1.4828986920209037,0.03317535545023697,0.3220292980694963,1.0,9/31,17.61%,CXCL12;CCL19;CXCL16;CXCL10;CCL2;PF4;CCL3;CCL28;CCL8
prerank,low-density lipoprotein particle binding (GO:0030169),0.6604646665368168,1.4796076567663947,0.048812664907651716,0.32493262969786363,1.0,5/16,12.32%,PLTP;TREM2;SORL1;STAB1;MSR1
prerank,triglyceride lipase activity (GO:0004806),0.6332526624697297,1.4789459590165157,0.04785894206549118,0.32072365781058554,1.0,4/20,8.93%,PNPLA2;LIPG;LIPE;LPL
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5991850084668052,-1.4770689939031685,0.0781758957654723,0.3526855406112159,0.994,6/10,18.18%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6863280425667408,1.4738358751095981,0.05750350631136045,0.3291416015851416,1.0,7/13,22.38%,ARHGDIA;ARHGDIB;ARHGDIG;GDI1;CCDC88A;GDI2;RANBP1
prerank,protein phosphatase activator activity (GO:0072542),0.6814109001987194,1.4729446643396387,0.06594885598923284,0.3257108924241905,1.0,8/13,21.18%,CALM1;CALM3;IGFBP3;B3GAT3;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,ligand-gated anion channel activity (GO:0099095),0.6578291359519663,1.4698130994996088,0.04381443298969072,0.3288298258897877,1.0,9/17,18.83%,GABRB1;GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GABRB3;GABRB2;GLRA3
prerank,chemokine receptor binding (GO:0042379),0.5664810111552417,1.463936951686607,0.032520325203252036,0.3406206158231726,1.0,10/35,17.61%,CXCL12;CCL19;CXCL16;CXCL10;CX3CR1;CCL2;PF4;CCL3;CCL28;CCL8
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.273776655468978,-1.4634424342481933,0.0,0.36833457412652,0.996,78/346,13.10%,RNF220;PDZRN3;UBE2E2;HECTD1;CNOT4;BIRC6;TTC3;MIB1;RNF216;UBR4;RNF152;SMURF2;TRIP12;KCMF1;WWP1;RNF38;RNF19A;UBR5;COP1;CBLB;PRKN;BIRC2;TRAF3IP2;PELI2;SH3RF1;SH3RF3;RNF146;ARIH2;RNF144A;UBR3;UBR1;RNF213;SMURF1;TRAF5;UBE2R2;BCOR;UBE2Q2;RNF24;RNF135;BIRC3;ARIH1;TRIM5;HUWE1;RNF8;UHRF2;PML;UBR2;DDB2;RNF41;FBXO10;FBXO11;NEURL2;ZNRF1;SH3RF2;NFX1;BTRC;TOPORS;RNF138;FBXO4;UBE2J2;TRIM24;RC3H2;ZFP91;ASB2;ITCH;RNF217;FBXW11;CUL4B;RNF115;UBE3C;CUL4A;PPIL2;RNF43;RNF14;HECW2;SIAH3;UBE3B;ERCC8
prerank,metal ion binding (GO:0046872),0.48276200208869735,1.4612213800477931,0.0,0.34241489507252193,1.0,127/477,19.23%,APOE;TPT1;SPARC;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;S100A6;CALM1;GSN;S100A1;SPARCL1;CALR;MT3;KCNIP4;MT2A;S100A11;HSPA5;NRXN1;SPOCK2;RCN3;S100B;PRNP;S100A10;CALM3;NME1;TGM2;ANXA5;PINK1;GJB2;IGFBP3;S100A13;HSPE1;RAN;S100A16;CANX;HSP90B1;LTBP4;S100A8;S100A9;BNIP2;CDH20;SLC25A13;NT5C3A;ADGRL3;SPOCK1;GRIN1;SYT1;F9;SELL;CLEC6A;CALB1;ENPP2;CDH18;MAST1;SDF4;SYT12;SYT11;TUBB4A;CLEC3B;LPL;LCP1;CDK5R1;RPH3A;SYT6;SYT4;NUDT3;DNER;AOC3;RASGRP3;PLA2G4F;GNAI1;PDCD6;APEX1;TRPM2;MAN1B1;AIF1;NUDT22;CDH12;PCDHB8;HPGDS;CDC42BPA;STK11;PCP4;CDH19;DCHS1;CETN3;FKBP9;TSSK6;TSSK4;DHH;KCNIP1;RRAGC;SLC8A1;SYT10;CDH7;RASGRP1;CDH24;EFHD1;CPNE6;RYR2;PPA1;NUDT16;SYT2;EFHD2;CDH10;CETN2;CDH5;BRSK2;SLIT3;SLIT1;SRI;SCIN;S100A4;GCA;TKT;NCS1;ANXA6;YDJC;PPP3CA;CALM2;SNCA;S100G
prerank,ferrous iron binding (GO:0008198),0.6218943886123759,1.4547459904788695,0.038944723618090454,0.3553258372207344,1.0,2/21,0.08%,FTH1;FTL
prerank,fibroblast growth factor binding (GO:0017134),0.6198961858621967,1.4507471972046793,0.053231939163498096,0.36037507572797717,1.0,3/21,3.22%,RPS19;RPS2;S100A13
prerank,insulin-like growth factor binding (GO:0005520),0.6601532592282531,1.4467315314797518,0.05019815059445178,0.3671364901811463,1.0,4/15,4.18%,IGFBP6;IGFBP3;IGFBP4;IGFBP5
prerank,manganese ion binding (GO:0030145),-0.38425700265018436,-1.439624459519302,0.01,0.4081684087900846,1.0,10/48,13.90%,MPPED2;LARGE1;ABL1;B4GALT1;XPNPEP3;NEK4;ABL2;GALNT1;MGAT5;ME1
prerank,water transmembrane transporter activity (GO:0005372),0.6949382599633069,1.4393235956102068,0.06954102920723226,0.38401256508895615,1.0,2/11,8.41%,AQP4;AQP1
prerank,sodium channel regulator activity (GO:0017080),0.5547301464220183,1.4371729525608494,0.059233449477351915,0.3846034311424216,1.0,12/37,15.84%,FXYD5;FXYD1;YWHAH;FGF14;SGK1;SCN4B;FGF11;FXYD7;FGF12;RSC1A1;PRSS8;FGF13
prerank,GABA receptor binding (GO:0050811),0.6986233385872005,1.429630864692193,0.07724719101123595,0.40178030996235914,1.0,5/11,5.53%,GABARAP;GABARAPL2;SHISA7;GABARAPL1;LHFPL4
prerank,hormone activity (GO:0005179),0.5220720890317261,1.4275419709071444,0.03384279475982533,0.40245788331687027,1.0,18/54,22.32%,NPPC;TRH;POMC;AGT;AMH;PENK;CRH;CALCB;PPY;HCRT;CCK;ADCYAP1;NMB;EDN3;INHBA;SST;INHBB;ERFE
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5423904822684592,1.4269645298998725,0.04482758620689655,0.398076669276467,1.0,14/42,15.44%,BSG;PPP1CA;S100A11;DSCAM;CNTN4;TRIM29;SIRPA;LRRC4C;ESAM;ROBO4;EMB;JAM3;IGSF9;DSCAML1
prerank,calcium channel regulator activity (GO:0005246),0.5493740830898372,1.426382072444458,0.044340723453908985,0.3938302618219224,1.0,13/37,19.10%,CALM1;SLC30A1;NRXN1;FKBP1A;YWHAE;SGK1;PHPT1;NRXN2;INAFM2;CACNG8;SRI;FKBP1B;CALM2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5666240044236699,-1.4257487764681707,0.09121621621621621,0.42759355735473936,1.0,4/11,5.63%,AKAP13;KSR1;SH3RF1;SPAG9
prerank,cadherin binding (GO:0045296),0.47651066905148876,1.424454349105766,0.002,0.39357713484128887,1.0,91/315,17.27%,BSG;HSPA8;RPL24;RPL34;ALDOA;EEF2;RACK1;RPL29;RPL6;RPL15;RPS2;RPS26;PCBP1;RPL23A;RPL7A;HSP90AB1;RPL14;PPP1CA;TAGLN2;PARK7;FXYD5;S100A11;HSPA5;PSMB6;EEF1G;EIF4G2;HNRNPK;PRDX6;CTNNA2;ANK3;CNN2;CTNNA3;RAN;LYPLA2;EEF1D;YWHAB;PKM;PLEC;ENO1;LDHA;RTN4;TRIM29;CDH20;PUF60;CTNNB1;FLNA;YWHAE;AHNAK;CHMP2B;GLOD4;PFN1;NDRG1;CDH18;KDR;YKT6;CDK5R1;PRDX1;CCT8;SLC3A2;FASN;CHMP5;LASP1;FNBP1L;PLIN3;PTPRB;CLIC1;ANLN;HSPA1A;ATXN2L;CDH12;SHTN1;YWHAZ;EVPL;PROM1;CAPG;SND1;CDH19;DCHS1;EHD1;SH3GLB2;DNAJB1;CDH7;CDH24;DAB2IP;SPTBN2;EFHD2;CDH10;USP8;CDH5;NUDC;RANGAP1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.43697144208081906,-1.4237937236122797,0.043478260869565216,0.42020676475328683,1.0,14/27,14.62%,DCUN1D3;RNF19A;ZMYM2;PRKN;PPARA;ARIH2;RNF144A;ARIH1;RNF217;RNF14;DCUN1D4;SIAH3;DCUN1D1;DCUN1D2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.6004165565419718,1.4178868830835596,0.06905370843989769,0.408596939540802,1.0,5/21,12.57%,CHRNA9;GRIK2;P2RX7;P2RX6;CHRNA4
prerank,purinergic nucleotide receptor activity (GO:0001614),0.6407799455362444,1.4148455585301432,0.08993288590604027,0.4126525555603697,1.0,5/15,10.80%,P2RX7;GPR34;P2RY1;P2RY12;P2RX6
prerank,ribosomal small subunit binding (GO:0043024),0.6256342932072503,1.4147105606077064,0.06842105263157895,0.4071234807256667,1.0,4/17,3.18%,EIF1;NME1;NPM1;EIF1B
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6730896700733628,1.4143833466525904,0.0891891891891892,0.4024017636917066,1.0,6/12,16.30%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.630204871815518,1.4134719367252326,0.06640106241699867,0.39978119173838805,1.0,3/16,10.53%,RPS3;DNPH1;NEIL1
prerank,phosphatidic acid binding (GO:0070300),-0.4653834768963585,-1.4104656464990175,0.09956709956709957,0.4398724413437407,1.0,7/19,6.50%,PITPNC1;RAPGEF2;MAPKAP1;PACSIN2;MARK1;SESTD1;RAPGEF6
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5627199208916205,1.4083323771322942,0.05199516324062878,0.4103396842438801,1.0,6/30,7.36%,CST3;MT3;UBE2Z;PRDX5;SPOCK1;CSTB
prerank,ligand-gated cation channel activity (GO:0099094),0.5020682791956561,1.4062570857967704,0.030526315789473683,0.4108994390667888,1.0,16/75,12.57%,ASIC2;CHRNA9;GRIA2;GRIK5;GRIK2;GRIN1;KCNJ10;GRIN3A;P2RX7;GRIA4;GRIN2A;P2RX6;TRPM2;KCNN2;GRIA1;CHRNA4
prerank,amino acid binding (GO:0016597),0.5628505167911811,1.4047873824903054,0.059665871121718374,0.41016999821509126,1.0,13/31,20.44%,AGXT;GRIN1;GRIN3A;GRM7;AARS2;GLRA2;GLRA1;DDAH1;DDAH2;NOS2;GRIN2B;GLRA3;SHMT2
prerank,GTPase activator activity (GO:0005096),-0.3081462422247753,-1.4044177844116892,0.0,0.44127859666384195,1.0,89/313,13.71%,ARHGAP29;AKAP13;RANBP3L;ARHGAP28;DOCK5;SIPA1L1;ARHGAP20;PLCE1;ARHGAP10;RAPGEF4;DOCK11;ASAP3;ALDH1A1;SBF2;DENND4A;ARHGEF11;ASAP1;ARHGAP17;LRRK2;ARHGAP42;DENND4C;FARP1;ARFGEF1;RANBP2;RAPGEF2;DENND2A;SGSM2;IQSEC2;NRP1;MON1A;ITSN1;USP6NL;TBC1D12;ERRFI1;RALGAPB;SMAP1;ARHGEF18;ARHGEF10L;FGD4;FNIP1;ANKRD27;EIF2B3;DENND5A;ASAP2;STARD13;SIPA1L3;TBC1D2B;RAPGEF6;RABGAP1;DENND1A;ARHGAP32;ARFGEF2;RAPGEF1;RIC8B;TBC1D9B;BCR;VAV2;RAPGEF5;TBC1D4;GAPVD1;ARHGEF6;SYDE2;ALS2;ARHGAP31;CCZ1;DNMBP;DENND1B;TBC1D8B;TBCK;OPHN1;RAPGEF3;DENND5B;DOCK1;MYO9B;SIPA1;ARHGAP18;RIC1;DENND3;SMAP2;RALGAPA1;ARHGEF2;STXBP5;ARHGEF17;DENND2C;WNT11;RGS16;EIF2B2;RAB3GAP2;RAP1GDS1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.41190552683278936,-1.4024947359016424,0.06521739130434782,0.4343337159873735,1.0,12/34,11.07%,PARD3;GAB2;FCHSD2;ZFYVE1;MAPKAP1;OGT;MYO1B;ADAP2;GBF1;DAPP1;KIF16B;FERMT2
prerank,deoxyribonuclease activity (GO:0004536),0.6440542093229279,1.3960713668814846,0.07513661202185792,0.430471196780731,1.0,2/14,2.70%,RPS3;NME1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6475312562542019,1.395750363602752,0.10277777777777777,0.42562674398008604,1.0,4/13,12.81%,MIF;DDT;ECH1;HSD3B2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.32715540251689557,-1.3934149536880316,0.0,0.44311291955751253,1.0,49/147,15.00%,AKAP13;DOCK5;PLCE1;RAPGEF4;DOCK11;SBF2;DENND4A;ARHGEF11;DENND4C;FARP1;ARFGEF1;RAPGEF2;DENND2A;IQSEC2;MON1A;ITSN1;ARHGEF18;FGD4;FNIP1;ANKRD27;EIF2B3;DENND5A;RAPGEF6;DENND1A;ARFGEF2;RAPGEF1;RIC8B;BCR;VAV2;RAPGEF5;GAPVD1;ARHGEF6;ALS2;CCZ1;DNMBP;DENND1B;RAPGEF3;DENND5B;DOCK1;RIC1;DENND3;ARHGEF2;ARHGEF17;DENND2C;EIF2B2;RAB3GAP2;RGL1;PREX2;NGEF
prerank,carboxypeptidase activity (GO:0004180),0.5503852076784203,1.3909488972934634,0.05730994152046784,0.43459547905185286,1.0,9/35,11.66%,CTSZ;CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2;CTSA
prerank,CoA-ligase activity (GO:0016405),-0.5096149824294778,-1.3895298242508538,0.09541984732824428,0.4417137109856596,1.0,10/14,38.04%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSBG1;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,GABA-A receptor activity (GO:0004890),0.6125216596503615,1.388280763031025,0.09171974522292993,0.43722584120331964,1.0,6/18,16.30%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.507068861210642,-1.3864983437652485,0.1070110701107011,0.43783677301671364,1.0,3/13,9.95%,DICER1;SLX4;DNASE1L1
prerank,tRNA methyltransferase activity (GO:0008175),-0.4804836234494584,-1.3859738192498876,0.11583011583011583,0.42945131357785915,1.0,6/16,15.31%,TRMT13;ALKBH8;THUMPD3;TRMT5;FTSJ1;TRMT9B
prerank,retinoid binding (GO:0005501),0.5890335154932818,1.3821552433996867,0.07806691449814127,0.45079687256502315,1.0,3/22,7.26%,PTGDS;RBP4;RBP1
prerank,U6 snRNA binding (GO:0017070),0.6288923565203307,1.3776557077769418,0.10377358490566038,0.46003010484977,1.0,5/14,10.66%,DDX39B;EIF5A;LSM4;LSM8;PRPF8
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.5129303220408744,-1.3759653744490592,0.12222222222222222,0.44241513929897125,1.0,4/12,18.06%,TENT4B;TUT1;PAPOLB;TENT2
prerank,sodium:proton antiporter activity (GO:0015385),-0.5374130179946128,-1.375142833630637,0.12786885245901639,0.4348089498284636,1.0,4/11,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,cholesterol transfer activity (GO:0120020),0.6219672557558471,1.373833264958692,0.08771929824561403,0.46706077668654084,1.0,4/16,9.19%,PLTP;NPC2;ABCG1;STARD4
prerank,ATPase activator activity (GO:0001671),0.586341120773729,1.3720432054286043,0.08260325406758448,0.46724720841331546,1.0,8/20,18.89%,ATP1B2;DNAJA1;DNAJB2;DNAJB1;ATP1B1;ATP1B3;AHSA1;DNAJC10
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5853996886022936,1.3697204795804627,0.09407216494845361,0.46863605782037526,1.0,5/21,12.57%,GRM5;DRD5;GRM1;GRIA1;CHRNA4
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.4093352397233512,-1.3671298334510282,0.05747126436781609,0.443772646172512,1.0,9/29,13.42%,ABL1;ATF7;PPM1D;NFATC1;DUSP16;DUSP10;MAPKAPK3;DUSP7;SIRT1
prerank,endopeptidase activator activity (GO:0061133),0.6586974799603316,1.3670988397303359,0.11549295774647887,0.47240698753877647,1.0,4/10,8.66%,PSME1;PSME2;PSENEN;VSIR
prerank,1-phosphatidylinositol binding (GO:0005545),-0.4892541504931789,-1.3640506656481826,0.1125,0.4409481706615091,1.0,7/15,9.94%,ZFYVE1;EEA1;SESTD1;ZFYVE9;WDFY3;PICALM;SNX9
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5931108255760023,1.3638699848821736,0.1183206106870229,0.4764853280296651,1.0,7/19,18.23%,NRG3;NRG1;GRM5;CD24;GAS6;ERCC6;ERBB3
prerank,sterol binding (GO:0032934),0.5016240304429327,1.3638456803124173,0.06441048034934498,0.47103289571998413,1.0,20/56,22.21%,APOD;TSPO;CD81;NPC2;SCP2;ABCG1;TSPO2;STARD4;OSBPL6;PROM1;SYP;CAV1;SOAT2;STARD3NL;OSBPL3;ANXA6;VDAC2;GPR183;OSBPL1A;GRAMD1A
prerank,chemorepellent activity (GO:0045499),0.5675687334835059,1.3637311542245347,0.09378806333739342,0.4659573774152824,1.0,8/25,13.41%,NRG3;NRG1;SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,phospholipase inhibitor activity (GO:0004859),0.6658207688519189,1.362636124900103,0.09865470852017937,0.4642209016311712,1.0,2/10,3.07%,APOC1;ANXA5
prerank,sterol transfer activity (GO:0120015),0.6072865632795437,1.3617555756369386,0.08823529411764706,0.4614830277577127,1.0,4/17,9.19%,PLTP;NPC2;ABCG1;STARD4
prerank,leak channel activity (GO:0022840),-0.45259856596587095,-1.3594900515823314,0.0825242718446602,0.44245300524022557,1.0,3/18,2.21%,KCNK2;NALCN;KCNK5
prerank,ATPase regulator activity (GO:0060590),0.5306230339848034,1.3583085006124234,0.08009153318077804,0.4669807542580667,1.0,15/38,18.89%,ATP5IF1;BAG5;PFN1;BAG1;ATP1B2;PLN;DNAJA1;DNAJB2;HSPBP1;DNAJB1;ATP1B1;BRSK2;ATP1B3;AHSA1;DNAJC10
prerank,estrogen receptor binding (GO:0030331),-0.3953470168901052,-1.3573720348726896,0.04294478527607362,0.43782312527563616,1.0,11/32,11.27%,NSD1;NRIP1;NCOA1;CNOT1;LCOR;STRN;MMS19;DCAF1;ESR1;PPID;DCAF13
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.6189781240724546,1.3564681027263177,0.11948051948051948,0.46736238826581905,1.0,7/14,13.02%,TIMP2;SPOCK2;SPOCK1;SPOCK3;TIMP1;TIMP3;BST2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.6629099088323076,1.354860189791889,0.11048158640226628,0.4673148286933709,1.0,4/11,17.54%,RPS3;NEIL1;APEX1;NEIL2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6089593274740481,1.353682029843647,0.10714285714285714,0.46097197425029013,1.0,12/16,28.13%,PTPRC;PTPRN2;PTPRD;PTPRB;PTPRR;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6089593274740481,1.353682029843647,0.10714285714285714,0.46097197425029013,1.0,12/16,28.13%,PTPRC;PTPRN2;PTPRD;PTPRB;PTPRR;PTPRZ1;PTPN6;PTPRU;PTPRO;PTPRE;PTPRT;PTPRG
prerank,delayed rectifier potassium channel activity (GO:0005251),0.536379857536259,1.3524791531919105,0.08214285714285714,0.45991214287450816,1.0,11/32,24.19%,KCNQ3;KCNQ2;KCNC3;KCNC1;KCNE4;KCNA2;KCNE5;KCNA1;KCNQ5;KCNC2;KCNG3
prerank,poly(A) binding (GO:0008143),-0.43658737994464036,-1.352474333344106,0.07537688442211055,0.4392349956100395,1.0,8/21,15.12%,RBMS3;RBMS1;RBPMS;DDX1;ZC3H14;PABPC4;PABPC4L;RBMS2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6127596364153889,1.3498935709325202,0.10751295336787564,0.4630658258234693,1.0,8/15,12.67%,SLC17A8;SLC1A4;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,fatty acid synthase activity (GO:0004312),0.6642887898773682,1.3475186428328096,0.13603473227206947,0.4657032131690736,1.0,4/10,11.14%,ELOVL1;ELOVL2;OXSM;ELOVL7
prerank,adenylate cyclase binding (GO:0008179),0.6633791192670411,1.3459618507945406,0.1222707423580786,0.4659675468758593,1.0,3/10,2.58%,CALM1;AKAP6;CALM3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4758871176117368,1.3442788857139143,0.0472193074501574,0.46693228730906167,1.0,31/85,28.06%,PNPLA2;PRDX6;LYPLA2;CA2;PLAAT3;PGLS;LIPG;ENPP2;LIPE;PNPLA7;LPL;AARS2;PLA2G7;PLA2G4F;GDE1;MRPL58;ABHD8;ACHE;GDPD1;FAAH;NOTUM;ESD;BCHE;APMAP;ABHD16A;GDPD3;ABHD12;PLA2G6;PON2;PGAP1;MGLL
prerank,translation initiation factor activity (GO:0003743),0.520932550666205,1.3438274039713298,0.08530805687203792,0.4635929995523509,1.0,18/36,25.32%,EIF1;EIF3F;EIF4G2;EIF3D;EIF1B;EIF3K;EIF3I;EIF3C;EIF4A1;EIF3B;EIF2B5;EIF3M;EIF5B;EIF4E2;EIF3H;EIF2S1;EIF2A;EIF3G
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5049195073053798,-1.343680969483308,0.12666666666666668,0.4501815139723547,1.0,4/12,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,glycine binding (GO:0016594),0.6566575642536097,1.3433677533864983,0.14305364511691884,0.46041985147923303,1.0,6/11,18.83%,GRIN1;GRIN3A;GLRA2;GLRA1;GRIN2B;GLRA3
prerank,kinase activator activity (GO:0019209),0.5283410220498739,1.3415054706526592,0.10194174757281553,0.46173246892045294,1.0,5/30,9.33%,RPLP1;MT3;TREM2;IL2;CDK5R1
prerank,semaphorin receptor binding (GO:0030215),0.562285395967997,1.340567195661312,0.1198044009779951,0.45988943120198406,1.0,6/23,13.41%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6270216151129283,1.3381473288040602,0.14381720430107528,0.4631164144278837,1.0,10/13,32.98%,GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GLRA3;GABRA4;GABRG2;GABRA1;GABRG1
prerank,gap junction channel activity (GO:0005243),0.5654759480746636,1.3341848153098015,0.11514392991239049,0.47038668103288306,1.0,5/22,13.23%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5249932258124252,-1.3322679581778412,0.15436241610738255,0.46549741387069565,1.0,2/11,3.46%,EGFR;MAP3K13
prerank,actin monomer binding (GO:0003785),0.5631758970658589,1.3317855882773273,0.1411764705882353,0.4730407913917035,1.0,5/22,7.45%,TMSB4X;TMSB10;MRTFA;PFN1;CORO1A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.41139163778602594,-1.3300419848388527,0.0967741935483871,0.46189727877059505,1.0,7/26,12.56%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;ABCG2;SLC16A6;SLC16A13
prerank,metallocarboxypeptidase activity (GO:0004181),0.5486710783306751,1.3272311080497665,0.1016949152542373,0.48197055089778257,1.0,7/26,11.06%,CPXM1;CPD;CPE;VASH1;AGBL4;AEBP1;CPXM2
prerank,phosphatase activator activity (GO:0019211),0.6059583067182445,1.3246480036319181,0.14191852825229961,0.48502944926210556,1.0,8/14,21.18%,CALM1;CALM3;B3GAT3;BMP2;PPP2R5D;PPP1R15A;CALM2;PPP2R5A
prerank,transcription corepressor binding (GO:0001222),-0.41329466903196543,-1.3245608489083318,0.11428571428571428,0.46508779604833966,1.0,11/27,14.95%,ZBTB16;PER2;USP11;PER3;EHMT1;LCOR;NEK6;ESR1;RORA;EHMT2;EZH2
prerank,protein tyrosine kinase binding (GO:1990782),0.4722893815293011,1.3212202732418963,0.07165775401069518,0.4908819653195704,1.0,12/71,6.27%,RACK1;HSP90AA1;NRG3;NRG1;TREM2;GRM5;GRB14;LRP4;DUSP3;SIRPA;HYAL2;SHC3
prerank,snRNA binding (GO:0017069),0.49984456582435033,1.32107242092359,0.10466439135381114,0.48681734115873515,1.0,19/42,23.24%,DDX39B;EIF5A;LSM4;LSM8;SNRPA;PRPF8;TOE1;HNRNPU;HEXIM1;MEPCE;PRPF31;SNRPD3;LSM7;RBM7;SNRNP35;CDK9;SNU13;ISG20;SNRPB2
prerank,platelet-derived growth factor binding (GO:0048407),0.6382980449861112,1.31974907481364,0.15350877192982457,0.48622346591160964,1.0,7/11,15.48%,COL1A1;PDGFB;COL6A1;COL4A1;COL3A1;COL1A2;PDGFA
prerank,pentosyltransferase activity (GO:0016763),-0.3688198629292321,-1.3186920499203107,0.10344827586206896,0.47022585964736774,1.0,10/36,15.22%,LARGE1;PARP4;PARP9;PARP16;PARP3;UPP2;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,transaminase activity (GO:0008483),0.6538240993072651,1.3181873703966192,0.15616438356164383,0.487015627464204,1.0,3/11,6.29%,AGXT;OAT;BCAT2
prerank,protein kinase inhibitor activity (GO:0004860),0.508491362349553,1.3172525512875264,0.10648148148148148,0.48538757745022004,1.0,15/42,19.11%,RACK1;NPM1;CAMK2N2;YWHAB;PPP1R1B;CDKN1C;INKA2;ITPRIP;CAMK2N1;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.6038414182553995,1.3166020001978571,0.1384820239680426,0.48304228943540234,1.0,5/14,15.07%,RACK1;RPS27L;MAL;CTSH;BAD
prerank,wide pore channel activity (GO:0022829),0.5513294966664767,1.3122887391932667,0.14035087719298245,0.4923399115449044,1.0,5/23,13.23%,GJA4;GJB2;GJB5;GJD2;GJA1
prerank,acetyltransferase activity (GO:0016407),-0.38436183370116117,-1.3090027474926538,0.10179640718562874,0.48393575002468364,1.0,12/31,19.32%,KAT6B;CREBBP;KAT2B;PAFAH2;SMARCE1;NAA16;NAA15;ESCO1;KAT6A;SPHK1;KAT8;DBT
prerank,glucuronosyltransferase activity (GO:0015020),-0.4397354411940494,-1.3079862999437173,0.12437810945273632,0.4782233120735573,1.0,2/19,1.07%,LARGE1;EXT1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.5768576396637783,1.30671791100838,0.14624505928853754,0.50530158876389,1.0,7/17,17.36%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3
prerank,acid-thiol ligase activity (GO:0016878),-0.48322033609198556,-1.3063438176771938,0.14652014652014653,0.4742412215192669,1.0,9/13,38.04%,ACSS3;ACSL1;SLC27A2;ACSS1;AACS;ACSM3;SLC27A5;ACSM2B;ACSM2A
prerank,metalloendopeptidase activity (GO:0004222),-0.31335930136485945,-1.3060620507644418,0.08571428571428572,0.4672428122917999,1.0,17/76,11.77%,ADAMTS10;TRABD2B;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;ADAMTSL5;ADAMTS9;ADAMTSL4;NRDC;ADAMTS5;ADAM9;ADAM33;ADAM19;ADAMTS6;NLN;ADAMTS14
prerank,mRNA binding (GO:0003729),0.4390367922930965,1.3059764205259479,0.011022044088176353,0.5034937652507969,1.0,28/249,5.63%,RPL41;RPL26;MRPL13;RPS3;RPS14;RPS5;RPS7;RPL5;RPS13;RPS2;RPL13A;RPS26;RPL7;PCBP1;CALR;RPL35;PARK7;HNRNPAB;EIF4G2;EIF3D;SHFL;HNRNPK;QKI;PKM;ZFP36L1;NCL;RBFOX3;PCBP4
prerank,histone acetyltransferase activity (GO:0004402),-0.37971666419941114,-1.3057819443839276,0.09701492537313433,0.4601730970453772,1.0,9/30,13.32%,KAT6B;CREBBP;NAA40;EPC1;KAT7;KAT2B;ATF2;MCM3AP;KAT6A
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.6030981862612255,1.3052419089770573,0.15332428765264586,0.5013384887294077,1.0,6/14,17.36%,NME1;AK4;NME4;NME2;CMPK2;NME3
prerank,carboxylic acid binding (GO:0031406),0.5050941978272676,1.3020673359626675,0.12354312354312354,0.5066753284002955,1.0,13/38,21.80%,PSAP;GRIN1;EPDR1;GRIN3A;GRM7;GLRA2;GLRA1;NOS2;GLUD1;GRIN2B;GLRA3;SHMT2;MAG
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5047428862329367,-1.2986223082472996,0.1288135593220339,0.4683204393175382,1.0,6/11,18.18%,CFLAR;CASP12;CASP3;CASP8;CASP7;CASP4
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.30426213013020026,-1.2965746911127936,0.0,0.46509777666785335,1.0,24/100,11.07%,PARD3;GAB2;FCHSD2;OSBPL8;ZFYVE1;MAPKAP1;PLA2G4A;OGT;MYO1B;PLEKHA4;ADAP2;SNX12;SESTD1;DENND1A;ANKFY1;ATG2B;GBF1;HIP1;DAPP1;ATG2A;SNX24;KIF16B;DENND1B;FERMT2
prerank,CCR chemokine receptor binding (GO:0048020),0.5205360390001027,1.2943431518094182,0.14303030303030304,0.5263389494572626,1.0,7/28,18.30%,CCL19;NES;NARS1;CCL2;CCL3;CCL8;CCR2
prerank,aspartic-type peptidase activity (GO:0070001),0.6354878358617172,1.2943069613144464,0.16355810616929697,0.5221281803505837,1.0,4/10,22.15%,CTSD;NAPSA;BACE1;CTSE
prerank,endodeoxyribonuclease activity (GO:0004520),0.5496442130132382,1.2931487761568488,0.15889029003783103,0.5211811189076367,1.0,2/20,3.48%,RPS3;ENDOG
prerank,GABA receptor activity (GO:0016917),0.5512665715500802,1.2903034002090012,0.17288557213930347,0.5260735789126622,1.0,10/21,29.77%,GABRB1;GABRG3;GABRA2;GABRA3;GABRB3;GABRB2;GABBR2;GABRA4;GABRG2;GABRA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6357394260215988,1.2881307743488528,0.1950207468879668,0.5286332917134514,1.0,7/10,32.98%,GABRG3;GABRA2;GABRA3;GABRA4;GABRG2;GABRA1;GABRG1
prerank,GTP binding (GO:0005525),0.4329888040708605,1.2868933816684478,0.043434343434343436,0.5284515727465503,1.0,48/172,19.61%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;ARF5;RAC1;TUBA4A;RHOG;RAB14;ADSS1;ARL11;TUBB4A;TUBB2B;SCG5;ARF6;RHOV;GNAI1;ARL4C;ARL4D;ARL1;HRAS;RHEBL1;RHOA;RHOU;GTPBP10;RRAS;ARF1;ARL2;RAB26;RRAGC;ARF4;RRAGD;NUDT16;RAC2;TUBB2A;GLUD1;AGAP2;TSR1;ANXA6;RAB31;RAB4A
prerank,histone methyltransferase binding (GO:1990226),0.6220444660568509,1.2847631568028228,0.16644113667117727,0.5309317394952138,1.0,6/11,21.92%,HSP90AB1;CTNNB1;PRDM12;CBX3;PHF1;NOP56
prerank,neuropeptide hormone activity (GO:0005184),0.5287534526255421,1.2817752238339948,0.17202970297029702,0.535997656164941,1.0,8/22,18.27%,PENK;CRH;CALCB;PPY;HCRT;CCK;ADCYAP1;NMB
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5873107350510043,1.2790156451209431,0.168,0.5401360469906743,1.0,7/14,12.67%,SLC17A8;SLC1A2;SLC25A13;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,anion channel activity (GO:0005253),0.47195881362338593,1.2733465419063863,0.11279826464208242,0.5536201022399697,1.0,16/61,18.96%,GABRB1;FXYD1;LRRC8A;SLC1A4;GABRG3;GABRA2;GLRA2;GLRA1;GABRA3;GABRB3;CLIC1;TTYH3;GABRB2;ANO4;GLRA3;VDAC2
prerank,hexosaminidase activity (GO:0015929),0.5987923913805564,1.2732909585940482,0.18915159944367177,0.5494650915307338,1.0,3/12,5.82%,HEXB;HEXA;HYAL2
prerank,growth factor activity (GO:0008083),0.45172725516065143,1.2708389959924606,0.12159329140461216,0.5530010727868281,1.0,21/74,25.43%,MDK;GRN;NRG3;NRG1;AGT;PDGFB;IL2;IL11;IGF2;PDGFA;JAG2;INHBA;IL6;HGF;OSGIN1;THPO;TGFA;PTN;FGF22;INHA;CSPG5
prerank,chloride channel activity (GO:0005254),0.472742922274456,1.2704453360639059,0.12581344902386118,0.5501636435082959,1.0,15/59,18.83%,GABRB1;FXYD1;SLC1A4;GABRG3;GABRA2;TTYH1;GLRA2;GLRA1;GABRA3;GABRB3;CLIC1;TTYH3;GABRB2;ANO4;GLRA3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.47395392016375,1.268809674581376,0.12806236080178174,0.5508183405024732,1.0,24/49,31.22%,ANXA5;SYT1;SYT12;SYT11;RPH3A;SYT6;SYT4;PLA2G4F;CPNE5;SYT10;CPNE6;SYT2;DOC2B;ANXA6;CPNE4;C2CD5;SYT3;SYT5;SYT17;CPNE3;PCLO;CPNE9;SYT7;MCTP1
prerank,protein kinase activator activity (GO:0030295),0.4528540392984655,1.2639157360122555,0.13504823151125403,0.5615019779532604,1.0,17/60,19.10%,RPLP1;CALM1;MT3;CALM3;NRG1;GRM5;CD24;CDK5R1;GAS6;STK11;IGF2;FGF13;ERCC6;AGAP2;ERBB3;MAP2K2;CALM2
prerank,potassium channel activity (GO:0005267),0.4469605665608841,1.2586716380639602,0.11075949367088607,0.5729190177823777,1.0,29/89,21.95%,KCNQ3;KCNQ2;KCNC3;KCND2;GRIK5;GRIK2;AQP1;KCNC1;KCNA2;KCNN2;KCNK9;ABCC8;KCNE5;KCNF1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;KCNH7;KCNMA1;KCNH8;KCNK13;KCNQ5;PKD2L1;TMEM38B;KCNC2;GRIK1
prerank,ion channel activity (GO:0005216),0.45080517865070824,1.2546381478893907,0.11395101171458999,0.5808195514507472,1.0,27/80,22.36%,GABRB1;GRIA2;LRRC8A;GRID2;GRIK5;GRIK2;GRIN1;GRIN3A;TMEM63B;CNGA3;GRIA4;GRIN2A;GRID1;TRPM2;GRIA1;CHRNA4;TRPC1;KCNK3;CNGB1;UNC80;GRIN2B;ANXA6;CALHM6;PKD2L1;GRIA3;GRIK1;CHRNA3
prerank,small GTPase binding (GO:0031267),-0.2792061387114402,-1.2537029057233235,0.0,0.5538325159448321,1.0,41/170,13.60%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;EXOC4;RNF152;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;FGD4;RAF1;ANKRD27;EXOC2;NOX1;DOCK7;UNC13B;NCKAP1;RAPGEF6;CDC42EP5;RABGAP1;ANKFY1;NUTF2;GGA2;TRIOBP;RNF41;PICALM;ALS2;OPTN;GOLGA5;PDE6D;MYO9B;RIC1;ARHGEF2;DVL3;RAB3GAP2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5702306511498977,1.2536442778756638,0.1994851994851995,0.5757263545870647,1.0,4/16,11.17%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5702306511498977,1.2536442778756638,0.1994851994851995,0.5757263545870647,1.0,4/16,11.17%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2
prerank,chemoattractant activity (GO:0042056),0.511444579932613,1.2518832085873441,0.19612590799031476,0.5770409616338303,1.0,6/26,9.82%,GPNMB;PDGFB;LGALS3;MIF;CXCL10;HMGB1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4888344545118066,1.2515749969718994,0.1672473867595819,0.5738572399284679,1.0,12/37,18.78%,LARS2;GARS1;SARS1;SARS2;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;EPRS1;QARS1
prerank,ankyrin binding (GO:0030506),0.5427212235327644,1.250044880183485,0.18297331639135958,0.5744619757981082,1.0,6/19,15.65%,KCNQ2;PTPRC;PLEC;NRCAM;SLC8A1;SPTBN4
prerank,ATPase binding (GO:0051117),0.4490014456435444,1.2470486022594454,0.1405579399141631,0.5794627944192289,1.0,27/71,21.40%,S100A1;UBXN1;GABARAPL2;ATP6V1G1;ATP5IF1;FBL;ATP1B2;PLN;PIH1D1;TAF9;SVIP;WFS1;SYVN1;TMEM106B;TRPC1;BBC3;DNAJB1;ATP1B1;NR1H2;CAV1;BRSK2;ATP1B3;DNAJC10;PPP3CA;SNU13;RALB;SELENOS
prerank,CXCR chemokine receptor binding (GO:0045236),0.5950404304304222,1.2452327704145958,0.214992927864215,0.5809617405977001,1.0,3/11,14.72%,CXCL12;CXCL10;PF4
prerank,ATP hydrolysis activity (GO:0140603),0.4778106093318151,1.2448537853838484,0.1732283464566929,0.5780146018033185,1.0,21/41,32.13%,CLU;HSP90AA1;HSPA1B;ABCB6;VCP;KIF26A;ATP2B1;HSPA1A;ABCB10;CHD3;TDRD9;ABCA3;KIF20B;RUVBL2;DHX9;RHOBTB3;TOR3A;ABCD2;MYO1E;DNA2;DDX3X
prerank,peptidoglycan binding (GO:0042834),0.6001667744638244,1.2443812102825171,0.24397163120567375,0.5756015788687472,1.0,8/10,36.12%,PGLYRP1;NLRP3;RNASE7;TLR2;NOD2;JCHAIN;NOD1;HK1
prerank,iron ion binding (GO:0005506),0.46834346145664085,1.24429314198205,0.16799091940976163,0.5719762166214274,1.0,4/48,3.05%,FTH1;FTL;SCD5;DOHH
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4771861702099087,-1.2432660429213862,0.1950354609929078,0.5688470681063152,1.0,3/12,4.54%,GAB2;FRS2;IRS1
prerank,zinc ion binding (GO:0008270),0.4150292391359197,1.2363060338785294,0.03507014028056112,0.592480079419655,1.0,38/293,9.76%,CRIP1;RPS29;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;RPS27;CRIP2;CALR;MT3;TIMM8B;TIMM13;SOD1;MT2A;TIMP2;S100B;S100A13;CA2;GLO1;CZIB;S100A8;S100A9;GALT;TRIM28;CALB1;ENPP2;GRIN2A;CSRP1;TIMP1;TRIM2;EGR1;ATP13A2;RPH3A;ALAD
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.584372267972569,1.2361783357151626,0.22544951590594745,0.5888579182295866,1.0,4/12,15.07%,RACK1;RPS27L;CTSH;BAD
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.25548773225879634,-1.2351488478700634,0.0,0.5785999970202905,1.0,29/173,11.42%,ZBTB20;FOXP1;FOXP2;ZEB1;ZNF148;PRDM5;KLF12;MXI1;ZBTB16;SKI;PPARA;ZFP90;FOXO3;NFATC4;FOXP4;NFKB1;FOXK2;ZFHX3;KCNIP3;ZBTB1;ZBTB26;NFX1;PPARG;ETV6;KLF8;FOXK1;ZKSCAN3;MZF1;NFATC3
prerank,SUMO binding (GO:0032183),-0.4716496836930918,-1.2324759028235095,0.22134387351778656,0.5771813961776451,1.0,5/13,20.35%,PML;TDG;CBX4;RNF111;HERC2
prerank,AMP binding (GO:0016208),-0.47066883229281276,-1.2321855051194204,0.23024054982817868,0.5695842666692982,1.0,2/11,0.48%,PRKAG2;MPPED2
prerank,phosphate ion binding (GO:0042301),0.6072055627580926,1.2320079027258348,0.23537604456824512,0.5980581826086943,1.0,6/10,24.93%,ADSS1;RPH3A;PNP;CHST14;RELA;PDE2A
prerank,guanyl ribonucleotide binding (GO:0032561),0.4134070026141148,1.2319445517465333,0.07560483870967742,0.5942787706710755,1.0,55/196,19.61%,EEF1A1;TUBB;TUBA1A;TUBA1B;TUBB4B;RHOB;NME1;TGM2;TUBAL3;RAN;RHOC;ARF5;RAC1;TUBA4A;RHOG;RAB14;CNGA3;ADSS1;CNGA4;ARL11;TUBB4A;TUBB2B;SCG5;ARF6;RHOV;GNAI1;ARL4C;ARL4D;ARL1;HRAS;RHEBL1;RHOA;SLC19A1;NME2;RHOU;GTPBP10;RRAS;ARF1;ARL2;RAB26;RRAGC;ARF4;CNGB1;RRAGD;NUDT16;RAB5C;RAC2;TUBB2A;GLUD1;AGAP2;TSR1;ANXA6;RAB18;RAB31;RAB4A
prerank,transition metal ion binding (GO:0046914),0.40888985756624996,1.2301290156725926,0.022,0.5960071436301736,1.0,59/397,13.12%,FTH1;FTL;CRIP1;RPS29;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;RPS27;ATOX1;SCD5;CRIP2;CALR;MT3;TIMM8B;TIMM13;PARK7;SOD1;MT2A;TIMP2;S100B;PRNP;DOHH;S100A13;COX17;CA2;GLO1;CZIB;ANG;S100A8;S100A9;GALT;TRIM28;CALB1;ENPP2;GRIN2A;CSRP1;TIMP1;TRIM2;EGR1;ATP13A2;RPH3A;ALAD;SMPD1;AOC3;SCD;MGAT2;LCN2;GLRA1;ISCU;ZCCHC4;KLF4;THAP11;CUTA;MSRB1
prerank,calcium channel inhibitor activity (GO:0019855),0.5991991233724474,1.2287457908405512,0.23504273504273504,0.5965386932080955,1.0,6/11,19.10%,CALM1;SLC30A1;FKBP1A;PHPT1;FKBP1B;CALM2
prerank,protein kinase regulator activity (GO:0019887),0.4312641396241237,1.2286028883817042,0.14507772020725387,0.5930028744872063,1.0,28/95,19.11%,RPLP1;MT3;CCNI;CCND2;NPM1;CSNK2B;YWHAB;PPP1R1B;CDKN1C;CCND1;CXCL10;PRKAR1A;CDK5R1;PRKAR1B;ELP3;ITPRIP;CCNG1;MAPK8IP1;STK11;HEXIM1;FGF13;GMFB;PRKAR2B;CCNJL;PRKRIP1;AGAP2;QARS1;SNCA
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4789489520939507,-1.2254129293610159,0.21223021582733814,0.5785596126087649,1.0,4/12,10.33%,PAN3;CNOT1;PARN;CNOT7
prerank,potassium channel regulator activity (GO:0015459),0.4604984617308554,1.225276675918824,0.17497231450719822,0.5993193333675974,1.0,12/49,17.39%,KCNIP4;AKT1;DPP10;FLNA;YWHAE;SGK1;DPP6;KCNE4;KCNE5;KCNIP1;ARPP19;LRRC55
prerank,single-stranded telomeric DNA binding (GO:0043047),0.5953239150413109,1.223148363077744,0.21715076071922546,0.6019155654695624,1.0,5/11,18.54%,TERF1;RPA2;HNRNPA1;CTC1;TERF2IP
prerank,neuropeptide receptor activity (GO:0008188),0.49118432749842345,1.2225626855307925,0.21299638989169675,0.5998540395863775,1.0,8/29,22.00%,NPY1R;SORCS1;SSTR4;TACR1;SORCS3;GRPR;NPY5R;SSTR2
prerank,DNA polymerase binding (GO:0070182),0.5374758615903946,1.2224894609555101,0.21923076923076923,0.5962585066199237,1.0,5/18,14.87%,HSP90AA1;HSP90AB1;HMGB1;PCNA;PTGES3
prerank,kinesin binding (GO:0019894),0.5054941614361446,1.2220436640140473,0.23433583959899748,0.593821999544743,1.0,8/27,19.11%,ACTB;NEFH;MAPK8IP1;MAPK8IP2;CLSTN1;FAM83D;ATCAY;SNCA
prerank,exopeptidase activity (GO:0008238),0.46120427468953173,1.2219668671901387,0.19911504424778761,0.5903096307668083,1.0,13/50,16.28%,CTSZ;RCE1;METAP1;DPEP3;DPP10;CPE;DPEP2;DPP6;METAP2;CTSA;LAP3;CTSH;NUDT16
prerank,nucleoside-triphosphatase activity (GO:0017111),0.40732658497346363,1.214428351409382,0.0732196589769308,0.6094328232035627,1.0,68/248,23.20%,EEF1A1;MYL6;CLU;EEF2;HSP90AA1;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;GNG11;RAC1;GNA11;PIN1;HSPA1B;ABCB6;EEF1A2;VCP;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;RHOV;KIF5A;GNG3;KIF26A;GNAI1;NKIRAS1;GNAO1;MYL6B;ARL1;HRAS;ATP2B1;RHEBL1;HSPA1A;RHOA;NKIRAS2;RHOU;GTPBP10;RRAS;ARL2;ABCB10;RRAGC;RRAGD;RAB20;RAB5C;DNM1L;RAC2;AGAP2;TSR1;RAB18;RAB31;RAB4A;CHD3;GPN3;RAB6B;RALB;RERG;TDRD9;RAB27B;RAB28;DNM1;MTG2;KIF1A;NUGGC
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.39466624234247993,-1.2124200175788191,0.17307692307692307,0.6022029835319882,1.0,5/21,7.04%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,receptor ligand activity (GO:0048018),0.4071288489277011,1.212004966869207,0.06018054162487462,0.6129622487368349,1.0,64/245,23.40%,MDK;GRN;GPNMB;NBL1;NRG3;NPPC;NRG1;POMC;AGT;TAFA1;TNF;SEMA3F;PDGFB;LGALS3;SEMA7A;AMH;MIF;SEMA4C;LRPAP1;LEFTY2;SEMA6D;CXCL10;TNFSF12;IL2;CRH;TIMP1;HMGB1;KITLG;SEMA4A;WNT5A;IL11;PPY;NTS;SEMA4G;BMP2;CCK;GAS6;WNT10B;LEFTY1;SLURP1;GDF15;IGF2;PDGFA;JAG2;CCL3;NMB;SCGB3A1;EDN3;INHBA;IL6;HGF;TGFB1;OSGIN1;THPO;GDF11;CRLF1;SST;INHBB;TGFA;SCG2;ERFE;WNT7A;PTN;FAM3C
prerank,methylated histone binding (GO:0035064),-0.30144129125340896,-1.2107735014839984,0.09722222222222222,0.5981211576984182,1.0,26/62,23.60%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;MORC3;ZCWPW2;LRWD1;PHF8;ING2;FMR1;TAF7;KAT8;L3MBTL2;MORC4;ZCWPW1;DPF2;TAF1;CHD5;NCAPD3;RRP8;CBX8;ZMYND8
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.3746402925915445,-1.2095918934795398,0.18478260869565216,0.5930593852815308,1.0,5/27,6.28%,ITPR1;ITPR2;CNNM2;SLC9B2;TUSC3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.378147751625041,-1.2085136270044405,0.19487179487179487,0.5875947288035428,1.0,8/25,15.22%,PARP4;PARP9;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,GTPase regulator activity (GO:0030695),-0.2664185554689046,-1.206663838784551,0.0,0.584640306644902,1.0,54/212,13.71%,ARHGAP29;RANBP3L;ARHGAP28;SIPA1L1;ARHGAP20;ARHGAP10;ASAP3;ALDH1A1;ASAP1;ARHGAP17;LRRK2;ARHGAP42;ARFGEF1;RANBP2;RAPGEF2;SGSM2;SLIT2;NRP1;USP6NL;TBC1D12;ERRFI1;RALGAPB;SMAP1;ARHGEF10L;ASAP2;STARD13;SIPA1L3;TBC1D2B;RABGAP1;ARHGAP32;RIC8B;TBC1D9B;BCR;TBC1D4;ARHGEF6;SYDE2;ALS2;ARHGAP31;KRIT1;TBC1D8B;TBCK;OPHN1;PDE6D;DOCK1;MYO9B;SIPA1;ARHGAP18;SMAP2;RALGAPA1;STXBP5;WNT11;RGS16;RAB3GAP2;RAP1GDS1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.28260302100805523,-1.2059164428399995,0.0,0.5786192578345649,1.0,92/335,14.72%,ROCK2;GRK5;EGFR;MAPK4;STK3;ACVR1;DAPK1;BMPR1A;LRRK2;ROCK1;SIK3;FAM20A;BRD4;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K13;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RAF1;ARAF;TLK2;TGFBR1;CASK;IRAK3;STK24;WNK4;SNRK;CDK12;CDK6;EIF2AK3;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MYLK;MARK3;MAPKAPK3;TOP1;SIK1;PRKD3;TAOK3;BCR;PRKAA2;NEK6;AAK1;STK10;MAPK9;HIPK3;CLK1;NEK7;MAP4K4;ALPK1;NRK;RIPK1;MAP4K3;CCNK;TESK2;DMPK;PDIK1L;CDK13;NUAK1;SLK;DAPK2;TRIO;TBK1;LATS2;MAPK6;NEK3;STK38;CLK4;ATM;CSNK2A1;CSNK2A2;NLK;ULK2;PRKD1;SRPK2;IRAK4;GSK3B;MARK2;PRKCI;CDK7;CDKL3;TAOK1
prerank,acylglycerol lipase activity (GO:0047372),0.5887204198941376,1.202996721322791,0.27097661623108665,0.6365732222504714,1.0,5/11,28.06%,LIPE;FAAH;ABHD16A;ABHD12;MGLL
prerank,ion channel inhibitor activity (GO:0008200),0.47165934293242595,1.201268709689706,0.2270081490104773,0.6381059600247676,1.0,7/35,12.48%,RACK1;CALM1;SLC30A1;FKBP1A;PHPT1;VAMP8;RSC1A1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.41574800798577016,-1.1992217339046025,0.23357664233576642,0.5874275080602359,1.0,5/16,12.80%,MTMR3;MTMR11;PTEN;SACM1L;MTMR10
prerank,G protein-coupled receptor binding (GO:0001664),0.40881230923350187,1.1940289717577421,0.1377551020408163,0.6569999800339179,1.0,25/132,14.29%,HSPA8;GNAI2;CXCL12;CCL19;POMC;HOMER2;GNA11;HSPA1B;FLNA;S1PR1;PENK;INSL5;PDYN;REEP2;GNAI1;GNAO1;CALCB;WNT5A;DNAJA1;PPY;NTS;GPRASP2;HSPA1A;WNT10B;SDCBP
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4885108047250261,1.1933310861298634,0.2514827995255042,0.6552629469796546,1.0,9/27,21.89%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4881423732019201,1.1923444901552864,0.23236009732360097,0.6543277838063352,1.0,10/26,23.30%,B4GALNT1;B4GALNT4;B3GNT9;CHPF2;CHPF;B3GNT3;CSGALNACT2;CHSY3;B3GALT5;B3GALT2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.47038362756465857,-1.1907638475086118,0.2560553633217993,0.6003318518622148,1.0,2/11,2.98%,KCNK2;KCNT2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5083025387934816,1.1887329814460805,0.25925925925925924,0.6614185091749383,1.0,8/22,23.57%,ATP6V0C;ATP5F1B;ATP6V0E2;ATP6V0D2;ATP6V1A;ATP2A2;ATP6V0A1;ATP6V0B
prerank,potassium:proton antiporter activity (GO:0015386),-0.48036921980836805,-1.1868275124515533,0.2598684210526316,0.6027445833621147,1.0,3/10,12.18%,SLC9A1;SLC9A2;SLC9A8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5738788535330462,1.1860785158261107,0.27350427350427353,0.6660497584384748,1.0,5/10,27.73%,APOBEC2;APOBEC1;CDA;GDA;ADA
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.263384331030645,-1.185528697150692,0.0,0.5986856972788681,1.0,38/188,11.45%,ZBTB20;PBX1;SMAD3;BNC2;TCF7L2;SMAD6;PRDM5;TCF12;SOX5;GABPB2;DHX36;HDAC4;PER2;NFYC;YAP1;PER3;FOXO3;NCOR1;TBL1X;SP1;NFKB1;BCOR;FOXK2;ARID4B;STAT3;VSX1;ARID5B;ASH2L;TBL1XR1;PPARG;FOXK1;SMAD4;ATF6;CREB3L2;HNRNPL;BRD7;MZF1;KMT2D
prerank,galactosyltransferase activity (GO:0008378),-0.4507457699382954,-1.184111447281843,0.2636986301369863,0.5946233189623462,1.0,2/11,1.61%,A4GALT;B4GALT1
prerank,semaphorin receptor activity (GO:0017154),-0.4677767822159235,-1.1829697339330287,0.25806451612903225,0.5900918032841458,1.0,4/11,15.29%,PLXNA2;NRP1;NRP2;PLXNA4
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5073230599910867,1.1821371117795154,0.26947637292464877,0.6745213669010837,1.0,4/20,7.01%,SLC30A1;SLC39A1;SLC39A10;SLC39A7
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5500098729631467,1.181927752689889,0.2853297442799462,0.6712567400463637,1.0,3/13,9.10%,SLC38A5;SLC25A29;SLC15A4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.571746225154093,1.181266942962846,0.2839335180055402,0.6693446766564981,1.0,4/12,27.17%,H3-3A;TBP;RELA;RUVBL2
prerank,anion:anion antiporter activity (GO:0015301),0.5237432163881048,1.1804253824719915,0.25997425997426,0.6682183344856023,1.0,6/17,18.49%,SLC25A5;SLC25A4;SLC26A4;SLC25A11;SLC19A1;SLC4A2
prerank,transferrin receptor binding (GO:1990459),0.5837665493493498,1.1746408900705911,0.29656160458452724,0.6830504481486014,1.0,1/10,1.05%,CD81
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2939990096019813,-1.1719609776360629,0.19298245614035087,0.6106804882621696,1.0,17/71,11.93%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PTPN14;TNS2;MTMR3;PTPN3;PALD1;CDC14A;EYA4;PTPN12;CDC25B;PTEN;EYA3;PTPN2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5732179428700273,1.169281116770221,0.30575035063113604,0.6958156214478727,1.0,4/10,22.23%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,FAD binding (GO:0071949),-0.35550025739409075,-1.1683960620768714,0.21182266009852216,0.6117815006088089,1.0,6/24,10.16%,MICAL3;MICAL2;DDO;MTHFR;SQOR;PRODH
prerank,voltage-gated potassium channel activity (GO:0005249),0.4158798447210243,1.1683919008636159,0.22316684378320936,0.6947064433193909,1.0,23/80,24.67%,KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;KCNC1;KCNE4;KCNA2;KCNN2;KCNE5;KCNF1;HCN1;KCNA1;LRRC55;HCN3;KCNH7;KCNMA1;KCNH8;KCNQ5;KCNC2;KCNJ3;KCNG3;KCNJ6
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.25950490870799725,-1.1665214243807158,0.0,0.6092020863888349,1.0,60/254,16.61%,NFIA;NFAT5;SMAD3;NFIB;TCF4;HOXB3;PRRX1;TCF12;HLF;ZBTB16;ELF1;NFYC;HOXA5;NRF1;PPARA;HOXC4;NFATC1;FOXO3;TFCP2;MEOX2;SP1;NFKB1;FOXK2;MDM4;STAT3;SMAD1;MEF2A;PRDM15;TFDP1;MYBL1;ATF2;CREBRF;ESR1;NR2C2;SMAD4;ATF6;ELF4;GMEB1;MZF1;NFATC3;RBPJ;AR;RREB1;SIX1;HSF2;KLF7;NFIC;SMAD2;RLF;ZFP62;TFCP2L1;MLXIP;MDM2;IRF2;NFYB;HINFP;FOXO1;TP53;NR3C1;MITF
prerank,potassium ion antiporter activity (GO:0022821),-0.40905663427791455,-1.1650953156361887,0.22868217054263565,0.6052523000547573,1.0,3/15,2.68%,SLC24A3;SLC9A1;SLC9A2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4611077720044427,-1.1636849784801988,0.25796178343949044,0.6014686828218637,1.0,6/11,20.60%,PRMT9;FBXO11;CARM1;PRMT6;NDUFAF7;PRMT8
prerank,lysine N-methyltransferase activity (GO:0016278),-0.3754270923087679,-1.1631708994858563,0.24757281553398058,0.5958248638742223,1.0,9/20,20.46%,SETD2;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.44968874431423617,-1.1619682626365602,0.2339622641509434,0.5922300763151769,1.0,5/12,10.49%,TGFBR3;ACVR1;BMPR1A;TGFBR1;LTBP1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5586784033497262,1.1619621645844531,0.32162921348314605,0.7070930093613955,1.0,4/11,14.26%,BAG5;PFN1;BAG1;HSPBP1
prerank,adenyl nucleotide binding (GO:0030554),0.5586784033497262,1.1619621645844531,0.32162921348314605,0.7070930093613955,1.0,4/11,14.26%,BAG5;PFN1;BAG1;HSPBP1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3859307617814295,-1.1586489016248613,0.24761904761904763,0.5937198349991055,1.0,8/18,16.73%,TGFBR3;ACVR1;BMPR1A;TGFBR1;LTBP1;ACVR2A;BMPR2;ACVR2B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5576140084128558,1.1579182898161093,0.2988505747126437,0.7157285756587846,1.0,4/11,27.91%,CHRNA9;CHRNA4;CHRNA3;CHRNA7
prerank,phospholipase activity (GO:0004620),0.42479827655403285,1.1559888580945812,0.22556390977443608,0.7177073023520096,1.0,14/67,14.12%,PRDX6;LYPLA2;PLD3;PLAAT3;LIPG;PDIA3;ENPP2;PNPLA7;LPL;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2
prerank,kinase binding (GO:0019900),0.3850896747404808,1.1541118374975938,0.088,0.7196921030056697,1.0,78/434,13.60%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;CALM1;GSN;HSPB1;HSP90AB1;ACTA2;PGAM1;PARK7;RHOB;ATF4;RPS6;CALM3;ITGB2;CCND2;NPM1;PEBP1;CAMK2N2;PFKL;RHOC;EMP2;TOLLIP;PTPRC;HCLS1;RAC1;TUBA4A;ACVRL1;DLG2;CHEK2;CAV2;PARP1;DUSP3;CTNNB1;NEFH;FLNA;EEF1A2;SNAP91;BAG5;ADD2;SHC3;BTG1;FRMD5;TFRC;RHOG;MSN;CCND1;INKA2;HNRNPA0;CEBPA;CLTC;THY1;MAPT;CD24;UNC5C;CDK5R1;CADPS;ZFP36;ARHGEF7;PIH1D1;PIK3IP1;CDC37;ATF5;WARS1;FBXW5;ATP1A4;DOK7;CAMK2N1;SYN1;PTPRR;DCTN1;RHOA;SRCIN1;FBXO5;YWHAZ
prerank,cAMP response element binding (GO:0035497),-0.4649624698989756,-1.1528403320518867,0.30716723549488056,0.6007312448631663,1.0,4/10,11.14%,ATF7;CREB5;ATF2;CREB3L2
prerank,acetylcholine receptor activity (GO:0015464),0.4845809501568576,1.1512996162092195,0.2925,0.724533815915339,1.0,7/22,27.91%,CHRM3;CHRM2;CHRNA4;CHRM5;CHRNA3;CHRFAM7A;CHRNA7
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4518175520516192,-1.1501797418021324,0.2808219178082192,0.6008685634833452,1.0,3/11,3.53%,SLC1A3;SLC6A13;SLC6A12
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5235122134918335,1.1498750072574506,0.32340425531914896,0.7248265861837656,1.0,3/12,13.31%,SLC25A5;LRRC8A;SLC19A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.4529804013631533,1.1488421854222277,0.295662100456621,0.7241915629527089,1.0,12/32,26.36%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC3A2;SLC1A1;MFSD12;SLC7A10;SFXN1;SLC43A2;SLC38A3;SLC6A9
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5315803525197771,1.1484835978391796,0.31713900134952766,0.7212576575489593,1.0,5/13,16.89%,PRKAR1A;PRKAR1B;SOX9;RYR2;PRKAR2B
prerank,NAD+ binding (GO:0070403),-0.4451087706484026,-1.1477527841380466,0.2798507462686567,0.6001804280401732,1.0,5/12,20.89%,CRYL1;PARP9;SIRT1;ZC3HAV1;SIRT6
prerank,voltage-gated cation channel activity (GO:0022843),0.4048411911086865,1.1435940103128135,0.23044838373305526,0.7333166587607856,1.0,32/97,25.26%,KCNQ3;KCNQ2;KCNC3;KCND2;GRIN1;CACNA1A;GRIN3A;GRIN2A;HVCN1;KCNC1;KCNA2;KCNE5;KCNF1;HCN1;KCNA1;CACNG8;LRRC55;HCN3;GRIN2B;NCS1;KCNH7;KCNMA1;KCNH8;CACNG5;KCNQ5;CACNB4;KCNC2;CACNA1E;CACNG2;KCNG3;CACNA2D1;CACNA1B
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4511103118179586,1.1426430043836682,0.3037825059101655,0.7321393453514554,1.0,8/30,15.43%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TTYH1;SLC40A1;SLC11A1;SLC31A1
prerank,neurexin family protein binding (GO:0042043),0.5671545604351936,1.1394284939704566,0.3509544787077827,0.7385237634812253,1.0,4/10,18.58%,NLGN1;CPE;SYTL2;SYTL1
prerank,GTPase activity (GO:0003924),0.38385536307476675,1.1387471381432095,0.19678714859437751,0.7369238130173725,1.0,52/192,23.20%,EEF1A1;EEF2;GNAI2;RHOB;GNB2;GNG5;RAN;RHOC;GNG11;RAC1;GNA11;EEF1A2;DNM3;ARHGDIB;RHOG;SAR1A;RAB14;RAB3C;RHOV;GNG3;GNAI1;NKIRAS1;GNAO1;ARL1;HRAS;RHEBL1;RHOA;NKIRAS2;RHOU;GTPBP10;RRAS;ARL2;RRAGC;RRAGD;RAB20;RAB5C;DNM1L;RAC2;AGAP2;TSR1;RAB18;RAB31;RAB4A;GPN3;RAB6B;RALB;RERG;RAB27B;RAB28;DNM1;MTG2;NUGGC
prerank,protein kinase C binding (GO:0005080),0.43454201200430514,1.1379912218351607,0.2862029646522235,0.735260622353168,1.0,14/43,16.86%,RACK1;HSPB1;HINT1;TIRAP;CAVIN3;NELL1;PKN1;YWHAG;ADCY4;HDAC5;CCDC88A;DACT3;HDAC9;SQSTM1
prerank,ubiquitin binding (GO:0043130),0.4119385869781728,1.135822435591853,0.2765957446808511,0.7376998569381344,1.0,25/73,22.19%,HSPB1;UBXN1;TOLLIP;AUP1;UCHL1;TNFAIP3;USP5;UBAP1L;RBCK1;BUB3;VPS28;DNAJB2;FBXW7;CXCR4;RNFT1;OTUB1;SQSTM1;TRIM32;WDR48;RAD23A;RAE1;USP13;SIRT2;UBXN11;VPS36
prerank,snoRNA binding (GO:0030515),0.4540045720870009,1.1331546424676413,0.3089622641509434,0.7420703911797519,1.0,14/30,23.89%,NOP10;NHP2;WDR3;IMP4;NUDT4;GAR1;NUDT16;TSR1;DKC1;SNU13;IMP3;NOP56;ISG20;NOP14
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.46659854032719994,1.1327241387551532,0.31234866828087166,0.739367292840408,1.0,8/28,16.28%,ELAC2;RNASEH2A;POP7;RNASEH1;APEX1;MRPL44;POP4;NUDT16
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.5180975361889802,1.1323571736162055,0.3242876526458616,0.7366616744805279,1.0,4/14,15.91%,CYBA;CYBB;MICAL1;NCF1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.44261225819311145,-1.1313301301018932,0.3236363636363636,0.6320971316874073,1.0,9/11,43.55%,SLC2A9;SLC5A11;SLC23A1;SLC23A2;SLC2A10;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4209356108473309,-1.1280817482711878,0.3146853146853147,0.6340920080127098,1.0,4/13,12.18%,SLC9A1;SLC9A2;SLC9B2;SLC9A8
prerank,carbohydrate kinase activity (GO:0019200),-0.42710956721012355,-1.1271300362293435,0.2832764505119454,0.6297729755956065,1.0,5/11,19.29%,GALK2;HK2;FGGY;GNE;NAGK
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4623864191811419,1.1267118826243707,0.3341317365269461,0.7501342515310061,1.0,9/27,21.89%,POLR2E;POLR2D;POLR2F;POLR1B;POLR2G;MED21;POLR1D;POLR1H;POLR3K
prerank,G protein-coupled receptor activity (GO:0004930),0.380860071274339,1.125986848611248,0.1891348088531187,0.7485494617989843,1.0,47/239,21.10%,MTNR1A;MTNR1B;GRM5;GPR37L1;ADGRB3;C5AR1;SCTR;ADGRL3;S1PR5;APLNR;S1PR1;DRD5;GPR6;SSTR4;GRM8;ADGRG1;P2RY6;RXFP1;GPR34;TPRA1;VIPR1;LGR6;P2RY1;P2RY12;GRM1;ADGRB1;MC1R;GPR18;ADGRB2;GRPR;CXCR4;CX3CR1;F2RL1;ADGRL4;ADRA1D;ADRA1A;ADGRE1;HCRTR1;ADGRA1;GRM4;GPR83;GPR183;GPR149;NTSR2;GABBR2;ADRA2B;QRFPR
prerank,protein kinase binding (GO:0019901),0.37531919623380056,1.1255193637112417,0.105,0.7462979591763941,1.0,150/479,25.68%,ACTB;EEF1A1;RPS3;RPS7;RPS19;EEF2;RACK1;CALM1;HSP90AA1;HSPB1;ACTA2;PGAM1;RHOB;ATF4;RPS6;CALM3;ITGB2;CCND2;TREM2;HINT1;GRM5;NPM1;PINK1;PEBP1;CAMK2N2;RHOC;EMP2;PTPRC;HCLS1;RAC1;TUBA4A;ACVRL1;CHEK2;PIN1;CAV2;PARP1;DUSP3;TIRAP;SIRPA;NEFH;EEF1A2;PDE3B;CAVIN3;SNAP91;BAG5;ADD2;SHC3;FRMD5;TFRC;RHOG;MSN;CCND1;NELL1;INKA2;HNRNPA0;PKN1;CLTC;THY1;YWHAG;PRKAR1A;MAPT;CD24;UNC5C;CDK5R1;CADPS;ZFP36;ARHGEF7;PIH1D1;PRKAR1B;WARS1;FBXW5;DOK7;CAMK2N1;SYN1;PTPRR;DCTN1;SOX9;RHOA;SRCIN1;FBXO5;YWHAZ;ADCY4;HDAC5;CCDC88A;BAD;DCTN2;MAPK8IP2;MAPRE3;RYR2;DACT3;DAB2IP;HDAC9;CAV1;CDH5;CASS4;SQSTM1;PRKAR2B;SKAP1;RAC2;MAP4K2;PRKRIP1;FAM83D;PPP1R15A;AGAP2;CDC25A;ACSL3;CIR1;QARS1;WDR45;CALM2;ANKRA2;DCX;CNKSR2;ARHGAP33;PTPN6;BANK1;DUSP2;MAP2K7;IRF5;AP2A1;STX1B;TNIP1;RCC2;ADIPOR1;DUSP1;DNM1;TRIM68;PARD6A;LLGL1;TWF2;PTPN1;TBL2;PTN;ELAVL1;LYST;RELA;FOXM1;CAVIN2;TCF3;CCNA2;CDKN2B;PPP1CB;VRK1;DNAJC3;PRKACA;INKA1;MAPRE1;CRK;DUSP8;BLNK
prerank,ubiquitin-specific protease binding (GO:1990381),0.4899016969232152,1.1255090793042513,0.31450577663671375,0.7425438292060552,1.0,7/19,21.85%,PARK7;VCP;CLTC;SYVN1;RAD23A;SELENOS;AMFR
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5051170495163075,1.1240001138782723,0.3459037711313394,0.7434872492237569,1.0,10/16,30.04%,SLC1A4;SLC25A13;SLC25A11;SLC1A1;SLC25A22;SLC25A18;SLC25A14;SLC25A12;SLC13A5;SLC25A30
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.41750149653549856,1.1235123794490527,0.2976190476190476,0.7412612861259071,1.0,12/53,12.67%,SLC38A5;SLC17A8;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC15A4;SLC3A2;SLC17A7;SLC17A6;SLC1A1;SLC25A22
prerank,kinase inhibitor activity (GO:0019210),0.4458039230229751,1.1204810665186453,0.3484848484848485,0.7468147178472893,1.0,16/33,27.10%,NPM1;YWHAB;PPP1R1B;CDKN1C;WARS1;ITPRIP;MAPK8IP1;HEXIM1;GMFB;PRKRIP1;QARS1;SNCA;SOCS3;DNAJC3;TRIB1;CDKN1A
prerank,titin binding (GO:0031432),0.5255130712457974,1.1203915572585788,0.3355614973262032,0.743400760023058,1.0,2/13,2.58%,CALM1;CALM3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4501759422548246,-1.1161322317460411,0.3377926421404682,0.6499140790529102,1.0,2/10,3.53%,SLC6A13;SLC6A12
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3969323866877331,1.1148973159332245,0.30053475935828877,0.756489769007505,1.0,9/78,7.53%,CTSB;CTSL;CTSZ;CAPNS1;CTSS;LGMN;UCHL1;USP5;PDIA3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.47550031101408985,1.1145082141226827,0.3269230769230769,0.7465402107539579,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,G protein-coupled amine receptor activity (GO:0008227),0.47550031101408985,1.1145082141226827,0.3269230769230769,0.7465402107539579,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,serotonin receptor activity (GO:0099589),0.47550031101408985,1.1145082141226827,0.3269230769230769,0.7465402107539579,1.0,5/22,17.09%,HTR2C;CHRM3;CHRM2;HTR7;CHRM5
prerank,lipase activator activity (GO:0060229),-0.44186271600432514,-1.1117533965885227,0.29260450160771706,0.6535361210362937,1.0,2/10,4.69%,ARHGAP6;PDPK1
prerank,death domain binding (GO:0070513),0.5269033015548285,1.1115092433142102,0.3547925608011445,0.752278126812195,1.0,2/11,11.32%,RACK1;BAX
prerank,phosphatidate phosphatase activity (GO:0008195),-0.40630845789538805,-1.1103894545756086,0.3137931034482759,0.6501607146968755,1.0,8/13,26.39%,PLPP3;PLPP5;PLPP1;PLPP2;PLPPR1;PLPPR3;LPIN2;LPIN3
prerank,actinin binding (GO:0042805),-0.3548358093785844,-1.10993290475308,0.30392156862745096,0.6447552747262018,1.0,7/21,14.17%,CACNA1C;PDLIM5;NFKB1;PDLIM4;PPARG;SYNPO2;CACNA1D
prerank,calcium-activated potassium channel activity (GO:0015269),0.5305090080932584,1.1084833646560364,0.3657219973009447,0.7575824065940078,1.0,5/11,26.88%,KCNN2;KCNMA1;PKD2L1;KCNN4;KCNMB4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.3424561161072113,-1.1062679862565385,0.28865979381443296,0.6468877159668639,1.0,5/25,13.70%,MICAL3;MICAL2;FMO5;CYP27A1;POR
prerank,nuclear receptor coactivator activity (GO:0030374),-0.28877563682277774,-1.106034302643489,0.21904761904761905,0.6414558255892115,1.0,20/52,22.90%,ZMIZ1;MED13;NCOA1;CCAR1;THRAP3;DCAF6;BRD8;PPARGC1B;CARM1;PRKCB;TACC1;NCOA7;HELZ2;FGF2;MED1;SS18;NCOA6;WDR77;NCOA3;SLC30A9
prerank,mRNA 3'-UTR binding (GO:0003730),0.3950432524681138,1.105138254935975,0.3167372881355932,0.7639931509546122,1.0,17/79,15.64%,RPL41;RPS7;RPL5;ZFP36L1;MEX3D;ZFP36L2;PCBP4;HNRNPA0;ZFP36;TARDBP;ELAVL4;PABPC1;RNF40;HNRNPU;ELAVL3;CIRBP;YBX3
prerank,cytokine activity (GO:0005125),0.3779310585791006,1.1045492358989153,0.28484231943031535,0.7622226563024332,1.0,34/131,23.40%,CXCL12;CCL19;NRG1;TNF;MIF;LEFTY2;CXCL16;CXCL10;IL2;TIMP1;HMGB1;KITLG;WNT5A;IL11;BMP2;WNT10B;LEFTY1;CCL2;PF4;SLURP1;GDF15;CCL3;CCL28;CCL8;SCGB3A1;INHBA;IL6;TGFB1;GDF11;CRLF1;INHBB;SCG2;WNT7A;FAM3C
prerank,cation transmembrane transporter activity (GO:0008324),0.4166353676889463,1.1011853315290718,0.3329608938547486,0.7689030014572589,1.0,8/48,12.43%,SLC38A5;SLC39A1;SLC7A5;SLC1A4;SLC6A6;SLC15A4;SLC3A2;SLC1A1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5302698738680406,1.0997132381503587,0.3688639551192146,0.7696753397244915,1.0,4/11,27.61%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.27983963068707274,-1.099471308773354,0.26229508196721313,0.6518699865215029,1.0,20/72,14.71%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;MYO1B;PLEKHA4;ADAP2;MARK1;SESTD1;HIP1;PICALM;KRIT1;TULP3;KCNJ2;PLCD1;STXBP6;CGAS
prerank,sodium channel activity (GO:0005272),0.43157666222018654,1.0985585588271862,0.3467455621301775,0.7697534558038266,1.0,12/37,26.72%,ASIC2;SCN1A;GRIK5;GRIK2;SCN4B;HCN1;HCN3;PKD2L1;SCN9A;GRIK1;SCN8A;SCN2A
prerank,hexose transmembrane transporter activity (GO:0015149),0.5143717369840451,1.0985062640648897,0.38115330520393814,0.766277912833907,1.0,8/12,36.98%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.427158116260273,-1.0981730875551117,0.35714285714285715,0.6487992447790749,1.0,5/11,18.51%,SASH1;PPEF2;STK38;ROR2;TRAF6
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.37347334010269206,-1.0979211301512277,0.30991735537190085,0.6373790459762472,1.0,4/17,10.73%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.37347334010269206,-1.0979211301512277,0.30991735537190085,0.6373790459762472,1.0,4/17,10.73%,EPHA7;EPHA3;EPHA4;EPHB2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.39036842398506966,1.0969795012734687,0.33191489361702126,0.7672877078136117,1.0,25/75,25.33%,MDH1;LDHA;HSD17B6;RDH5;PHGDH;HSD17B13;GRHPR;SPR;HSD17B4;PRXL2B;DCXR;AKR1B10;HSD3B2;UGDH;PGD;CBR3;IMPDH1;AKR1A1;CBR1;HSD17B11;NSDHL;KCNAB1;IMPDH2;EHHADH;LDHB
prerank,calcium-release channel activity (GO:0015278),-0.38246048549310735,-1.0962859010346413,0.3212669683257919,0.6353837547339884,1.0,2/17,1.63%,ITPR1;ITPR2
prerank,cysteine-type peptidase activity (GO:0008234),0.3919803393119294,1.0947585342682953,0.3461950696677385,0.7704924360237725,1.0,19/73,21.24%,CTSB;CTSL;CTSZ;CTSS;LGMN;UCHL1;USP5;PDIA3;OTULIN;TINAGL1;USP29;CTSH;USP26;USP8;CTSC;SFRP1;CAPN3;ATG4D;USP13
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4494881287777955,-1.0927062277512058,0.32867132867132864,0.6374806478862708,1.0,5/10,15.69%,DSE;RPE;GLCE;GNE;RENBP
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.28307093156809804,-1.0924474631378829,0.3058823529411765,0.6321437766488537,1.0,15/60,9.11%,EGFR;EPHA7;ROR1;EPHA3;CRIM1;NRP1;NTRK3;EPHA4;EFEMP1;IGF2R;INSR;MET;FGFR2;NRP2;PDGFRB
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3333743549881224,-1.0924428117869966,0.32142857142857145,0.6264790728422696,1.0,3/24,5.95%,OSBPL8;PLA2G4A;SESTD1
prerank,double-stranded RNA binding (GO:0003725),0.39367792155217374,1.0921048821835009,0.3466522678185745,0.7751990889280062,1.0,17/70,19.35%,VIM;TUBA1B;HSP90AB1;TUBB4B;TFRC;MSN;HSPD1;CLTC;SLC3A2;EIF4A1;ACTN1;HNRNPU;MRPL44;AGO1;PRKRIP1;OAS3;EIF4H
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4545968385750813,1.0897943482879655,0.35344827586206895,0.778578335174423,1.0,8/24,18.57%,NME1;AK4;AK3;NME4;NME2;CMPK2;NME3;IP6K1
prerank,methylation-dependent protein binding (GO:0140034),-0.2764192166903215,-1.0892015800864143,0.25882352941176473,0.6289894972978485,1.0,22/57,23.60%,KDM7A;ZMYND11;TDRD3;CDYL;PYGO1;CHD1;MBTD1;TRIM24;MORC3;ZCWPW2;LRWD1;PHF8;ING2;FMR1;KAT8;L3MBTL2;MORC4;ZCWPW1;NCAPD3;RRP8;CBX8;ZMYND8
prerank,potassium ion leak channel activity (GO:0022841),-0.38313801031790257,-1.0867199990862333,0.30434782608695654,0.6296110420699866,1.0,2/15,2.21%,KCNK2;KCNK5
prerank,single-stranded DNA helicase activity (GO:0017116),0.4727202736807433,1.0846712297921248,0.3935064935064935,0.7908928477142301,1.0,11/19,35.02%,MCM5;RFC2;RFC4;PIF1;RAD51;MCM7;MCM2;DHX9;DNA2;CHTF18;RFC3
prerank,neuropeptide binding (GO:0042923),0.4735735195622862,1.0828840001177278,0.39276139410187666,0.7927050806771324,1.0,7/18,31.29%,SORL1;SSTR4;GPR149;SSTR2;NMUR2;OPRL1;GPR37
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.436077460818167,1.0813835718123654,0.36705882352941177,0.7936973077982553,1.0,8/29,13.31%,SLC1A4;SLC25A13;SLC26A4;SLC25A11;SLC1A1;SLC25A21;SLC25A22;SLC19A1
prerank,lysophospholipase activity (GO:0004622),0.4681141965101694,1.0805547770480468,0.37516005121638923,0.7927646162492317,1.0,10/20,28.06%,LYPLA2;ENPP2;PNPLA7;GDE1;GDPD1;ABHD16A;GDPD3;ABHD12;PLA2G6;MGLL
prerank,GTPase binding (GO:0051020),-0.23903365801236123,-1.0784330555835706,0.2,0.6441695983182842,1.0,35/195,8.22%,AKAP13;STRN3;AFDN;PLCE1;RAPGEF4;GOLGA4;LRRK2;RANBP2;EXOC4;RNF152;SPTBN1;SGSM2;BRAF;MAPKAP1;USP6NL;EPS8;FGD4;RAF1;ANKRD27;EXOC2;NOX1;DOCK7;UNC13B;NCKAP1;RAPGEF6;CDC42EP5;RADIL;RRAGB;RABGAP1;ANKFY1;AMBRA1;NUTF2;GGA2;TRIOBP;RNF41
prerank,metalloaminopeptidase activity (GO:0070006),-0.37355189502155783,-1.0772646147308371,0.34934497816593885,0.6415059169317047,1.0,3/16,5.90%,NPEPPS;XPNPEP3;ANPEP
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2599818453609345,-1.0757673982645837,0.18518518518518517,0.6392214285203879,1.0,26/83,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,death receptor binding (GO:0005123),-0.3821584653666827,-1.0754611460901158,0.3474576271186441,0.6344762996693645,1.0,4/15,15.41%,EDA;RIPK1;NGF;BDNF
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4007518237397124,1.072370473539127,0.3869900771775083,0.813780067272533,1.0,18/54,21.45%,HDAC11;HINT1;TGM2;AMDHD2;HDAC5;GLS2;GLS;ACY1;NAAA;PDF;MIER2;NIT1;HDAC9;FAAH;ASAH2;ACY3;SIRT2;SUDS3
prerank,Hsp90 protein binding (GO:0051879),0.4296223514070718,1.071099132482961,0.40718562874251496,0.8139585400593826,1.0,8/33,23.33%,RPS3;KDR;MAPT;UNC45B;PTGES3;AHSA1;STUB1;CYP2E1
prerank,phospholipase A2 activity (GO:0004623),0.4390253213766989,1.0706424287840837,0.39709443099273606,0.8118204848012037,1.0,4/26,10.56%,PRDX6;PLAAT3;PLA2G7;PLA2G4F
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.41391609349807923,-1.068676284081141,0.4072727272727273,0.6439704280586896,1.0,4/12,16.50%,LARP1;EIF4E3;CYFIP2;AGO2
prerank,peptide hormone receptor binding (GO:0051428),0.5130926588596347,1.062225332506758,0.41944444444444445,0.8339002168492436,1.0,4/11,27.71%,CCK;ADCYAP1;PTHLH;PSMC5
prerank,transcription coregulator binding (GO:0001221),-0.27997634876399924,-1.0614463022776808,0.32038834951456313,0.6557909203606841,1.0,18/50,14.95%,SMAD3;VGLL4;ZBTB16;PER2;THRB;USP11;PER3;EHMT1;LCOR;NEK6;TEAD2;ESR1;SMAD4;TERT;AR;RORA;EHMT2;EZH2
prerank,NADPH binding (GO:0070402),0.4916915306664912,1.0608900590256214,0.4257703081232493,0.8341176597036759,1.0,7/13,32.90%,GRHPR;QDPR;CBR3;KCNAB1;CRYZ;DHFR;MTRR
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5213797356867599,1.060009103225263,0.415041782729805,0.8330723493684881,1.0,4/10,22.23%,LAPTM5;DNAJB2;ANKRD13D;FAAP20
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.379387576532546,-1.0591252529986843,0.3389830508474576,0.6560548149171483,1.0,9/15,18.12%,KMT2C;KMT2A;ASH2L;KMT2D;WDR82;SETD4;PRDM9;SETD1B;SETD3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.41177070014066536,-1.057532080657195,0.36727272727272725,0.6543695889994406,1.0,5/11,14.79%,ITPR1;ITPR2;TRPC4;TRPC6;TRPC3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3486305045580398,1.0516598630302605,0.328,0.8547461962104923,1.0,98/431,19.27%,EEF1A1;HSPA8;TUBB;TUBA1A;TUBA1B;HSP90AA1;HSP90AB1;ATP5F1D;TUBB4B;NDUFA13;RHOB;HSPA5;AKT1;ATP5F1A;NME1;TGM2;PINK1;TUBAL3;RAN;PFKL;RHOC;ARF5;RAC1;TUBA4A;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;RHOG;ATP1A3;RAB14;EPB42;P2RX7;ADSS1;MAST1;ARL11;TUBB4A;TUBB2B;SYN2;SCG5;P2RY1;ARF6;RHOV;SARS2;AARS2;MYO1F;BCKDK;GNAI1;ARL4C;P2RX6;ARL4D;ATP1A1;ARL1;HRAS;SYN1;RHEBL1;HSPA1A;RHOA;CARS1;HNRNPU;CDC42BPA;RHOU;STK11;GTPBP10;RRAS;ARF1;ARL2;TSSK6;TSSK4;PRPS1L1;PRPS1;RAB26;RRAGC;ARF4;PEX6;ABCA2;EIF4A3;RRAGD;NUDT16;BRSK2;HSPA4L;RAC2;TUBB2A;MAP4K2;ERCC6;GLUD1;GUK1;OAS3;AGAP2;TSR1;ANXA6;VPS4A;MKNK1;PSMA6;RAB31
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.41315367470903763,1.0507988543637259,0.40841865756541523,0.8535023036224004,1.0,9/35,20.51%,H3-3A;PARK7;NPM1;DRAP1;PIH1D1;UBTF;AGO1;TBP;MYC
prerank,ribonuclease activity (GO:0004540),0.3919346000638379,1.0506953243160428,0.42244224422442245,0.8501464416701864,1.0,15/56,21.52%,ENDOG;RNASE1;ELAC2;ANG;RNASE4;RNASEH2A;RNASEK;EXOSC2;RNASEH1;SND1;AGO1;EXOSC9;RNASE7;TSNAX;EXOSC4
prerank,"DNA binding, bending (GO:0008301)",0.4788288606871633,1.0506752454810022,0.41611624834874505,0.8465171718849666,1.0,3/14,9.82%,TERF1;HMGB3;HMGB1
prerank,ADP binding (GO:0043531),0.4358051785681762,1.0503376768736952,0.4110576923076923,0.8438916065511626,1.0,5/25,7.19%,ATP5F1D;ATP5F1A;ABCG1;PGK1;MYO3A
prerank,myosin II binding (GO:0045159),0.5185669570852863,1.0486549040873385,0.4369747899159664,0.845194070628076,1.0,2/10,9.95%,GSN;STXBP5L
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3303267887491382,-1.0464673193762248,0.41379310344827586,0.6752102732391421,1.0,5/23,7.04%,PDE1A;PDE7B;PDE5A;PDE8B;PDE7A
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.40851115484174827,-1.0450780192691451,0.3702290076335878,0.6730414171586628,1.0,1/11,0.15%,ITPR1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3808530424470566,1.0448477033529509,0.4353591160220994,0.8526513664776607,1.0,8/56,6.27%,RACK1;NRG3;NRG1;GRB14;LRP4;DUSP3;HYAL2;SHC3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.41290359533027154,1.0441221437793047,0.41973840665873957,0.8511078471636246,1.0,5/33,7.72%,RPS3;PARK7;TOLLIP;AUP1;FOXL2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4869945961525327,1.0428008865229368,0.4359673024523161,0.8514536112443754,1.0,5/12,27.51%,NDUFS7;DCXR;CBR1;NQO2;CRYZ
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3712733544363517,-1.0420085842974758,0.3588709677419355,0.6748656192507062,1.0,2/15,5.95%,PLA2G4A;SESTD1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.28681575522180236,-1.041339727009222,0.36363636363636365,0.6714030070686836,1.0,8/35,10.70%,FER;ABL1;YES1;DYRK1A;FRK;CLK1;ABL2;PTK2
prerank,C-C chemokine binding (GO:0019957),0.4352141630893811,1.0400268519584075,0.44331210191082804,0.8556360343709828,1.0,5/22,18.30%,CCR5;ZFP36;CXCR4;CX3CR1;CCR2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.47789953834925003,1.0379334482726819,0.43912448700410395,0.8581598504996686,1.0,1/14,1.52%,CAPNS1
prerank,regulatory RNA binding (GO:0061980),-0.29142201677204865,-1.0374730996969193,0.3565217391304348,0.6754790393665852,1.0,13/38,21.34%,ZNF346;DICER1;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TARBP2;TUT4;AGO2;FMR1;AGO4;SOX2
prerank,actin binding (GO:0003779),0.3548346578016772,1.037004609793711,0.4070707070707071,0.8571685718388425,1.0,45/170,17.68%,TMSB4X;ALDOA;TMSB10;GSN;FXYD5;PRICKLE4;TPM2;MAP1A;MOBP;ANG;MRTFA;ADD2;PFN1;IQGAP2;CCR5;P4HB;CORO1A;VASH1;TLNRD1;FMN2;MAPT;COTL1;LCP1;SLC6A2;MICAL1;MYO1F;FHDC1;GC;ANLN;MSRB1;FLII;CXCR4;HNRNPU;CDK5R2;CCDC88A;CAP1;SPTBN4;TMOD1;DMTN;ADCY8;PFN2;RUSC1;SYNE1;KLHL1;SCIN
prerank,endonuclease activity (GO:0004519),0.3910004994572173,1.0363665044683998,0.43546576879910215,0.8554524912298224,1.0,6/49,14.03%,RPS3;ENDOG;ANG;RNASEK;APEX1;SND1
prerank,BMP binding (GO:0036122),0.5049854763381665,1.0363136222173035,0.44963503649635034,0.8520461056623778,1.0,1/11,2.02%,NBL1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.36735685249310157,-1.0361145146349384,0.3882783882783883,0.6730719756942726,1.0,2/15,2.19%,ALDH1A1;ALDH1A2
prerank,magnesium ion binding (GO:0000287),-0.2289392228267863,-1.033610405355579,0.36,0.6736177068223158,1.0,23/135,12.21%,EYA2;ABL1;STK3;LRRK2;SIK3;CLYBL;DHX36;SIK2;MARK1;NUDT5;IRAK3;FOXK2;SNRK;MAST2;CDC42BPB;SIK1;NEK6;TDG;ABL2;SRR;EPHX2;STK38;NLK
prerank,heme binding (GO:0020037),0.37398517242535445,1.033495030750047,0.4511930585683297,0.8567066604975564,1.0,17/65,25.20%,HMOX1;PGRMC1;NR1D1;ABCB6;CYBB;STEAP4;PGRMC2;SLC48A1;CAT;NOS2;CYCS;CYB5A;TBXAS1;CYP2E1;SUOX;SDHD;HEBP2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3794151505424067,-1.0326425305341604,0.3971119133574007,0.670584848210625,1.0,4/14,12.80%,MTMR3;MTMR11;PTEN;MTMR10
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.3826890682258072,-1.032540288743023,0.38434163701067614,0.6656592331248683,1.0,2/13,2.19%,ALDH1A1;ALDH1A2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3533646564798836,1.030944441478641,0.42959183673469387,0.8605286325719835,1.0,47/134,28.08%,SLC38A5;SLC17A8;LRRC8A;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;SLC25A13;SLC6A6;SLC26A4;MFSD2A;SLC15A4;SLCO4C1;SLC3A2;SLC17A7;SLC17A6;SLC1A1;SLC25A21;SLC25A22;GJA1;SLC19A1;SLC35A3;SLC16A1;SLC25A1;SLC2A2;MFSD10;SLC52A1;SLC19A2;SLC35A1;SLC25A18;SLC35B4;SLCO1B1;SLC25A23;MFSD12;SFXN1;SLC35B1;SLC6A8;SLC4A8;SLC38A3;SFXN5;ABCC5;SLC2A6;SLC6A9;SLC25A12;SLC16A7;SLC13A5;RTBDN
prerank,telomerase RNA binding (GO:0070034),-0.34066484488096016,-1.03040929235566,0.38571428571428573,0.6657614842601083,1.0,8/22,11.11%,SMG6;DHX36;TEP1;TENT4B;XRN1;PARN;SMG7;TERT
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5034452825322543,1.0295035886022343,0.4639321074964639,0.8611142484136027,1.0,3/10,15.91%,CYBA;CYBB;NCF1
prerank,protein heterodimerization activity (GO:0046982),0.3456207952982527,1.0285666208469826,0.4368048533872599,0.8603275973413014,1.0,59/178,24.88%,ATF4;CYBA;TPM2;HEXA;RAN;PDGFB;FZD9;TRMT112;EPAS1;LSM6;YWHAH;PPP2R1A;YWHAE;ABCG1;TENM2;TENM3;ADD2;CYBB;P4HB;ATP1B2;TUBB2B;MLXIPL;MLX;BHLHE41;AOC3;NPAS3;SUPT4H1;TENM4;BAX;ATP1A1;TLR6;SDCBP;ATP1B1;RRAGC;PDGFA;ADRA1A;RRAGD;ADCY8;SRI;ZHX1;GCA;ERBB3;TFAP2B;VAPA;GABBR2;MEF2C;BAK1;GADD45A;DDIT3;KATNA1;VAPB;LSM5;MTTP;USF2;RCC1;METTL3;BARD1;TCF3;BOK
prerank,chloride channel inhibitor activity (GO:0019869),-0.41803459192395176,-1.0268109668717191,0.4478114478114478,0.6690073701022102,1.0,3/10,12.72%,STX8;WNK4;STX1A
prerank,thioesterase binding (GO:0031996),0.4899018174803059,1.0266248519578314,0.4515669515669516,0.8624388712734492,1.0,3/11,15.00%,RAC1;ARF6;TRAF3
prerank,protein tyrosine kinase activity (GO:0004713),-0.23042365892952557,-1.026169752614352,0.36363636363636365,0.6657591689384406,1.0,23/108,10.73%,EGFR;EPHA7;FER;ABL1;ROR1;EPHA3;NTRK3;EPHA4;INSR;YES1;DYRK1A;TYK2;BAZ1B;MET;FGFR2;WEE1;FRK;PDGFRB;HIPK3;CLK1;ABL2;PTK2;EPHB2
prerank,omega peptidase activity (GO:0008242),-0.2452445154320025,-1.0240464889303404,0.43137254901960786,0.6657204067388416,1.0,26/89,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,Hsp70 protein binding (GO:0030544),0.4129282800005372,1.0238087806120562,0.4584795321637427,0.8669357423239856,1.0,11/31,26.06%,RPS3;DNAJA1;DNAJB2;SACS;DNAJB1;DNAJC10;SNCA;STUB1;CYP2E1;DNAJC8;IQCG
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.49483344578850286,1.02137764537056,0.4789687924016282,0.8702694300059078,1.0,2/11,6.56%,PPP1R14A;PPP1R14B
prerank,cytokine receptor activity (GO:0004896),0.3640301217479648,1.019854049373064,0.44842105263157894,0.8712808455687288,1.0,26/83,23.50%,CD74;IL2RB;CSF3R;EPOR;CCR5;IL2RG;IL3RA;GFRA1;MPL;CX3CR1;IFNGR1;CSF2RB;IL17RB;GFRA2;CCR2;IL20RA;FLT3;IFNGR2;CSF2RA;IL10RB;IL1RAP;CRLF1;CRLF2;PRLR;IL12RB1;IL21R
prerank,pyridoxal phosphate binding (GO:0030170),0.43599570923235903,1.0184304430454583,0.4728877679697352,0.8718834756833782,1.0,6/20,21.88%,AGXT;OAT;SDS;PNPO;SHMT2;PYGL
prerank,sialyltransferase activity (GO:0008373),-0.33310480670311693,-1.0176533534163492,0.39690721649484534,0.6751571031785625,1.0,8/20,19.97%,ST3GAL4;ST3GAL3;ST6GAL1;ST3GAL5;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,protein homodimerization activity (GO:0042803),0.3366950478988994,1.0166707202012801,0.435,0.8734740176525997,1.0,105/589,15.63%,APOE;PSAP;S100A6;RACK1;B2M;S100A1;TYROBP;HSP90AA1;HSPB1;HSP90AB1;HMOX1;PARK7;PGRMC1;S100A11;GSTM1;AKT1;TXN;S100B;TPI1;S100A10;TPM2;CRYAB;ERBB4;TERF1;NPM1;AGXT;S100A13;S100A16;RASIP1;PDGFB;FZD9;NTRK2;ANG;CHEK2;ENO1;CAV2;ATP5IF1;FLNA;ABCG1;HES1;TENM2;TENM3;ADD2;SPPL2B;TFRC;RDH5;SDS;CEBPB;BNIP3L;CORO1A;CEBPA;PLN;GRHPR;TRIM9;LPL;HSD17B4;MLXIPL;MLX;HSPB8;SARS1;KARS1;BHLHE41;SYT6;MFSD1;CSF1R;PECAM1;TENM4;PDCD6;GSTM2;MGAT2;KLHL7;BAX;BANF1;CEP131;WARS1;FLT4;KCNN2;CADM3;MAP3K21;ACTN1;ACOT7;SYNDIG1;ODC1;GNPTG;SLC11A1;CLN6;BST2;HPGDS;LILRB1;CRYM;RIPK2;RNF40;MTCL1;PNPO;CAT;CCDC88A;IKZF3;ABCB10;PRPS1L1;PRPS1;MFF;GDF15;DSCAML1;PDGFA;ACHE
prerank,sulfotransferase activity (GO:0008146),-0.29553650339001347,-1.015775819989274,0.4110429447852761,0.6749756544187061,1.0,6/33,10.27%,UST;HS3ST3A1;CHST15;HS2ST1;CHST11;TPST1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.40531032533588635,1.0154173798572608,0.47101449275362317,0.8737892447066756,1.0,9/29,21.94%,HYAL2;OVGP1;GUSB;GAA;MOGS;NEU1;HPSE;HPSE2;ENGASE
prerank,metalloexopeptidase activity (GO:0008235),0.384872034502498,1.0126292631514202,0.48226164079822614,0.8784041147486644,1.0,13/51,17.33%,METAP1;CPXM1;CPD;CPE;VASH1;AGBL4;METAP2;AEBP1;CPXM2;LAP3;RNPEPL1;NUDT16;MMP14
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.44309528093153705,1.0119874327765896,0.4579560155239327,0.8766857601558122,1.0,3/18,12.81%,HSD17B6;RDH5;HSD3B2
prerank,phospholipase activator activity (GO:0016004),-0.4046669033823239,-1.010603530095479,0.389937106918239,0.6817778078055517,1.0,2/10,4.69%,ARHGAP6;PDPK1
prerank,histone deacetylase binding (GO:0042826),0.3546037679443242,1.01030466776508,0.4896265560165975,0.8777901652664911,1.0,25/88,21.45%,HSP90AA1;HSP90AB1;YWHAB;SPI1;HSPA1B;YWHAE;HES1;CCND1;GMNN;PKN1;BHLHE41;NCOR2;HSPA1A;HDAC5;IKZF3;MIER2;HDAC9;CIR1;MTA2;ANKRA2;HIC1;MEF2C;TFAP4;SIRT2;SUDS3
prerank,tubulin binding (GO:0015631),0.33740584127291035,1.009309477479938,0.49147442326980945,0.8770379404929848,1.0,68/295,20.55%,RPS3;ALDOA;GABARAP;GAPDH;TPPP3;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;GABARAPL1;NEFH;DNM3;STMN3;SBDS;NEFM;NDRG1;NAV3;PAK1;ABRAXAS2;AGBL4;CLASP1;MAST1;MAPT;MAP2;STMN4;UNC5C;CDK5R1;KIF26B;KIF5A;ARHGEF7;REEP2;KIF26A;ARL4C;ATF5;FHDC1;DCTN1;GJA1;CLIP3;MTCL1;STMN1;TTLL7;VBP1;CCDC88A;KIF21B;CETN3;MAPRE3;CDK5;TBCA;FGF13;DNM1L;PDCD5;BRCA2;TOGARAM2;HOOK1;FAM83D;KIF5C;KIFC2;TTLL5;SNCA;DCX;VAPA;GIT1;MAP1B;RAE1
prerank,motor activity (GO:0003774),0.36851796983213503,1.0089991975623551,0.47186147186147187,0.8744376566996618,1.0,11/60,14.30%,MYL6;PIN1;DYNLRB1;KIF26B;KIF5A;KIF26A;MYL6B;DNAH2;DNAH1;DYNLRB2;KIF21B
prerank,double-stranded DNA binding (GO:0003690),-0.20656798727328854,-1.0,1.0,0.6779257444450509,1.0,76/531,11.44%,ZBTB20;PBX1;FOXP1;NFAT5;RBMS1;TEAD1;NFIB;EGFR;NR3C2;TCF4;PKNOX2;RARB;HOXB6;ABL1;KLF12;TCF12;ARNT;MBNL2;CUX1;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;ARNT2;ZMYND11;HOXB4;ELF1;ATF7;THRB;HOXA5;KLF3;TEF;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;NFATC4;TBX15;TFCP2;MEOX2;SP1;NR1D2;HOXB5;ELF2;HDGFL3;VSX1;MSH3;TOP1;RBBP8;ZNF638;ZBTB26;TDG;ATF2;FBH1;TEAD2;PPARG;ESR1;NR2C2;FOXK1;XPA;ZNF23;ERCC5;ZIC1;ATF6;ELF4;HOXA6;RAD51B;GMEB1;PRRX2;NFATC3;TERF2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.27059984574276147,-1.0,1.0,0.6779257444450509,1.0,164/731,16.37%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;ATF2;TEAD2;PPARG;SP4;KLF8;ESR1;TRIM24;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;CREB3L2;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;RORA;NFIC;SMAD2;ZFP62;TFCP2L1;PBX4;MLXIP;GMEB2;RUNX2;HEY2;STAT5A;ZBTB5;SOX13;IRF2;NFYB;ZSCAN12;ZBTB6;HOXA2;BATF;HINFP;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NR3C1
prerank,sequence-specific DNA binding (GO:0043565),-0.2358350807832646,-1.0,1.0,0.6779257444450509,1.0,121/590,16.37%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;FOXP2;TEAD1;NFIB;ZNF148;NR3C2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;PRDM5;ZNF423;KLF12;TCF12;ARNT;FOXD1;MBNL2;KDM2A;CUX1;SMG6;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;ARNT2;HOXB4;ELF1;NR2F2;ATF7;HDAC4;THRB;HOXA5;KLF3;TET3;SMG1;KMT2A;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;NFATC4;TBX15;TFCP2;MEOX2;FBXL19;SP1;NR1D2;FOXK2;HOXB5;ELF2;VSX1;ZBTB38;MEF2A;ZBTB26;UPF2;ATF2;TEAD2;PPARG;SP4;ESR1;NR2C2;FOXK1;SMG7;XPA;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;TERT;HOXA6;GMEB1;PRRX2;NFATC3;TERF2;RBPJ;LRWD1;SLTM;BCL2;HIVEP1;CXXC5;SIX1;NR2F1;HSF2;TINF2;RORA;CBFB;NFIC;STN1;ZBTB21;TFCP2L1;ZNF276;PBX4;GMEB2;RUNX2;HEY2;FOXN2;PRDM9;SOX13;IRF2;HOXA2;BATF;MECP2;ESRRA;FOXO1;FOXL1;NR3C1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.24239287956947744,-1.0,1.0,0.6779257444450509,1.0,95/597,11.45%,ZBTB20;PBX1;FOXP1;NFAT5;SMAD3;TEAD1;NFIB;BNC2;NR3C2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;SMAD6;PRDM5;KLF12;TCF12;ARNT;SOX5;MBNL2;GABPB2;CUX1;BBX;GLI3;HLF;NR6A1;ZIC4;GLI2;DHX36;ARNT2;HOXB4;ELF1;ATF7;HDAC4;PER2;NFYC;THRB;HOXA5;MLH3;YAP1;PER3;KLF3;TEF;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;KDM5B;KAT7;NFATC4;NCOR1;TBX15;TFCP2;TBL1X;MEOX2;SP1;NFKB1;NR1D2;BCOR;FOXK2;HOXB5;ARID4B;ELF2;STAT3;VSX1;ARID5B;ASH2L;ZBTB26;ATF2;TBL1XR1;TEAD2;PPARG;CENPC;ESR1;NR2C2;FOXK1;XPA;ZNF23;SMAD4;ZIC1;ATF6;ELF4;HOXA6;CREB3L2;GMEB1;HNRNPL;BRD7;PRRX2;MZF1;NFATC3;KMT2D
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.27269797398808937,-1.0,1.0,0.6779257444450509,1.0,164/732,16.37%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;FOXN3;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;PRDM15;ZBTB26;EBF1;MYBL1;ATF2;TEAD2;PPARG;SP4;KLF8;ESR1;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;RORA;NFIC;SMAD2;ZFP62;TFCP2L1;PBX4;MLXIP;GMEB2;RUNX2;HEY2;FOXN2;STAT5A;ZBTB5;SOX13;IRF2;NFYB;ZSCAN12;ZBTB6;HOXA2;BATF;HINFP;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NR3C1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.24454235015322223,-1.0,1.0,0.6779257444450509,1.0,146/831,13.20%,ZBTB20;PBX1;NFIA;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;GLIS3;HIVEP2;ZNF148;NR3C2;DNMT3A;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;PRDM5;ZNF423;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;SOX5;FOXD1;PBX3;NRIP1;STAT5B;MXI1;CUX1;BBX;GLI3;HLF;ZBTB16;NR6A1;ZIC4;HOXA3;GLI2;DHX36;CCAR1;ARNT2;MGA;SKI;HOXB4;ELF1;NR2F2;ATF7;HDAC4;NFYC;THRB;CHD2;NFXL1;HOXA5;HIVEP3;ZKSCAN2;KLF3;THRAP3;NRF1;TEF;PPARA;NFIX;HOXC4;CREB5;ZFP90;RARG;NFATC1;FOXO3;NFATC4;ZNF182;SMAD9;TBX15;TFCP2;FOXP4;MEOX2;SP1;NFKB1;NR1D2;FOXK2;HOXB5;ZSCAN26;STAT3;HIF3A;SMAD1;ZIC2;ZFHX3;ZBTB38;KCNIP3;ZFP30;TOP1;ZBTB1;MYNN;ZFHX4;EBF4;MEF2A;STAT2;RBAK;PRDM15;ZBTB26;EBF1;TFDP1;NFX1;MYBL1;ATF2;TEAD2;PPARG;CREBRF;ETV6;SP4;KLF8;ESR1;NR2C2;FOXK1;HOXC6;ZNF23;SMAD4;ZKSCAN3;ZIC1;ATF6;ELF4;HOXA6;GMEB1;PRRX2;MZF1;NFATC3;RBPJ;ZBTB34;AR;HOXC5;HIVEP1;IKZF2;ZBTB8A;ZNF8;RREB1;MKX;SIX1;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7
prerank,tRNA binding (GO:0000049),0.37925693329321497,0.995798331831643,0.4910112359550562,0.9076272656491003,1.0,13/43,24.96%,EEF1A1;SARS1;SARS2;KARS1;AARS2;CARS1;CTU1;SEPSECS;RPUSD4;YARS2;TRNT1;TRMT10C;EIF2A
prerank,PDZ domain binding (GO:0030165),-0.25455197183432876,-0.9943942660002651,0.4,0.686057577920533,1.0,13/61,11.47%,ARHGAP29;TGFBR3;CRIM1;RAPGEF2;PRKN;PLEKHA2;SLC22A4;GNG12;DLG4;PTEN;SRR;PSEN1;KIDINS220
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.426861462982698,0.9942582226759101,0.4881889763779528,0.9082798824178904,1.0,3/18,4.83%,PPP1CA;S100A11;TRIM29
prerank,lipase activity (GO:0016298),0.3836190097392624,0.993084588426684,0.5028312570781427,0.907985316889076,1.0,14/43,31.89%,PNPLA2;LIPG;LIPE;LPL;PLBD2;FAAH;ABHD16A;ABHD12;MGLL;PLBD1;PNPLA8;PITPNM3;CEL;LIPA
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3777827294984649,-0.9928327716740306,0.4580152671755725,0.6849775982354889,1.0,6/12,14.45%,BRD4;CDK12;CDK6;CCNK;CDK13;CDK7
prerank,chemokine binding (GO:0019956),0.39763340791359,0.9927791671353842,0.5030450669914738,0.9053675919154804,1.0,10/30,31.16%,CCR5;HMGB1;ZFP36;CXCR4;CX3CR1;CCR2;ACKR1;ITGB1;PLP2;ACKR3
prerank,protein kinase C activity (GO:0004697),-0.36063920974580344,-0.9922253557355848,0.4356060606060606,0.6817710851695794,1.0,6/14,15.34%,PRKCE;SMG1;PRKD3;PRKD1;PRKCI;PRKCB
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3188695371963282,-0.9894854615313405,0.46464646464646464,0.6833991269598488,1.0,2/21,3.48%,FGF1;FRS2
prerank,protein phosphatase 2A binding (GO:0051721),-0.31699693622093583,-0.9879433098826266,0.41232227488151657,0.6821659332884035,1.0,10/23,18.21%,STRN3;ANKLE2;STRN;ENSA;SMG7;BOD1L1;SPHK1;FOXO1;TP53;CTTNBP2NL
prerank,nuclease activity (GO:0004518),0.3689228444941049,0.9875587177784896,0.5105672969966629,0.9158240883371113,1.0,10/52,14.03%,NME1;ENDOG;RNASE1;ANG;RNASE4;RNASEH2A;RNASEH1;APEX1;PDE12;SND1
prerank,gamma-tubulin binding (GO:0043015),0.42463214045155534,0.9847746263415591,0.5089514066496164,0.9197771843465875,1.0,10/21,32.13%,NDRG1;PAK1;ARHGEF7;BRCA2;GIT1;BLOC1S2;B9D2;DIXDC1;TUBGCP2;DDX3X
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.41344471470569666,0.9839148565196225,0.5177664974619289,0.9185794168628342,1.0,10/22,23.63%,ZFP36L1;MEX3D;ZFP36L2;HNRNPA0;ZFP36;ELAVL4;ELAVL3;EXOSC9;EXOSC4;ELAVL1
prerank,endopeptidase activity (GO:0004175),0.3281610605156495,0.9830712207046065,0.543,0.9174891631929246,1.0,57/257,20.34%,CTSB;CTSL;PSMB4;CTSZ;CTSS;LGMN;PSMB6;PSMB8;CD5L;RCE1;UCHL1;ADAMTS4;OMA1;MMP21;F9;PSMA7;USP5;PDIA3;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PSMB9;PMPCB;MMP3;PSMB3;PLAT;USP29;PSMB11;PSMB10;CTSH;ADAMTS16;SPG7;USP26;GZMM;HPR;HP;PSMB1;MMP27;PSMB5;NAPSA;BACE1;USP8;PLAU;PSEN2;F10;MMP14;ADAM17;ADAMTS1;CTSC;PRSS12;PSMA6;HGF;ADAMTS20;SFRP1;PSMA4
prerank,hormone receptor binding (GO:0051427),0.45256441610631776,0.9805903321867873,0.5195154777927322,0.9207110180218097,1.0,3/14,17.29%,NPPC;CCK;ADCYAP1
prerank,pre-mRNA binding (GO:0036002),-0.3032689072890545,-0.9800413577112218,0.4662576687116564,0.6964264383572862,1.0,9/28,17.70%,CELF2;RBM41;ZRSR2;TRA2B;RBM4;HNRNPL;TARBP2;SLU7;CELF1
prerank,protein phosphatase regulator activity (GO:0019888),0.3661492931343055,0.9782702305629084,0.521311475409836,0.9232970982481326,1.0,7/53,5.11%,CALM1;RCAN3;CALM3;PPP1R15B;LGALS3;PPP1R1B;PPP2R1A
prerank,glutamate receptor binding (GO:0035254),0.4328072947356234,0.9779954542718083,0.5117801047120419,0.9205932414378021,1.0,8/17,31.96%,HOMER2;SHISA7;SYNDIG1;SQSTM1;SHISA6;HOMER1;SHANK1;HOMER3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.3967686012315681,0.9771153252371909,0.527511961722488,0.9195617829357139,1.0,11/31,20.00%,SLC12A5;AQP1;KCNA2;KCNK9;ABCC8;KCNF1;HCN1;KCNK3;KCNA1;KCNK10;TMEM38B
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4065873116755973,-0.9751930673494545,0.5,0.7026193272086759,1.0,1/10,1.69%,ANO6
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.42336131468002225,0.9741444297387063,0.517555266579974,0.9239846862648076,1.0,2/18,3.05%,MT3;PRDX5
prerank,glucose transmembrane transporter activity (GO:0005355),0.4270736107720581,0.9696150588018375,0.5403973509933775,0.9325808138758818,1.0,8/17,36.98%,SLC2A1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,dynactin binding (GO:0034452),-0.3678990242694813,-0.969055193013869,0.44964028776978415,0.7117801686194483,1.0,2/12,2.43%,SNX6;PAFAH1B1
prerank,channel activity (GO:0015267),0.37186510644565984,0.9660105933053611,0.5254813137032842,0.938449084081767,1.0,8/41,22.81%,AQP4;AQP1;P2RX6;BAX;SLC14A1;KCNK3;MPV17;PANX2
prerank,damaged DNA binding (GO:0003684),0.3669333239083459,0.9640827466894811,0.5471264367816092,0.9400653914098548,1.0,13/44,26.73%,RPS3;RPA2;HMGB1;DDB1;APEX1;PCNA;DCLRE1C;ERCC1;POLD1;PNKP;RPA3;XPC;ERCC2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.34942054447974663,0.9633979780261198,0.5479744136460555,0.9383979628742696,1.0,12/73,16.98%,GPR37L1;SCTR;APLNR;SORCS1;RXFP1;VIPR1;MC1R;SORCS3;GRPR;CX3CR1;CCKBR;HCRTR1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4445929200853175,0.9633959721052895,0.5133333333333333,0.9349886677160995,1.0,3/14,13.83%,ELAC2;POP7;POP4
prerank,mechanosensitive ion channel activity (GO:0008381),-0.375372825340265,-0.9607239557040513,0.4966442953020134,0.7267365415680529,1.0,7/12,29.46%,PIEZO2;PIEZO1;TMC6;TMC7;TMC3;TMC4;TMC8
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4015141969419188,0.9597686561641686,0.5430303030303031,0.940885165604718,1.0,5/26,9.53%,LGALS3;PPP1R1B;PPP1R14A;PPP1R14B;SET
prerank,serine-type endopeptidase activity (GO:0004252),0.34104187223589066,0.9566977852301582,0.5858050847457628,0.9450129551822465,1.0,16/80,19.67%,CD5L;F9;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PLAT;CTSH;GZMM;HPR;HP;PLAU;F10;PRSS12;HGF
prerank,miRNA binding (GO:0035198),-0.28637426721555653,-0.9548630205598712,0.5098039215686274,0.7359935216901032,1.0,11/30,21.34%,ZNF346;ZC3H7A;TUT7;RBM4;ZC3H7B;PUM2;TUT4;AGO2;FMR1;AGO4;SOX2
prerank,voltage-gated sodium channel activity (GO:0005248),0.40511987883249245,0.9525746557957285,0.5436156763590392,0.951863534363919,1.0,8/22,29.41%,SCN1A;SCN4B;HCN1;HCN3;SCN9A;SCN8A;SCN2A;SCN1B
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.230311416025808,-0.9506003821934194,0.6458333333333334,0.7415175945603522,1.0,18/91,10.91%,PARD3;SVIL;FCHO2;SLC9A1;ACTN2;FRMPD4;MAPKAP1;MYO1B;PLEKHA4;ADAP2;MARK1;SESTD1;GBF1;HIP1;PICALM;KIF16B;KRIT1;TULP3
prerank,sequence-specific mRNA binding (GO:1990825),0.46596533905894,0.9449944768585554,0.5507649513212796,0.9675204409272004,1.0,4/10,28.38%,SHFL;ETF1;DHFR;DHX9
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4248581430142292,0.9428348334883784,0.5384615384615384,0.9692270141599292,1.0,2/14,6.68%,HSD17B6;RDH5
prerank,leucine zipper domain binding (GO:0043522),0.467712125943591,0.9411523294234099,0.5585331452750353,0.9696812172192343,1.0,4/10,21.15%,ATF4;MRTFA;NRL;DDIT3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.2986854860268554,-0.9379023277895637,0.5245098039215687,0.7661209734981925,1.0,6/23,10.18%,MAPKAP1;PLEKHA4;SESTD1;GBF1;HIP1;KIF16B
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.35196256359010814,-0.9349347930036623,0.5467625899280576,0.7679224753204169,1.0,7/12,23.22%,SULF1;ARSK;SULF2;ARSB;ARSI;ARSA;ARSJ
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.2458803723112578,-0.9348684543077674,0.6103896103896104,0.7632239556499826,1.0,4/55,1.63%,SLC24A3;ITPR1;MCU;ITPR2
prerank,CoA hydrolase activity (GO:0016289),0.4102194146252097,0.931008240951581,0.5676741130091985,0.991165118070857,1.0,4/16,16.69%,ACAA2;ACOT1;ACOT7;ACOT4
prerank,aspartic-type endopeptidase activity (GO:0004190),0.43613903959876266,0.9246981673151448,0.5784172661870504,1.0,1.0,5/12,22.15%,SPPL2B;NAPSA;BACE1;SPPL2A;CTSE
prerank,palmitoyltransferase activity (GO:0016409),0.3760397742251804,0.924666922188822,0.5831353919239906,0.9991951057162567,1.0,10/28,29.53%,GLUL;YKT6;ZDHHC5;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2732563927665163,-0.9240779859276465,0.6195652173913043,0.7828292455164587,1.0,4/27,7.42%,SLC9A1;SLC9A2;SLC9B2;SLC8B1
prerank,myosin V binding (GO:0031489),0.4265527573688116,0.9233629406791215,0.5812743823146944,0.9988525326374451,1.0,6/15,22.12%,RAB14;RAB3C;RAB3D;RAB39B;RAB6B;RAB27B
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.42250346978375464,0.9230717888681901,0.5775401069518716,0.9960517254558525,1.0,8/14,32.09%,PYCR2;QDPR;CRYM;ALDH4A1;NOXRED1;BLVRB;DHFR;ALDH1L1
prerank,C-C chemokine receptor activity (GO:0016493),0.3898568205646275,0.9207299138183942,0.5882352941176471,0.9980572250281655,1.0,4/21,18.30%,CCR5;CXCR4;CX3CR1;CCR2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3555505000102043,0.9190983296682591,0.5956964892412231,0.9985756573595675,1.0,16/42,27.26%,CCNI;CCND2;CCND1;CDK5R1;CCNG1;CDK5R2;HEXIM1;CCNJL;CCNA2;CDKN2B;CCNC;CCNQ;CCNG2;CCNH;CDKN1A;CNPPD1
prerank,single-stranded DNA binding (GO:0003697),0.3229202242299805,0.9172065420136396,0.6582809224318659,0.9994604254047208,1.0,37/93,29.78%,PCBP1;PARK7;POLR2D;MCM5;NUCKS1;RPA2;HSPD1;MAPT;HMGB1;POLR2G;DDX11;HNRNPU;HNRNPA1;SUB1;BRCA2;CTC1;WDR48;RAD23A;POU4F1;ERCC1;FAM111A;POLR2H;RADX;BLM;CDC45;LONP1;PCBP2;PURB;RPA3;XPC;RAD51;MCM7;MCM2;DHX9;WBP11;SMC6;POLR3C
prerank,signal sequence binding (GO:0005048),0.3581636800752209,0.9164009351675111,0.6214953271028038,0.9979472344736198,1.0,10/35,20.78%,PEX5L;AP2M1;KDELR1;SEC61A1;IPO4;CAT;TOMM20L;CABP1;BRAP;NFKBIA
prerank,O-methyltransferase activity (GO:0008171),0.44703994220197674,0.9156571406997476,0.5800865800865801,0.9962303789305961,1.0,3/10,21.77%,CMTR1;MEPCE;FTSJ3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.36288208227678975,-0.9151294436681033,0.5454545454545454,0.7991328397867853,1.0,3/11,9.86%,NAA40;NAA16;NAA15
prerank,androgen receptor binding (GO:0050681),0.37663259808846095,0.9140600848898243,0.61557478368356,0.9965346343196704,1.0,5/25,12.39%,CALR;PARK7;PKN1;ZBTB7A;SNW1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.31520713206055884,-0.9115427392508718,0.5757575757575758,0.8025949206787778,1.0,4/18,12.45%,ALDH1A1;ALDH1A2;FAR1;AKR1B1
prerank,beta-tubulin binding (GO:0048487),0.36472904375293624,0.9109112881600921,0.6002344665885111,1.0,1.0,7/31,17.19%,GABARAP;GABARAPL2;GABARAPL1;CDK5R1;TTLL7;FGF13;PDCD5
prerank,pseudouridine synthase activity (GO:0009982),0.42470996355481133,0.9054927402235553,0.6282225237449118,1.0,1.0,5/13,20.53%,TRUB2;PUSL1;DKC1;PUS7;RPUSD4
prerank,alpha-actinin binding (GO:0051393),-0.27700201823507525,-0.9054077277937542,0.6342857142857142,0.8109625162551692,1.0,7/24,16.87%,CACNA1C;PDLIM5;PDLIM4;PPARG;SYNPO2;CACNA1D;PDLIM2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.36121633995969826,0.9053966156967215,0.6220095693779905,1.0,1.0,5/34,7.70%,UBE2Z;UBE2G2;UBE2Q1;CDC34;UFC1
prerank,E-box binding (GO:0070888),-0.26104138910705676,-0.9053713270423008,0.6073619631901841,0.8060810805048793,1.0,2/34,0.90%,ZEB1;TCF4
prerank,adenylyltransferase activity (GO:0070566),-0.303575278641132,-0.9051832903729397,0.5566502463054187,0.8015895179901042,1.0,9/21,21.13%,ABL1;TENT4B;FLAD1;TUT1;OAS2;PAPOLB;TENT2;NMNAT2;NMNAT3
prerank,gated channel activity (GO:0022836),-0.3314383803839,-0.9044090547205523,0.579136690647482,0.7984953424860629,1.0,3/14,11.28%,PIEZO2;PIEZO1;TMC6
prerank,phosphatidylglycerol binding (GO:1901611),0.41810238316242176,0.9031645516969782,0.6049046321525886,1.0,1.0,2/13,12.26%,PLTP;NME4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.29645173829005966,-0.8998197343620914,0.6230366492146597,0.803934488910658,1.0,9/22,15.83%,OTUD7B;UIMC1;ZBTB1;RNF169;OPTN;TAB2;ZRANB1;PARP10;TAB3
prerank,cytokine receptor binding (GO:0005126),0.31626519423297555,0.8958705113313534,0.6747368421052632,1.0,1.0,22/83,23.31%,CXCL12;CCL19;FKBP1A;MIF;DDT;IL2;KITLG;IL11;TIMM50;SDCBP;TLR5;CD300LF;ADAM17;SYK;IL6;IL1RAP;CRLF1;PYCARD;CRLF2;ERAP1;PRLR;IL12RB1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.36052784360816864,0.8943662167380249,0.630937880633374,1.0,1.0,7/29,16.89%,HSPB1;INKA2;YWHAG;PRKAR1A;PRKAR1B;HEXIM1;PRKAR2B
prerank,deubiquitinase activity (GO:0101005),-0.20880514248447507,-0.8915526466072773,0.7962962962962963,0.81787424617306,1.0,26/88,18.73%,USP3;USP47;OTUD4;USP24;USP11;MINDY3;USP34;OTUD7B;USP50;MYSM1;USP49;USP40;USP16;USP36;USP4;OTUD3;USP28;ZRANB1;USP46;STAMBPL1;UCHL5;USP45;USP37;USP53;USP33;USP9X
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3141467609271573,-0.8911904953370445,0.6470588235294118,0.8138021118776468,1.0,6/17,18.61%,DPYD;PTGR2;BDH2;PECR;TM7SF2;PTGR1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.38874677120685697,0.8889756034502103,0.6146788990825688,1.0,1.0,6/17,26.51%,ACAA2;ACOT1;ACOT7;ACOT4;THEM4;PLA2G6
prerank,hydro-lyase activity (GO:0016836),0.34201089181861416,0.8868210075206401,0.6502857142857142,1.0,1.0,10/41,17.37%,PARK7;CA2;ENO1;HSD17B4;ALAD;CA4;FAHD2A;ENO3;NAXD;ECHS1
prerank,Wnt-activated receptor activity (GO:0042813),-0.31081542820231756,-0.8861728967875289,0.6349206349206349,0.8199134423403954,1.0,3/15,4.09%,ROR1;LRP5;FZD6
prerank,WW domain binding (GO:0050699),0.3671666489312079,0.8835146903497789,0.6540342298288508,1.0,1.0,9/26,28.92%,TCEAL9;DAZAP2;TCEAL7;TCEAL5;TCEAL8;KIF20B;TNK2;ENAH;WBP11
prerank,transcription coactivator binding (GO:0001223),0.3796012470613496,0.8828773219450614,0.6261437908496732,1.0,1.0,1/20,0.13%,RPL23
prerank,serine-type peptidase activity (GO:0008236),0.31075657985863026,0.8828444796848678,0.7226890756302521,1.0,1.0,18/96,19.67%,CD5L;F9;KLK8;KLK1;KLK6;PIK3IP1;PCSK2;PLAT;CTSH;GZMM;PRSS8;HPR;HP;KLK10;PLAU;F10;PRSS12;HGF
prerank,RNA stem-loop binding (GO:0035613),-0.3336462904443911,-0.8788851775409822,0.6165413533834586,0.8310446591539677,1.0,6/12,23.40%,MYH10;CPEB3;RC3H2;FMR1;METTL16;LARP6
prerank,solute:proton symporter activity (GO:0015295),0.3946562130180994,0.8762487045366709,0.6327608982826949,1.0,1.0,4/16,15.42%,SLC15A4;SLC33A1;MFSD3;SLC15A2
prerank,ATP binding (GO:0005524),0.2940795571123713,0.875333317254881,0.8108108108108109,1.0,1.0,77/266,26.66%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;ATP1A3;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;HSPA1A;CARS1;HNRNPU;CDC42BPA;STK11;TSSK6;TSSK4;PRPS1L1;PRPS1;PEX6;ABCA2;EIF4A3;BRSK2;HSPA4L;MAP4K2;ERCC6;GUK1;OAS3;AGAP2;VPS4A;MKNK1;TWF1;HSPA2;HSPA9;MTHFS;PYGL;BLM;YARS2;TWF2;LONP1;PMVK;TRNT1;ACLY;DYRK2;PNKP;LANCL2;HSPA14;PIF1;ABCG5;RAD51;PIM1;OXSR1;TRIB1;CDK11B;PEX1;GALK1
prerank,N-acyltransferase activity (GO:0016410),0.34811795213197083,0.875151633351637,0.6627497062279671,1.0,1.0,6/32,17.43%,TGM2;CERS2;PLAAT3;NAA10;GLYAT;NAT8L
prerank,calcium activated cation channel activity (GO:0005227),0.38248290898005594,0.8748205820440819,0.6350832266325224,1.0,1.0,7/17,26.88%,TMEM63B;TMEM63C;KCNN2;KCNMA1;PKD2L1;KCNN4;KCNMB4
prerank,methyl-CpG binding (GO:0008327),-0.2770730753609839,-0.8746931243286388,0.6105263157894737,0.8354995821634589,1.0,15/22,34.09%,TET3;ZBTB38;LRWD1;CXXC5;ZBTB21;MECP2;ZCWPW1;WDR77;CHTOP;CXXC4;ERH;LHX4;TET1;MBD2;UHRF1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2758680199440762,-0.8742241349174907,0.6443298969072165,0.8316358770872827,1.0,4/21,7.25%,ARFGEF1;AKAP7;AKAP9;ARFGEF2
prerank,mannosyltransferase activity (GO:0000030),-0.2868083205558423,-0.8727626400746649,0.6192893401015228,0.8299279048884277,1.0,10/21,24.38%,TMTC1;TMTC4;PIGM;DPY19L4;POMT1;DPM1;TMTC3;POMT2;ALG1;PIGB
prerank,cyclic nucleotide binding (GO:0030551),0.37241797484224015,0.8719570353857471,0.6469072164948454,1.0,1.0,9/21,24.93%,PDE4B;CNGA3;CNGA4;SLC19A1;HCN1;CNGB1;PDE11A;POPDC3;PDE2A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.42279316109957554,0.8713056965831883,0.6386666666666667,1.0,1.0,5/11,24.21%,NUDT3;NUDT4;NUDT16;NUDT10;NUDT11
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3640629138311616,0.8712951764545017,0.6419001218026796,1.0,1.0,8/24,28.67%,GLUL;YKT6;GOLGA7B;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,mRNA methyltransferase activity (GO:0008174),0.41636907569083237,0.870260826182412,0.6492637215528781,1.0,1.0,5/12,25.02%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3970419932019712,0.8694376872772099,0.6513513513513514,1.0,1.0,4/14,27.61%,KCNE4;KCNE5;KCNJ3;KCNQ1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.2512173433130517,-0.8665541538187669,0.7142857142857143,0.8382469142802157,1.0,3/37,3.82%,CACNA2D3;CACNA1C;CACHD1
prerank,receptor antagonist activity (GO:0048019),0.3804864341512405,0.8660068788266986,0.6509186351706037,1.0,1.0,2/17,6.62%,LRPAP1;WFIKKN2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3206005200060675,0.8659668117230745,0.6914414414414415,1.0,1.0,19/49,25.72%,PPP1CA;DUSP3;DUSP28;SMPD1;APEX1;SMPDL3A;GDPD1;ENPP6;PGP;PTPRO;DUSP23;DUSP12;DUSP15;SBF1;GDPD3;ACP2;PPP1CB;DUSP8;PGAM5
prerank,adenyl ribonucleotide binding (GO:0032559),0.28998474470635516,0.8653379096749648,0.84,1.0,1.0,85/291,26.66%,HSPA8;HSP90AA1;HSP90AB1;ATP5F1D;NDUFA13;HSPA5;AKT1;PDE4B;ATP5F1A;NME1;PINK1;PFKL;ACVRL1;HSPA1B;ABCB6;ABCG1;UHMK1;TAP2;PGK1;APRT;ATP1A3;MYO3A;EPB42;P2RX7;MAST1;SYN2;P2RY1;SARS2;AARS2;MYO1F;BCKDK;P2RX6;ATP1A1;SYN1;HSPA1A;SLC19A1;CARS1;HNRNPU;CDC42BPA;STK11;TSSK6;TSSK4;PRPS1L1;PRPS1;HCN1;PEX6;ABCA2;EIF4A3;BRSK2;HSPA4L;MAP4K2;ERCC6;GLUD1;GUK1;OAS3;AGAP2;VPS4A;MKNK1;TWF1;HSPA2;HSPA9;MTHFS;PYGL;BLM;YARS2;TWF2;LONP1;PMVK;TRNT1;ACLY;DYRK2;PNKP;POPDC3;LANCL2;PDE2A;HSPA14;PIF1;ABCG5;RAD51;PIM1;OXSR1;TRIB1;CDK11B;PEX1;GALK1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.40209245855363274,0.8625417203187551,0.6375358166189111,1.0,1.0,3/11,22.04%,LRRC8A;SLC19A1;SLC25A23
prerank,myosin binding (GO:0017022),0.3224620216649003,0.862351042976506,0.7016216216216217,1.0,1.0,21/55,27.19%,GSN;MOBP;RAB14;CORO1A;RAB3C;STXBP5L;RAB3D;HAP1;RHOA;CXCR4;RAB39B;TRIM32;RAB6B;PYCARD;RAB27B;USH2A;LLGL1;NCKIPSD;NKD2;MYOC;RAB8A
prerank,ribonuclease P RNA binding (GO:0033204),0.42869073919436773,0.8620706430972287,0.6619318181818182,1.0,1.0,2/10,13.83%,POP7;POP4
prerank,phosphoric diester hydrolase activity (GO:0008081),0.33743503555820764,0.8576631419149394,0.6933019976498237,1.0,1.0,11/35,20.27%,PLD3;PDIA3;ENPP2;SMPD1;APEX1;GDE1;SMPDL3A;GPCPD1;GDPD1;ENPP6;PDE11A
prerank,GDP binding (GO:0019003),0.3122141851199746,0.8573487207682137,0.7252747252747253,1.0,1.0,25/63,30.96%,RAN;RAB14;ARF6;GNAI1;HRAS;RHEBL1;NME2;RRAS;RRAGC;RRAGD;RAB5C;RAB18;RAB31;RAB4A;RALB;RERG;RAB27B;RAB28;RAB42;RAB8A;RAP1B;RAP2A;RAB9B;RIT2;RALA
prerank,protein phosphorylated amino acid binding (GO:0045309),0.327764524201398,0.8571540554664664,0.7008055235903338,1.0,1.0,12/42,22.39%,YWHAB;PIN1;YWHAE;PFN1;SHC3;HCK;FBXW7;VAV1;SYK;PTPN6;SHE;PTPN5
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.31525423728813556,-0.8538708129467315,0.6541353383458647,0.860573794289105,1.0,12/12,68.50%,GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;OPN3;GPR88;ELOVL4
prerank,ion gated channel activity (GO:0022839),0.35762489328044267,0.8525540657715304,0.6592317224287485,1.0,1.0,6/24,19.69%,TMEM63B;TTYH1;TMEM63C;TTYH3;ANO4;PKD2L1
prerank,voltage-gated ion channel activity (GO:0005244),0.3820618882863474,0.8517836007255165,0.6680327868852459,1.0,1.0,5/14,22.83%,KCND2;HVCN1;HCN1;VDAC2;CACNA1E
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4190728652805403,0.8488592563110148,0.6666666666666666,1.0,1.0,7/10,39.94%,SHISA7;SQSTM1;SHISA6;SHANK1;NSF;GNAS;IGSF11
prerank,pyrophosphatase activity (GO:0016462),0.3195771741264677,0.8481996067671645,0.7232635060639471,1.0,1.0,12/50,19.20%,BNIP2;ENTPD3;NUDT3;TRPM2;NUDT22;NUDT4;PPA1;NUDT16;PRUNE2;ATCAY;NUDT10;NUDT9
prerank,kinase activity (GO:0016301),0.2958170407454047,0.8474777914686756,0.7523029682702149,1.0,1.0,25/109,21.44%,CHKB;CKB;AKT1;RFK;PINK1;CKMT1A;PGK1;FN3KRP;DGKH;DGKI;CDK5R1;PIK3C2G;BCKDK;DOLK;CDK5;CCL3;PIK3CD;COASY;CERKL;IP6K1;MAPK15;NEK1;SPHK2;DGKK;DGKB
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.33691633665088605,-0.8462939359832747,0.6241379310344828,0.871196676501643,1.0,1/10,0.05%,PRKAG2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.37257288341102623,0.8447561583002988,0.6760204081632653,1.0,1.0,2/17,5.55%,PLTP;ABCG1
prerank,NAD binding (GO:0051287),-0.26204261190668154,-0.8433071958431436,0.7422680412371134,0.8721868910141688,1.0,8/26,16.50%,ALDH1A1;CRYL1;PARP9;BDH2;SIRT1;ME1;ZC3HAV1;NNT
prerank,microtubule binding (GO:0008017),0.28377771162259,0.8425829722211962,0.8402010050251256,1.0,1.0,57/222,25.38%,RPS3;GAPDH;PRNP;MAP1LC3B;TERF1;MAP1LC3A;MAP1A;GABARAPL2;S100A8;S100A9;NEFH;DNM3;SBDS;NEFM;NDRG1;NAV3;ABRAXAS2;CLASP1;MAST1;MAPT;MAP2;KIF26B;KIF5A;REEP2;KIF26A;FHDC1;DCTN1;CLIP3;MTCL1;CCDC88A;KIF21B;CETN3;MAPRE3;CDK5;FGF13;DNM1L;TOGARAM2;HOOK1;FAM83D;KIF5C;KIFC2;DCX;VAPA;MAP1B;RAE1;KATNA1;RCC2;SYBU;DNM1;SUN2;KIF1A;VAPB;SGIP1;KIF27;GAS2L3;MAPRE1;KIF20B
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3375328588726936,-0.8425365991892431,0.657439446366782,0.8688356503406208,1.0,2/10,6.12%,B4GALT1;B3GALT1
prerank,transforming growth factor beta binding (GO:0050431),0.34828937177404956,0.8423328811590154,0.6957605985037406,1.0,1.0,4/23,6.62%,LTBP4;ACVRL1;HYAL2;WFIKKN2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.31309330587666334,-0.8420839818595405,0.6872727272727273,0.8647760790136182,1.0,1/13,0.23%,BMP6
prerank,5'-nucleotidase activity (GO:0008253),-0.30704371726899304,-0.8416269931780741,0.6812749003984063,0.8608088165019735,1.0,5/13,19.86%,NT5DC1;NT5C2;NT5C1A;NT5M;ACP3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.25629158657685225,-0.8416029540144506,0.7740112994350282,0.8561012487240297,1.0,4/28,9.73%,EDA;BABAM2;TRAF5;RIPK1
prerank,cation channel activity (GO:0005261),0.29735214436347884,0.840065829711342,0.777315296566077,1.0,1.0,28/94,21.58%,SLC24A4;SLC24A2;GRIN1;TMCO1;TMEM63B;AQP1;TMEM63C;HVCN1;KCNA2;TRPM2;KCNK9;SEC61A1;ABCC8;TRPC1;KCNF1;HCN1;KCNK3;RYR2;KCNA1;ORAI1;KCNK10;UNC80;ANXA6;CALHM6;PKD2L1;TMEM38B;PKDREJ;PKD1L2
prerank,histone acetyltransferase binding (GO:0035035),0.3560552642335024,0.8379493007796368,0.6945876288659794,1.0,1.0,8/21,22.65%,EID1;EPAS1;EGR1;ZBTB7A;PCNA;CITED2;SIRT2;TRIM68
prerank,single-stranded RNA binding (GO:0003727),0.3163045617648783,0.8369775383158414,0.7267637178051511,1.0,1.0,12/43,23.05%,POLR2D;POLR2G;DDX11;L1TD1;HNRNPU;HNRNPA1;AGO1;CNBP;EIF4H;RBM7;HNRNPF;LONP1
prerank,hyaluronic acid binding (GO:0005540),0.4093688232840448,0.8354281018204979,0.6727019498607242,1.0,1.0,3/10,23.51%,HYAL2;LYVE1;C1QBP
prerank,vinculin binding (GO:0017166),-0.3221857151043479,-0.8351893429151006,0.705685618729097,0.8637872405979333,1.0,4/11,13.83%,SORBS3;PXN;UTRN;CTNNA1
prerank,alkali metal ion binding (GO:0031420),-0.3016439425491602,-0.8349760222411713,0.690566037735849,0.8594290400258487,1.0,3/13,8.98%,HDAC4;ATP1A2;TDG
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.39818535118687437,0.8309052567833208,0.6845070422535211,1.0,1.0,2/11,16.45%,DDAH1;DDAH2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.335018213545302,0.8295928264006005,0.7257281553398058,1.0,1.0,4/31,6.18%,UBE2Z;UBE2G2;UBE2Q1;CDC34
prerank,tropomyosin binding (GO:0005523),0.37151815390239673,0.8294120093888684,0.7236315086782377,1.0,1.0,1/16,0.66%,S100A6
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.32584411718976697,-0.8227188154356166,0.6844106463878327,0.8784296125516853,1.0,1/10,0.51%,CACNA1C
prerank,UDP-glycosyltransferase activity (GO:0008194),0.29594462743365796,0.8222071369811844,0.7545945945945945,1.0,1.0,18/70,24.70%,HEXB;HEXA;B4GALNT1;B4GALNT4;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;B3GNT3;RFNG;CSGALNACT2;CHSY3;B3GALT5;LFNG;B3GALT2;MGAT4B
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.34347925607753893,-0.8221836016972812,0.7263843648208469,0.8699052302285015,1.0,3/10,10.86%,DUSP16;DUSP10;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.34347925607753893,-0.8221836016972812,0.7263843648208469,0.8699052302285015,1.0,3/10,10.86%,DUSP16;DUSP10;DUSP7
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3671636200744217,0.822034099409206,0.6984334203655352,1.0,1.0,3/15,18.30%,CCR5;CX3CR1;CCR2
prerank,TBP-class protein binding (GO:0017025),0.3478008091201768,0.8206570704209318,0.7092882991556092,1.0,1.0,9/21,33.25%,DRAP1;THRA;PSMC1;HHEX;RUVBL2;TAF13;PSMC5;PSMC2;TAF11
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.21377056489326346,-0.82050497009654,0.810126582278481,0.8681110291618171,1.0,12/55,13.67%,SLC6A13;SLC7A2;SLC16A12;SLC38A9;SLC6A12;SLC16A9;SLC22A4;SLC38A6;SLC16A6;SLC16A13;SLC36A4;SLC38A11
prerank,frizzled binding (GO:0005109),-0.23581382455930572,-0.8203658744476781,0.8227848101265823,0.8637203988328896,1.0,12/34,21.54%,LRP6;WNT5B;WNT16;RNF43;DVL3;WNT11;WNT4;WNT9A;RYK;FZD7;ZNRF3;WNT2B
prerank,general transcription initiation factor binding (GO:0140296),0.3372571638971257,0.8179738117096537,0.7295373665480427,1.0,1.0,10/25,30.41%,DRAP1;THRA;TBP;PSMC1;RELA;HHEX;RUVBL2;TAF13;PSMC5;PSMC2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.23753140981908094,-0.8169202040665865,0.8095238095238095,0.865786865642102,1.0,8/34,13.81%,PAN3;CNOT1;PARN;ERI3;CNOT7;ERI2;DIS3L;ANGEL1
prerank,BMP receptor binding (GO:0070700),-0.3130934438082576,-0.8167887154633764,0.7192982456140351,0.8614816739658442,1.0,1/12,0.23%,BMP6
prerank,O-acyltransferase activity (GO:0008374),0.3205147460589449,0.816184496179766,0.7283372365339579,1.0,1.0,10/30,27.15%,PRDX6;MOGAT2;DGAT2L6;LRAT;SOAT2;DGAT1;LPCAT2;MOGAT1;MBOAT7;GPAM
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3024992989389687,-0.8131532562053478,0.68359375,0.8631577735524832,1.0,6/13,17.51%,ITGA5;PDGFRB;IL1R1;VEGFD;PDGFC;PDGFRA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.39868226161184195,0.812425255401353,0.7089337175792507,1.0,1.0,6/10,29.63%,CRMP1;OPLAH;DPYS;DPYSL2;DPYSL5;CAD
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.32756099470048067,0.8123549909475377,0.7399756986634265,1.0,1.0,11/28,28.98%,AKT1;SGK1;PAK3;MAPK10;MAP2K2;MAP2K7;PRKACA;TNK2;MAP3K9;RPS6KA1;AURKB
prerank,CARD domain binding (GO:0050700),-0.2944568794023428,-0.8117219392745764,0.7445255474452555,0.8611906639899769,1.0,2/14,5.60%,CARD16;CARD14
prerank,RNA polymerase binding (GO:0070063),0.35101793066960313,0.8091263644984573,0.7174770039421814,1.0,1.0,3/18,10.02%,PPIB;TAF10;ZFP36
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2563703868938712,-0.8056765665225312,0.7722222222222223,0.8664488403060794,1.0,6/25,15.86%,FER;ATXN2;EFEMP1;HIP1;SNX2;SNX1
prerank,ribosomal large subunit binding (GO:0043023),0.39263909179749085,0.8050401124047325,0.746031746031746,1.0,1.0,1/11,3.04%,NPM1
prerank,calcium:sodium antiporter activity (GO:0005432),0.3882821625838714,0.8045963479620659,0.7281831187410587,1.0,1.0,4/10,15.37%,SLC24A4;SLC24A2;SLC3A2;SLC8A1
prerank,syntaxin-1 binding (GO:0017075),0.33799852612079906,0.8039341655872453,0.7628205128205128,1.0,1.0,5/22,9.25%,SNAP25;SYT1;SYPL1;VAMP3;VAMP2
prerank,phosphotyrosine residue binding (GO:0001784),-0.2282431082787903,-0.8037924996794453,0.835820895522388,0.8653472490400174,1.0,7/37,10.19%,ABL1;IRS1;PTPN3;YES1;VAV2;BCAR3;ABL2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3163498254385833,0.8030825635646532,0.7346698113207547,1.0,1.0,9/33,19.53%,MAF1;ELOF1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2998359875833577,-0.8015875936726743,0.767175572519084,0.8643089987269771,1.0,7/13,23.90%,THUMPD3;TRMT5;FTSJ1;TRMT1L;TARBP1;TRMT1;TRMT10B
prerank,cAMP binding (GO:0030552),-0.32204320630770333,-0.8003525689852451,0.698051948051948,0.8618591588543927,1.0,3/11,9.52%,RAPGEF4;RAPGEF2;CNBD2
prerank,cardiolipin binding (GO:1901612),0.3931753396980371,0.7982630598830186,0.7274052478134111,1.0,1.0,3/10,27.02%,NME4;STOML2;PLEKHN1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3373188926617087,0.7963599149841417,0.7267002518891688,1.0,1.0,10/22,25.89%,DUSP3;DUSP2;DUSP23;PPM1F;DUSP12;DUSP1;DUSP15;SBF1;DUSP8;DUSP6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.37625395148194696,0.794482396893932,0.7333333333333333,1.0,1.0,2/12,5.48%,PDE4B;PDE3B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.38924087958956866,0.7939992367575779,0.7240398293029872,1.0,1.0,2/10,16.91%,PIK3C2G;PIK3CD
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.38837865459518955,0.7891331630992737,0.7266483516483516,1.0,1.0,1/10,5.31%,SIRPA
prerank,Notch binding (GO:0005112),0.3333645298931705,0.7888622513991659,0.7593307593307593,1.0,1.0,7/22,17.48%,KCTD10;DNER;SNW1;NCOR2;DLL1;JAG2;ADAM17
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3364175340594662,0.7883312334590209,0.7623762376237624,1.0,1.0,5/20,18.08%,DLG2;AK4;AK3;CMPK2;GUK1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.29510755371117364,0.7876025052204705,0.7955307262569833,1.0,1.0,16/49,25.42%,UBXN1;VCP;TNFAIP3;ABRAXAS2;OTUD7A;PRPF8;UBQLN2;SQSTM1;RAD23A;FAAP20;TNIP1;ZFAND2B;UBQLN4;ATRIP;MINDY1;PSMD4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2978903571195346,0.7870893481003151,0.8004459308807135,1.0,1.0,6/47,11.28%,SLC38A5;SLC7A5;SLC25A29;SLC6A6;SLC3A2;SLC7A14
prerank,solute:anion antiporter activity (GO:0140323),-0.2932263037244609,-0.7854155375643275,0.7732793522267206,0.8811993126324233,1.0,3/14,12.83%,SLC26A7;SLC7A11;SLC26A2
prerank,store-operated calcium channel activity (GO:0015279),0.38595445581151133,0.78442017772251,0.754874651810585,1.0,1.0,3/10,16.88%,TRPC7;TRPC1;ORAI1
prerank,lipid phosphatase activity (GO:0042577),-0.29045022745605104,-0.7840080496823696,0.8171641791044776,0.8787653956500463,1.0,7/14,22.11%,PLPP3;EPHX2;PLPP1;PLPP7;PLPP2;PLPPR1;PLPPR3
prerank,DNA secondary structure binding (GO:0000217),-0.2312753189226644,-0.7828167697754105,0.8395061728395061,0.8759995246145693,1.0,11/31,21.79%,ABL1;KMT2A;RBBP8;ERCC5;RAD51B;CLSPN;FANCM;YY1;WRN;XRCC3;XRCC2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2941931926397943,0.7825014186692468,0.7835990888382688,1.0,1.0,13/46,24.70%,HEXB;HEXA;PIGQ;MGAT2;B3GNT9;GCNT1;B3GNT3;RFNG;B3GALT5;MGAT1;LFNG;B3GALT2;MGAT4B
prerank,adrenergic receptor binding (GO:0031690),0.35018317162419454,0.7816999115463353,0.7665369649805448,1.0,1.0,5/16,23.51%,UCHL1;APLP1;ARRDC3;GRK2;C1QBP
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.37850740308361686,0.7814237239446474,0.7525035765379113,1.0,1.0,4/11,25.34%,AKR1B10;DHRS13;AKR1A1;RDH14
prerank,antiporter activity (GO:0015297),0.3283764877533403,0.7807636479250674,0.7518796992481203,1.0,1.0,6/20,23.83%,ATP1A3;SLC25A11;SLC35E1;SLC35A1;SLC25A14;SLC25A16
prerank,nuclear import signal receptor activity (GO:0061608),-0.26987899801242005,-0.7784446160593331,0.7863247863247863,0.8784306279619414,1.0,10/15,35.37%,KPNA4;KPNA2;TNPO2;KPNA3;KPNA6;HIKESHI;TNPO3;IPO5;KPNA7;IPO9
prerank,aminopeptidase activity (GO:0004177),0.32327173178096785,0.7776042992409511,0.7826617826617827,1.0,1.0,6/26,17.33%,METAP1;METAP2;LAP3;CTSH;RNPEPL1;MMP14
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3078005618107339,0.7770981017425753,0.7841981132075472,1.0,1.0,10/33,19.53%,ELOF1;DRAP1;RTRAF;SUPT4H1;HNRNPU;RECQL5;AGO1;CCAR2;TBP;ESRRB
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.37092263472777515,0.7765770678647347,0.75,1.0,1.0,4/12,16.80%,CADM4;CCDC88A;DAB2IP;CDH5
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.317855216457526,0.7735420330547778,0.7779097387173397,1.0,1.0,3/27,9.20%,LRRC8A;SLC26A4;SLC25A11
prerank,histone deacetylase activity (GO:0004407),0.3369343266235046,0.7727826338597237,0.7467532467532467,1.0,1.0,6/19,21.45%,HDAC11;HDAC5;MIER2;HDAC9;SIRT2;SUDS3
prerank,symporter activity (GO:0015293),0.3822133581807519,0.7722975504210695,0.7648766328011611,1.0,1.0,2/10,20.59%,MFSD2A;SLC46A2
prerank,phosphatase activity (GO:0016791),0.27425724019205694,0.7698420804192038,0.837953091684435,1.0,1.0,25/73,29.29%,PPP1CA;DUSP3;BPNT2;DUSP28;DUSP26;NUDT16;NT5C;PLPP6;PLPPR2;PGP;PTPRO;PTPMT1;DUSP23;DUSP12;DUSP15;SBF1;ACP2;PPP1CB;PLPPR4;DUSP8;PGAM5;ENOPH1;ACP5;PLPP4;ACP4
prerank,LRR domain binding (GO:0030275),0.3578132494192798,0.7696778614536142,0.7650200267022697,1.0,1.0,5/14,21.69%,ATF4;MRTFA;NRL;DDIT3;ZXDC
prerank,phosphatase binding (GO:0019902),0.27151430153154615,0.7694885785996438,0.8762886597938144,1.0,1.0,20/105,18.54%,RACK1;MAPK3;RCAN3;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;CD22;MTMR9;SYTL2;FLT4;TRAF3;BAD;SPTBN4;CDH5;SKAP1;CTSC;TERF2IP
prerank,insulin-like growth factor receptor binding (GO:0005159),0.36621680157138436,0.7693899809154225,0.7229080932784636,1.0,1.0,3/12,15.42%,YWHAH;YWHAG;IGF2
prerank,protein phosphatase binding (GO:0019903),0.26777973504416674,0.7673574602295952,0.8775720164609053,1.0,1.0,23/117,18.08%,RACK1;SOD1;HSP90B1;LGALS3;SIRPA;CTNNB1;VCP;RPA2;GRIN3A;MAPT;CD22;MTMR9;FLT4;LILRB1;TRAF3;BAD;ARPP19;DAB2IP;ADCY8;CDH5;SKAP1;PPP1R3D;PPP1R15A
prerank,vitamin D receptor binding (GO:0042809),-0.27750873476068555,-0.767322923633304,0.7669172932330827,0.889930694665101,1.0,2/14,4.37%,MED13;THRAP3
prerank,nuclear export signal receptor activity (GO:0005049),0.37155160227884587,0.7639073807356936,0.773224043715847,1.0,1.0,3/11,17.31%,RAN;XPO1;EIF4ENIF1
prerank,SH2 domain binding (GO:0042169),0.3072011190049806,0.7615571665916891,0.8091236494597839,1.0,1.0,7/31,17.00%,RACK1;LILRB1;CCDC88A;SH2B2;DLC1;SQSTM1;SKAP1
prerank,chemokine receptor activity (GO:0004950),0.3132373704381381,0.7578230943748941,0.7714285714285715,1.0,1.0,7/24,31.16%,CCR5;CXCR4;CX3CR1;CCR2;GPR17;GPR35;ACKR3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.30095136115314075,-0.7575124259236313,0.8127208480565371,0.8991588533352669,1.0,3/10,18.15%,NAA40;ATF2;KAT8
prerank,cGMP binding (GO:0030553),0.36454492958625273,0.7563551002965264,0.7918424753867792,1.0,1.0,5/11,24.93%,CNGA3;CNGA4;CNGB1;PDE11A;PDE2A
prerank,phospholipase C activity (GO:0004629),-0.238163840663456,-0.7503384680817583,0.8954248366013072,0.9044763390478718,1.0,4/25,7.49%,PLCE1;EDNRA;PLCL1;PLCD3
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2928045193860183,0.7454273251898555,0.8215527230590962,1.0,1.0,7/34,19.10%,CALM1;CALM3;CDK5R1;CDK5R2;IGF2;MAP2K2;CALM2
prerank,chloride transmembrane transporter activity (GO:0015108),0.3383871866219278,0.7443456027400643,0.7979669631512071,1.0,1.0,3/16,12.43%,SLC12A5;SLC26A4;SLC1A1
prerank,ribonuclease P activity (GO:0004526),0.3625144222556821,0.7441611955982053,0.7823033707865169,1.0,1.0,2/11,13.83%,POP7;POP4
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.29982219432940727,-0.7421248345141692,0.7676767676767676,0.9105859892363097,1.0,3/10,10.88%,ECHDC1;ECHDC3;AUH
prerank,four-way junction DNA binding (GO:0000400),-0.25962853583424483,-0.7395700549440822,0.8642533936651584,0.9093274389261127,1.0,7/17,21.79%,ABL1;RAD51B;FANCM;YY1;WRN;XRCC3;XRCC2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3473013790609127,0.7395573842015531,0.7823691460055097,1.0,1.0,6/12,37.81%,PIK3C2G;PIK3CD;PIK3R6;IPMK;PIK3C2B;PIK3CB
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.2750429673001822,0.739316738337727,0.8577680525164114,1.0,1.0,16/60,19.63%,ERBB4;ACVRL1;NTRK2;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;TIE1;EPHB1;FLT1;TYRO3;DDR2;ERBB3;FLT3
prerank,MAP kinase activity (GO:0004707),0.33777060416860577,0.7366273173770757,0.800524934383202,1.0,1.0,4/14,19.80%,MAPK3;MAPK10;MAPK11;MAPK15
prerank,phospholipid transfer activity (GO:0120014),0.3134112554448164,0.7364471488706759,0.8178294573643411,1.0,1.0,10/21,31.05%,PLTP;GLTP;PRELID1;MTTP;ABCA3;PRELID3B;CERT1;CPTP;C2CD2L;PRELID2
prerank,syntaxin binding (GO:0019905),0.2662983508598556,0.7320652891562457,0.8726673984632273,1.0,1.0,15/61,16.40%,SNAP25;CACNA1A;SYT1;SYPL1;SYT12;VAMP3;VAMP2;SYT6;STXBP5L;TMED9;VAMP8;SYP;SYT10;NAPA;SYT2
prerank,hexosyltransferase activity (GO:0016758),0.256379192855901,0.7309476837534168,0.9125,1.0,1.0,23/101,23.43%,HEXB;HEXA;TMTC2;B4GALNT1;PIGZ;B4GALNT4;B4GALT6;POGLUT3;B3GNT9;CHPF2;B3GAT3;CHPF;GCNT1;FUT9;B3GNT3;DPY19L1;RFNG;CSGALNACT2;CHSY3;B3GALT5;LFNG;B3GALT2;B4GALT3
prerank,DNA-binding transcription factor binding (GO:0140297),0.24795139382914305,0.7298923566449511,0.9457831325301205,1.0,1.0,25/189,13.79%,PTMA;HSPB1;CHCHD2;PARK7;ATF4;NPM1;BEX1;HCLS1;SPI1;TLE5;CTNNB1;HES1;HIPK2;HES6;DUSP26;JUN;HMGB1;BHLHE41;ZBTB49;TAF9;CTBP1;ZBTB7A;KLF4;YWHAZ;HDAC5
prerank,SH3 domain binding (GO:0017124),0.2610893261044762,0.7289761088964604,0.868675995694295,1.0,1.0,11/62,17.17%,GPX1;CYBA;ADAM15;ADAM12;ELMO1;MAPT;MICAL1;NCF1;DAB2IP;SKAP1;CRB3
prerank,GTPase inhibitor activity (GO:0005095),0.3370525271705301,0.7274596640373068,0.810368349249659,1.0,1.0,7/13,33.62%,IQGAP2;ARL2;CDC42SE1;RTKN;TNK2;GPS1;GPS2
prerank,ligand-gated calcium channel activity (GO:0099604),0.3218191896811228,0.7244722098877667,0.8382165605095542,1.0,1.0,5/19,18.26%,GRIN1;GRIN2A;TRPM2;RYR2;GRIN2B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.23088302136337593,-0.7218104839515307,0.8977272727272727,0.9268162394962349,1.0,3/23,7.49%,PLCE1;EDNRA;PLCD3
prerank,phosphatase inhibitor activity (GO:0019212),0.3115479584937416,0.7194326868055381,0.8090322580645162,1.0,1.0,6/20,23.14%,LGALS3;PPP1R1B;SET;ARPP19;ANP32E;PTN
prerank,alpha-tubulin binding (GO:0043014),-0.20885529728911242,-0.7193425522540542,0.927710843373494,0.9252544992134606,1.0,6/31,14.72%,EML4;SETD2;OFD1;INO80;WASHC1;TAOK1
prerank,inward rectifier potassium channel activity (GO:0005242),0.2948140758140349,0.7187302349009809,0.8474784747847478,1.0,1.0,5/24,24.67%,KCNJ10;KCNN2;ABCC8;KCNJ3;KCNJ6
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2429623331233915,0.713587305048982,0.9468405215646941,1.0,1.0,31/181,19.19%,ACTB;HSPB1;ATF4;NPM1;BEX1;HCLS1;SPI1;GABARAPL1;CTNNB1;HES1;HIPK2;HES6;DUSP26;PROX1;JUN;BHLHE41;DNAJA1;SNW1;NCOR2;KLF4;HDAC5;MIER2;DLL1;GATA4;TRIM32;PPARGC1A;COMMD7;MTA2;TBP;PSMA6;DDRGK1
prerank,intracellular chloride channel activity (GO:0061778),0.32256846245547216,0.71327853465382,0.8210947930574098,1.0,1.0,3/16,18.11%,TTYH1;TTYH3;ANO4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.32256846245547216,0.71327853465382,0.8210947930574098,1.0,1.0,3/16,18.11%,TTYH1;TTYH3;ANO4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2932916885703973,0.7095971132012274,0.842170160295931,1.0,1.0,6/24,19.12%,PNCK;CAMK1D;CAMK1;CAMKV;CAMKK1;MKNK1
prerank,anion transmembrane transporter activity (GO:0008509),0.3297838324967863,0.7095216848876257,0.841225626740947,1.0,1.0,5/12,28.61%,SLC19A1;MFSD10;SLC4A2;ABCC5;SLC26A11
prerank,metallopeptidase activity (GO:0008237),0.24920097030785507,0.7093037120365302,0.9411764705882353,1.0,1.0,22/113,18.07%,RCE1;COPS6;ADAM15;METAP1;ADAM23;ADAMTS4;ADAM12;OMA1;MMP21;METAP2;PMPCB;PRPF8;MMP3;LAP3;ADAMTS16;SPG7;MMP27;NUDT16;MMP14;ADAM18;ADAM17;ADAMTS1
prerank,DNA replication origin binding (GO:0003688),0.2988725085537797,0.708835896930351,0.8476903870162297,1.0,1.0,7/23,28.38%,MCM5;HSPD1;DDX11;CDC45;MCM7;MCM2;DHX9
prerank,nucleotidase activity (GO:0008252),0.3183971027138641,0.7033812955262183,0.8123359580052494,1.0,1.0,2/15,6.02%,NT5C3A;BPNT2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.34389996728884314,0.7026717175765488,0.8151862464183381,1.0,1.0,2/10,9.48%,SLCO1C1;SLCO4C1
prerank,NF-kappaB binding (GO:0051059),0.29326209503831246,0.7000316736431976,0.8590686274509803,1.0,1.0,6/24,27.39%,NPM1;COMMD7;PSMA6;NFKBIA;RELA;HIF1AN
prerank,dipeptidyl-peptidase activity (GO:0008239),0.343423796562482,0.6992750916111199,0.8202247191011236,1.0,1.0,2/10,7.87%,DPP10;DPP6
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.32091867553510567,0.6956078015866612,0.8500687757909215,1.0,1.0,5/14,28.67%,SDHB;ISCU;RSAD2;EXO5;CIAO3
prerank,diacylglycerol kinase activity (GO:0004143),0.3343188224134306,0.6953297409268832,0.8290013679890561,1.0,1.0,6/11,30.97%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.24603809053055337,-0.6928330990883496,0.875,0.94897709365636,1.0,2/14,4.66%,MINDY3;OTUD7B
prerank,filamin binding (GO:0031005),0.3345479719327427,0.6887608827644717,0.828080229226361,1.0,1.0,2/11,6.93%,RFLNB;CRMP1
prerank,3'-5' exonuclease activity (GO:0008408),0.26159514728195926,0.685444559712377,0.8983050847457628,1.0,1.0,15/45,26.94%,EXOSC2;APEX1;TOE1;PDE12;EXOSC9;USB1;POLG;EXOSC4;ISG20;ERI1;POLD1;PAN2;PNPT1;TRIR;RAD9A
prerank,glycerophospholipid flippase activity (GO:0140333),0.33208482174047715,0.6842866053250259,0.8561736770691994,1.0,1.0,2/11,10.95%,ATP8A2;ATP8A1
prerank,MAP kinase phosphatase activity (GO:0033549),0.32604707394346594,0.6802076039843862,0.8587570621468926,1.0,1.0,5/12,25.89%,DUSP3;DUSP2;DUSP1;DUSP8;DUSP6
prerank,microtubule motor activity (GO:0003777),0.25203038043122894,0.6792873234459759,0.9203056768558951,1.0,1.0,16/51,29.38%,DYNLRB1;KIF26B;KIF5A;KIF26A;DNAH2;DNAH1;DYNLRB2;KIF21B;KIF5C;KIFC2;KIF1A;KIF27;KIF20B;DNAH17;KIF6;KIF1B
prerank,voltage-gated anion channel activity (GO:0008308),-0.25014479916119653,-0.6791429973168652,0.8958333333333334,0.9573764662957867,1.0,1/15,1.69%,ANO6
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3099613552823315,0.6786955331040678,0.8696808510638298,1.0,1.0,6/15,25.66%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST1;HS6ST2
prerank,P-type ion transporter activity (GO:0015662),0.3229563393039603,0.678305605816712,0.875,1.0,1.0,5/12,29.22%,ATP2B1;ATP2A2;ATP2B4;ATP2B2;ATP2C1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.23700416878133723,-0.6721040869049713,0.9169960474308301,0.9589801961622235,1.0,2/15,12.01%,PI4KA;ATM
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3171639024100869,0.670800580188961,0.8660084626234132,1.0,1.0,1/11,6.94%,SLC25A29
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3181148274063912,0.6706015942631636,0.8603351955307262,1.0,1.0,4/11,26.77%,GATA2;TAF9;ZXDC;LEF1
prerank,transcription cis-regulatory region binding (GO:0000976),0.22221331949573217,0.6698621595995377,0.999,1.0,1.0,78/406,22.29%,RPS3;JUND;PARK7;ATF4;SOX18;ERBB4;NPM1;PRDX5;TNF;DRAP1;NR1D1;SPI1;EPAS1;ENO1;NKX2-2;TBX22;KLF17;FOXF2;CEBPB;ARID4A;FOXD3;SALL2;CREBZF;CEBPA;PROX1;BASP1;CREB3;MLX;EGR1;HOXD4;JUN;HMGB1;TAF9;PHOX2A;NPAS3;AEBP1;SOX17;ATF5;MSX1;DBP;THRA;KLF4;HOXD8;SOX9;ZBTB43;HDAC5;ATMIN;IKZF5;NONO;GATA4;GLIS2;TWIST1;RBBP5;AGO1;ZNF22;SOX11;TBP;SNCA;ZFP41;ZBTB14;ESRRB;TFAP2B;KLF11;CHD3;MEF2C;FOXA2;TFAP4;MYC;FOSL2;CDC5L;DDIT3;SOX10;FOXA1;DACH1;MEN1;REST;HOXB8;GRHL2
prerank,exoribonuclease activity (GO:0004532),0.31787989571996766,0.666454879742701,0.8756983240223464,1.0,1.0,3/12,21.52%,EXOSC2;EXOSC9;EXOSC4
prerank,DNA binding (GO:0003677),0.21908856112522604,0.662711873171573,1.0,1.0,1.0,148/694,24.62%,RPS3;RPS15;RPS27;RPL6;RPL7;PCBP1;CALR;CHCHD2;PARK7;ATF4;KLF2;POLR2D;TERF1;LYL1;ETS2;MBD3;DRAP1;SYCP2;ANG;EPAS1;JUNB;GTF3C6;MCM5;CENPB;HMGB3;HES1;NUCKS1;RPA2;HMGN1;TBX22;FOXF2;CEBPB;PQBP1;ARID4A;TRIM28;CENPX;FOXL2;HSPD1;CREBZF;CEBPA;APLP2;PROX1;NR2F6;CSRNP3;MAPT;YBX1;IKZF1;NUPR1;MLXIPL;MLX;EGR1;JUN;HMGB1;ZBTB49;DDB1;TAF9;H1-0;TARDBP;POLR2G;MYRF;APEX1;ATF5;BANF1;POU3F1;ZBTB7A;PCNA;DDX11;SOX8;MAEL;THAP11;SOX9;PAX3;NME2;FOXS1;HNRNPU;TSN;MAFA;IKZF3;HNRNPA1;IRF7;REPIN1;ZMYM3;NR1H2;SUB1;E2F4;GATA4;PCID2;BRCA2;PPARGC1A;DCLRE1C;ERCC6;CNBP;ZNF22;CTC1;NRL;TIGD4;IMPDH1;HIC1;ZBTB14;WDR48;NLRP3;ESRRB;TFAP2B;RAD23A;MLF1;CHD3;POU4F1;RNF11;FOXA2;TFAP4;MYC;ERCC1;FAM111A;TSNAX;CAMTA1;CDC5L;POLR2H;DDIT3;CEBPZ;CDK9;SOX10;FOXA1;POLG;PHF1;MEN1;IRF5;HLX;RADX;BLM;GRHL2;SOX1;CDC45;CSRNP1;SAFB;ERF;LONP1;MEIS2;POLD1;PCBP2;OSR2;PURB;PNKP;RELA;MAFB;USF2;APP;TCF7L1;TCF3
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.23383147055129977,-0.6626084593690503,0.9090909090909091,0.9623935503606706,1.0,16/16,76.65%,SLC22A4;SLC25A26;SLC25A42;SLC22A5;SLC22A1;SLC22A3;SLC25A17;SLC22A16;SLC44A4;SLC22A2;SLC18A3;SLC7A8;SLC29A4;SLC44A1;SLC44A2;SLC5A7
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.25700128209478557,-0.6591633169501891,0.906896551724138,0.9607241033088275,1.0,4/11,17.60%,SGMS2;PIGN;PIGO;PIGF
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.25416451517483635,-0.6591256196163682,0.9163763066202091,0.956208242699437,1.0,2/12,5.94%,BABAM2;TRAF5
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2790660350789585,0.6586585051941767,0.8854568854568855,1.0,1.0,1/20,1.82%,EIF3F
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.3133889057907351,0.6585153633160234,0.8836206896551724,1.0,1.0,4/12,22.03%,SDHB;ISCU;CIAPIN1;CISD1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.30793433389905694,0.6553580945790316,0.8932584269662921,1.0,1.0,4/12,23.30%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,RNA polymerase II complex binding (GO:0000993),0.2603795462011966,0.6533362002488425,0.9133574007220217,1.0,1.0,9/32,19.53%,ELOF1;RTRAF;SUPT4H1;PCIF1;HNRNPU;RECQL5;AGO1;CCAR2;ESRRB
prerank,calcium channel activity (GO:0005262),0.23346284334658007,0.6517239147499831,0.9602925809822361,1.0,1.0,24/84,25.26%,SLC24A4;SLC24A2;GRIN1;CACNA1A;TMCO1;TRPM2;TRPC7;SEC61A1;TRPC1;RYR2;CACNG8;ORAI1;NCS1;ANXA6;CACNG5;PKD2L1;PKDREJ;CACNB4;PKD1L2;CACNA1E;SLC24A5;CACNG2;CACNA2D1;CACNA1B
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.22723488213286772,-0.6428033473652799,0.9110169491525424,0.9638398958447174,1.0,1/15,3.64%,PLA2G4A
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.3154596358219449,0.6423440160928695,0.8954154727793696,1.0,1.0,2/10,19.29%,TNFAIP3;DESI2
prerank,neuropeptide receptor binding (GO:0071855),0.2910010030330883,0.6423318134014124,0.8890410958904109,1.0,1.0,5/14,31.80%,PPY;NTS;NPY;NMU;SHANK1
prerank,FMN binding (GO:0010181),0.303722524217384,0.6419788155118175,0.8877840909090909,1.0,1.0,2/11,17.56%,PNPO;NOS2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.23804126584880295,0.6402788061231421,0.945474372955289,1.0,1.0,20/60,26.67%,PPP1CA;CTDSP2;CTDNEP1;CTDSP1;PHLPP1;TIMM50;PDP2;PPP1R3D;PPM1J;PDP1;TAB1;PPP3CA;PPEF1;PPM1F;DUSP1;PPP3R1;CAMK2G;PPP1CB;PGAM5;MTMR6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.22816866623272203,-0.6378510325739012,0.9409282700421941,0.9626740622196515,1.0,10/15,38.53%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A11;SLC26A3;SLC26A5;SLC26A1;CFTR;SLC26A9
prerank,5'-3' exonuclease activity (GO:0008409),-0.23175519619629065,-0.6375109290934673,0.9272030651340997,0.95843104245012,1.0,8/14,36.44%,XRN1;EXOG;DXO;EXO1;DCLRE1A;CPSF3;DCP2;MRE11
prerank,exonuclease activity (GO:0004527),0.24143957349076503,0.6366147890677675,0.9486033519553073,1.0,1.0,12/46,26.94%,ENPP2;EXOSC2;APEX1;PDE12;DCLRE1C;EXOSC9;POLG;EXOSC4;ISG20;ERI1;TRIR;RAD9A
prerank,RNA cap binding (GO:0000339),0.28410816355891777,0.6347272731255633,0.8941018766756033,1.0,1.0,2/16,10.68%,EIF3D;EIF4A1
prerank,muscle alpha-actinin binding (GO:0051371),0.2853019413735056,0.6327172605523226,0.91015625,1.0,1.0,1/15,2.03%,PRICKLE4
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2309199683325013,0.6286191424910337,0.9577464788732394,1.0,1.0,11/51,23.83%,SLC7A5;SLCO1C1;MFSD2A;SLC25A11;SLCO4C1;SLC35E1;SLC35A1;SLCO1B1;SLC46A2;SLC25A14;SLC25A16
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2717355439364333,0.6286104199135478,0.9127686472819216,1.0,1.0,6/20,23.69%,MOGAT2;AGPAT5;DGAT1;LPCAT2;MOGAT1;AGPAT2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.23004590634344307,0.6249662736898154,0.9583333333333334,1.0,1.0,14/53,24.87%,ACADVL;CYB5R3;CYBB;STEAP4;MICAL1;PPOX;KDM1B;NOS2;CYB5R1;QSOX1;SDHA;ILVBL;ACOX3;NQO2
prerank,NADP binding (GO:0050661),0.24566813344107924,0.6245702760132562,0.950530035335689,1.0,1.0,8/32,18.50%,GRHPR;SPR;QDPR;CRYM;CAT;PGD;NOS2;CBR3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.2722236586757266,0.6165850035284469,0.9092071611253197,1.0,1.0,4/18,25.16%,CCKBR;AGAP2;SOCS3;PIK3R5
prerank,N-acetyltransferase activity (GO:0008080),-0.2034291491298374,-0.6157264180512955,0.9747474747474747,0.9674171333498772,1.0,3/19,12.67%,KAT2B;SMARCE1;ESCO1
prerank,microtubule plus-end binding (GO:0051010),0.2586817574523141,0.6110260346191062,0.926860025220681,1.0,1.0,4/20,15.68%,CLASP1;DCTN1;CLIP3;MAPRE3
prerank,sulfate transmembrane transporter activity (GO:0015116),0.2839961213025033,0.6102874783905285,0.9256844850065189,1.0,1.0,2/14,9.20%,SLC26A4;SLC25A11
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.29422736770038355,0.6089868912768434,0.9274965800273598,1.0,1.0,4/11,21.85%,PRPF19;RBX1;STUB1;AMFR
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.22006600919205213,0.6078823349894921,0.9669156883671292,1.0,1.0,14/74,21.44%,CHKB;RFK;PKM;NT5C3A;DGKH;DGKI;PIK3C2G;DOLK;PIK3CD;COASY;SPHK2;KHK;DGKK;DGKB
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.21941975055462326,0.6047493374020253,0.978494623655914,1.0,1.0,15/69,22.74%,CERS2;SCP2;PLAAT3;ZDHHC5;NAA10;MOGAT2;ELP3;GLYAT;DGAT2L6;SOAT2;PORCN;DGAT1;ZDHHC12;ZDHHC8;MOGAT1
prerank,ephrin receptor binding (GO:0046875),0.25587152303608307,0.6045000763902768,0.9401041666666666,1.0,1.0,10/21,33.35%,ANKS1B;EFNB1;EFNA1;PTPN1;CRK;EFNA2;EFNB3;ANKS1A;GRB2;FYN
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2952088502805132,0.6037899441149741,0.9275147928994083,1.0,1.0,4/10,30.84%,APEX1;DCLRE1C;POLD1;MGME1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.22597117569774688,0.597451398492228,0.9646017699115044,1.0,1.0,8/48,19.69%,ATP6V1F;SLC39A1;AQP1;TRPM2;TRPC1;UNC80;CALHM6;PKD2L1
prerank,N-methyltransferase activity (GO:0008170),0.25628103556802406,0.5959502966714619,0.9518377693282636,1.0,1.0,3/20,13.19%,ZCCHC4;PRMT1;METTL18
prerank,carboxy-lyase activity (GO:0016831),0.24845247210599683,0.5938553704148507,0.9449423815620999,1.0,1.0,8/23,35.76%,ODC1;UROD;GAD1;FAHD1;ACOD1;PISD;AZIN1;BCKDHA
prerank,RNA methyltransferase activity (GO:0008173),0.26049985417128135,0.5906464784918127,0.9356499356499357,1.0,1.0,6/19,26.11%,FBL;MEPCE;FTSJ3;METTL3;LCMT2;TYW3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.23257486656595425,0.584358895957309,0.9681227863046045,1.0,1.0,10/33,25.41%,EXOSC2;TOE1;PDE12;EXOSC9;USB1;EXOSC4;ISG20;ERI1;PAN2;PNPT1
prerank,telomeric DNA binding (GO:0042162),0.235631643891223,0.5838068195834059,0.9622195985832349,1.0,1.0,12/32,32.71%,TERF1;NCL;APEX1;CTC1;TERF2IP;BLM;PIF1;XRCC6;HNRNPA2B1;UPF1;HNRNPD;ACD
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.26791695053903564,0.5829607227029577,0.9477211796246648,1.0,1.0,4/15,23.69%,ABHD8;AGPAT5;LPCAT2;AGPAT2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.24741680860558782,0.5808980361682539,0.9625468164794008,1.0,1.0,7/21,26.46%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.24741680860558782,0.5808980361682539,0.9625468164794008,1.0,1.0,7/21,26.46%,CDK8;CDK19;CDKL4;CDK5;CDK9;CDK10;CDK11B
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.2226115720657183,-0.5806004650796373,0.9769230769230769,0.980317208492267,1.0,4/12,21.97%,NUDT5;ENTPD5;ENTPD7;SLC25A42
prerank,solute:sodium symporter activity (GO:0015370),-0.16654591550908843,-0.5741833383419428,0.9883040935672515,0.9784495241740616,1.0,1/27,1.99%,SLC4A10
prerank,nucleotide diphosphatase activity (GO:0004551),0.26162760955741987,0.5675229693651906,0.9475100942126514,1.0,1.0,5/14,24.21%,NUDT3;NUDT4;ENPP5;NUDT10;NUDT11
prerank,chloride channel regulator activity (GO:0017081),0.2611659293713071,0.5673883502994653,0.9555256064690026,1.0,1.0,2/14,11.89%,SGK1;VAMP8
prerank,growth factor receptor binding (GO:0070851),0.19809848193358867,0.5662658071181615,0.9916492693110647,1.0,1.0,21/95,25.44%,ERBB4;PDGFB;IL2;IL11;TIMM50;CCDC88A;SDCBP;TLR5;ARF4;PDGFA;CD300LF;ADAM17;KLB;IL6;IL1RAP;PYCARD;TGFA;ERAP1;IL12RB1;FGF22;TNK2
prerank,clathrin adaptor activity (GO:0035615),0.2612624315596509,0.5660971685778383,0.941101152368758,1.0,1.0,2/15,9.52%,AP2M1;AP2S1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.27986014649363095,0.5660627749716444,0.9364844903988183,1.0,1.0,4/10,31.87%,NAA10;NAA25;NAA30;NAA60
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2212552036910462,0.5647531701538245,0.9628339140534262,1.0,1.0,4/35,12.31%,ELAC2;NT5C3A;AARS2;MRPL58
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.26353123419309243,0.5627309877817757,0.9651324965132496,0.9989244159117824,1.0,2/13,16.91%,PIK3C2G;PIK3CD
prerank,MAP kinase kinase activity (GO:0004708),0.24943408358942015,0.5587780551350365,0.9517241379310345,0.9984140811370997,1.0,5/15,25.84%,PAK3;MAPK10;MAP2K2;MAP2K7;MAP3K9
prerank,3'-5' DNA helicase activity (GO:0043138),0.24676269115222754,0.5477065531421443,0.9443708609271523,1.0,1.0,6/16,28.38%,MCM5;RECQL5;BLM;MCM7;MCM2;DHX9
prerank,nuclear localization sequence binding (GO:0008139),0.234296812617714,0.5432743317311366,0.9727979274611399,1.0,1.0,6/18,28.34%,IPO4;CABP1;BRAP;NFKBIA;KPNB1;RANBP6
prerank,endoribonuclease activity (GO:0004521),0.2132523721480685,0.5337382352167402,0.9836257309941521,1.0,1.0,5/32,20.97%,ENDOG;RNASEK;SND1;AGO1;TSNAX
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.2447625748282095,0.5316202862022847,0.9625668449197861,0.9997510795681677,1.0,3/15,25.16%,CCKBR;SOCS3;PIK3R5
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.18849300349446152,-0.5153297819495787,0.9924242424242424,0.9906364885296984,1.0,4/13,21.01%,AGPAT4;GPAT3;ABHD5;PNPLA3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.25372574361001576,0.5134206970965701,0.9713876967095851,1.0,1.0,6/10,39.27%,HEXIM1;CDKN2B;CDKN1A;CDKN2D;HEXIM2;CDKN2C
prerank,death receptor activity (GO:0005035),0.2436918080649477,0.5101182373079534,0.9754689754689755,1.0,1.0,4/11,32.57%,TNFRSF1A;TNFRSF11A;TNFRSF1B;TNFRSF25
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.19672795698166623,0.5060418702298414,0.994232987312572,1.0,1.0,6/40,19.62%,FBL;ICMT;METTL18;MEPCE;DNMT3B;GAMT
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.21705804414945168,0.5052302563982926,0.9812967581047382,0.9984765172045093,1.0,8/21,31.55%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.21679194783011907,0.48821890299374354,0.9869791666666666,0.9998822800072357,1.0,3/16,27.44%,IDO2;BCO2;ADI1
prerank,protein phosphatase 1 binding (GO:0008157),0.20117325135749714,0.47395552107237526,0.9899749373433584,1.0,1.0,8/21,32.67%,LILRB1;PPP1R3D;PPP1R15A;KCNQ1;PPP1R9B;PPP1R11;PPP1R16B;PPP1R3E
prerank,methyltransferase activity (GO:0008168),0.176845549132023,0.4636100171161371,0.9954699886749717,0.9996191565687157,1.0,16/46,35.41%,EEF1AKMT2;PRMT1;MEPCE;DNMT3B;GAMT;FTSJ3;EEF1AKMT4;METTL3;EEF1AKMT3;COMTD1;LCMT1;DNMT1;NSUN2;NNMT;GCSH;PRMT5
prerank,cation:chloride symporter activity (GO:0015377),0.22495573063903296,0.447437456226349,0.9857142857142858,0.9994230612119676,1.0,1/10,7.90%,SLC12A5
prerank,steroid hydroxylase activity (GO:0008395),0.19360764957017773,0.4299268574298477,0.994750656167979,0.9988542634472053,1.0,5/16,30.69%,CH25H;CYP2E1;CYP2U1;CYP39A1;CYP46A1
prerank,DNA polymerase activity (GO:0034061),0.18191127339508836,0.4275351781679514,0.996309963099631,0.9969698969336926,1.0,8/22,31.55%,POLE4;POLD4;POLG;POLD1;POLE3;POLN;POLD3;POLK
